<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66904</article-id><article-id pub-id-type="doi">10.7554/eLife.66904</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Defects in translation-dependent quality control pathways lead to convergent molecular and neurodevelopmental pathology</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-225129"><name><surname>Terrey</surname><given-names>Markus</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7359-4810</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-207112"><name><surname>Adamson</surname><given-names>Scott I</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49657"><name><surname>Chuang</surname><given-names>Jeffrey H</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-20585"><name><surname>Ackerman</surname><given-names>Susan L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6740-593X</contrib-id><email>sackerman@ucsd.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Howard Hughes Medical Institute, Department of Cellular and Molecular Medicine, Section of Neurobiology, Division of Biological Sciences, University of California San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Graduate School of Biomedical Sciences and Engineering, University of Maine</institution><addr-line><named-content content-type="city">Orono</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>The Jackson Laboratory for Genomic Medicine</institution><addr-line><named-content content-type="city">Farmington</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Genetics and Genome Sciences, Institute for Systems Genomics, UConn Health</institution><addr-line><named-content content-type="city">Farmington</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Hatten</surname><given-names>Mary E</given-names></name><role>Reviewing Editor</role><aff><institution>The Rockefeller University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><role>Senior Editor</role><aff><institution>Texas Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>26</day><month>04</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e66904</elocation-id><history><date date-type="received" iso-8601-date="2021-01-26"><day>26</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-04-05"><day>05</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Terrey et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Terrey et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66904-v1.pdf"/><abstract><p>Translation-dependent quality control pathways such as no-go decay (NGD), non-stop decay (NSD), and nonsense-mediated decay (NMD) govern protein synthesis and proteostasis by resolving non-translating ribosomes and preventing the production of potentially toxic peptides derived from faulty and aberrant mRNAs. However, how translation is altered and the in vivo defects that arise in the absence of these pathways are poorly understood. Here, we show that the NGD/NSD factors <italic>Pelo</italic> and <italic>Hbs1l</italic> are critical in mice for cerebellar neurogenesis but expendable for survival of these neurons after development. Analysis of mutant mouse embryonic fibroblasts revealed translational pauses, alteration of signaling pathways, and translational reprogramming. Similar effects on signaling pathways, including mTOR activation, the translatome and mouse cerebellar development were observed upon deletion of the NMD factor <italic>Upf2</italic>. Our data reveal that these quality control pathways that function to mitigate errors at distinct steps in translation can evoke similar cellular responses.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cerebellum</kwd><kwd>neurogenesis</kwd><kwd>translation</kwd><kwd>ribosome</kwd><kwd>n-Tr20</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS094637</award-id><principal-award-recipient><name><surname>Ackerman</surname><given-names>Susan L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ackerman</surname><given-names>Susan L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Disruption of quality control pathways that function at distinct steps to mitigate errors in translation evoke similar cellular responses and pathologies.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Regulation of gene expression is essential for cell growth and development. Although epigenetic mechanisms and transcriptional regulation are initial steps in gene expression, translation and its regulation have emerged as major hubs to control the production of functional proteins. In fact, translation is intricately coordinated with the degradation of faulty mRNAs and their resulting peptide products to balance gene expression and proteostasis (<xref ref-type="bibr" rid="bib20">Collart and Weiss, 2020</xref>). Numerous studies have revealed that mRNA levels show limited correlation with protein levels, particularly when cells undergo dynamic transitions (<xref ref-type="bibr" rid="bib1">Abreua R de et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Kristensen et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib90">Maier et al., 2009</xref>). Indeed, post-transcriptional mechanisms, such as translation, play vital roles in rapidly altering gene expression and the signaling pathways that mediate cell identity and cell fate changes necessary for mammalian development (<xref ref-type="bibr" rid="bib5">Blair et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Blanco et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Fujii et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Gabut et al., 2020</xref>; <xref ref-type="bibr" rid="bib69">Kong and Lasko, 2012</xref>; <xref ref-type="bibr" rid="bib113">Rodrigues et al., 2020</xref>; <xref ref-type="bibr" rid="bib121">Signer et al., 2014</xref>; <xref ref-type="bibr" rid="bib129">Tahmasebi et al., 2019</xref>).</p><p>The process of translation is highly organized, and ribosomes need to accurately perform the steps of translation initiation, elongation and termination. However, multiple factors can perturb translation including secondary structures of mRNAs, amino acid limitations, tRNA deficiencies, rare codons, interactions of nascent peptides with the ribosome, chemically damaged mRNAs, and cleaved or aberrant mRNAs (<xref ref-type="bibr" rid="bib7">Brandman and Hegde, 2016</xref>; <xref ref-type="bibr" rid="bib10">Brule and Grayhack, 2017</xref>; <xref ref-type="bibr" rid="bib12">Buhr et al., 2016</xref>; <xref ref-type="bibr" rid="bib27">Drummond and Wilke, 2008</xref>; <xref ref-type="bibr" rid="bib47">Hu et al., 2009</xref>; <xref ref-type="bibr" rid="bib122">Simms et al., 2014</xref>; <xref ref-type="bibr" rid="bib126">Spencer et al., 2012</xref>; <xref ref-type="bibr" rid="bib132">Thommen et al., 2017</xref>; <xref ref-type="bibr" rid="bib141">Wolf and Grayhack, 2015</xref>; <xref ref-type="bibr" rid="bib147">Yu et al., 2015</xref>). In turn, these defects may trigger translation-dependent quality control pathways including non-stop decay (NSD), no-go decay (NGD), or nonsense-mediated mRNA decay (NMD) to release ribosomes, eliminate potentially toxic or faulty peptide products, and co-translationally decay problematic or aberrant mRNAs (<xref ref-type="bibr" rid="bib20">Collart and Weiss, 2020</xref>).</p><p>NSD rescues stalled ribosomes at the ends of truncated mRNAs that lack a stop codon and those in the 3’UTR of mRNAs that were not recycled at canonical stop codons (<xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib40">Guydosh and Green, 2014</xref>; <xref ref-type="bibr" rid="bib98">Mills et al., 2017</xref>; <xref ref-type="bibr" rid="bib146">Young et al., 2015</xref>). Resolution of these stalled elongation complexes is mediated by Dom34 (yeast; PELO in mammals), and this activity is promoted in the presence of its binding partner Hbs1 (HBS1L in mammals) (<xref ref-type="bibr" rid="bib50">Ikeuchi et al., 2016</xref>; <xref ref-type="bibr" rid="bib106">Pisareva et al., 2011</xref>; <xref ref-type="bibr" rid="bib118">Shoemaker et al., 2010</xref>; <xref ref-type="bibr" rid="bib119">Shoemaker and Green, 2011</xref>; <xref ref-type="bibr" rid="bib134">Tsuboi et al., 2012</xref>). In contrast, NGD resolves stalled ribosomes that are due to secondary mRNA structures, amino acid starvation or tRNA deficiency (<xref ref-type="bibr" rid="bib51">Ikeuchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Inada, 2020</xref>; <xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>; <xref ref-type="bibr" rid="bib124">Simms et al., 2017b</xref>). Defects in the resolution of stalled elongation complexes may trigger endonucleolytic cleavage of mRNAs resulting in 5’RNA intermediates that lack a stop codon and in turn, may be NSD substrates (<xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Doma and Parker, 2006</xref>; <xref ref-type="bibr" rid="bib35">Glover et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Guydosh and Green, 2017</xref>; <xref ref-type="bibr" rid="bib52">Inada, 2020</xref>). Unlike NSD or NGD that utilize specialized termination factors (e.g. Dom34:Hbs1, GTPBP1, or GTPBP2 <xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>; <xref ref-type="bibr" rid="bib131">Terrey et al., 2020</xref>), NMD relies on the canonical termination factors eRF1 and eRF3 (<xref ref-type="bibr" rid="bib23">Dever and Green, 2012</xref>; <xref ref-type="bibr" rid="bib123">Simms et al., 2017a</xref>). UPF proteins (UPF1, UPF2, and UPF3) are critical in eliminating mRNAs that contain premature stop codons or retained introns, thus preventing generation of their potentially faulty protein products (<xref ref-type="bibr" rid="bib64">Karousis and Mühlemann, 2019</xref>; <xref ref-type="bibr" rid="bib87">Lykke-Andersen and Bennett, 2014</xref>; <xref ref-type="bibr" rid="bib110">Raimondeau et al., 2018</xref>).</p><p>Defects in translation and translation-dependent quality control pathways impair cellular homeostasis and have been linked to proteotoxicity, changes in synaptic function, and neurodegeneration (<xref ref-type="bibr" rid="bib16">Choe et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">Chu et al., 2009</xref>; <xref ref-type="bibr" rid="bib48">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>; <xref ref-type="bibr" rid="bib59">Johnson et al., 2019</xref>; <xref ref-type="bibr" rid="bib63">Kapur et al., 2020</xref>; <xref ref-type="bibr" rid="bib92">Martin et al., 2020</xref>; <xref ref-type="bibr" rid="bib102">Notaras et al., 2020</xref>; <xref ref-type="bibr" rid="bib131">Terrey et al., 2020</xref>; <xref ref-type="bibr" rid="bib145">Yonashiro et al., 2016</xref>). Here, we demonstrate that the ribosome rescue factors <italic>Pelo</italic> and <italic>Hbs1l</italic>, which are implicated in NSD and NGD, are critical for embryonic and brain development, but dispensable for neuronal survival in the adult brain. Our analysis of <italic>Pelo</italic>- and <italic>Hbs1l</italic>-deficient fibroblasts reveals translational reprogramming of multiple pathways. Inhibition of NMD via deletion of <italic>Upf2</italic> resulted in strikingly similar effects on the translatome, signaling pathways, and neurogenesis. Our data reveal that defects in translation-dependent quality control pathways, which mitigate errors in translation to prevent the production of defective peptide products from aberrant mRNAs, can trigger similar cellular responses and neurodevelopmental abnormalities.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Hbs1l</italic> is required for embryogenesis</title><p>Multiple neurological abnormalities, including defects in motor control, were recently described in a patient with biallelic mutations in <italic>Hbs1l</italic> (<xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>). Alternative splicing of <italic>Hbs1l</italic> produces transcripts that encode two distinct proteins (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Levels of full length <italic>Hbs1l</italic> (<italic>Hbs1l</italic>-V1 and Hbs1 in human and yeast, respectively) were dramatically decreased in <italic>Hbs1l</italic> patient fibroblasts (<xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>). The levels of the shorter isoform II (<italic>Hbs1l</italic>-V3 in human), which is encoded by the first 4 exons of full-length <italic>Hbs1l</italic> and a unique last exon (‘exon 5a’) located between exon 4 and exon 5 of the <italic>Hbs1l</italic> locus, were relatively unaffected in the <italic>Hbs1l</italic> patient fibroblasts (<xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>). In contrast to the translation-dependent quality control function of <italic>Hbs1l</italic>, previous studies suggest that isoform II of <italic>Hbs1l</italic> is likely an ortholog of the <italic>Saccharomyces cerevisiae</italic> protein SKI7 (<xref ref-type="bibr" rid="bib11">Brunkard and Baker, 2018</xref>; <xref ref-type="bibr" rid="bib62">Kalisiak et al., 2017</xref>; <xref ref-type="bibr" rid="bib91">Marshall et al., 2018</xref>), which is involved in global mRNA turnover (<xref ref-type="bibr" rid="bib62">Kalisiak et al., 2017</xref>). Although an additional splice variant (<italic>Hbs1l</italic>-V2 in human) which lacks the third coding exon is annotated in the human transcriptome (<xref ref-type="bibr" rid="bib97">Mills et al., 2016</xref>; <xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>), this splice variant is not annotated in mice, and we were unable to detect it by RT-PCR.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Hbs1l</italic> is required for embryogenesis.</title><p>(<bold>A</bold>) Domain structure of HBS1L and isoform II and the exons encoding the two splice variants. (<bold>B</bold>) Design of <italic>Hbs1l</italic> loss-of-function alleles that target <italic>Hbs1l</italic> and isoform II. <italic>Hbs1l</italic><sup>tm1a</sup> allele, <italic>Hbs1l</italic> specific gene trap (<italic>hypomorph</italic>); <italic>Hbs1l</italic><sup>delta</sup> allele, <italic>Hbs1l</italic> specific deletion of exon 5 (<italic>Hbs1l</italic><sup>-</sup>, <italic>knock out</italic>); and <italic>Hbs1l</italic><sup>GTC</sup> allele, <italic>Hbs1l</italic> gene trap to target <italic>Hbs1l</italic> and isoform II (<italic>knock out</italic>). (<bold>C</bold>) Cresyl violet-stained cross-sections of testis from P45 control (<italic>Hbs1l</italic><sup>tm1a/+</sup>) and <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> mice. Immunofluorescence was performed with antibodies to proliferating cell nuclear antigen (PCNA, red) and sections were counterstained with DAPI. (<bold>D</bold>) Cresyl violet-stained sagittal brain section from 4-month-old control (<italic>Hbs1l</italic><sup>+/+</sup>) and <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> mice. (<bold>E</bold>) Splicing analysis of correctly spliced <italic>Hbs1l</italic> and trapped <italic>Hbs1l</italic> transcripts in various tissues from 4-month-old control (<italic>Hbs1l</italic><sup>+/+</sup>) and <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> mice. <italic>β-actin</italic> was used as an input control. (<bold>F</bold>) Quantitative RT-PCR analysis of <italic>Hbs1l</italic> and isoform II using cDNA from E8.5 embryos. Data were normalized to <italic>Gapdh</italic> and the fold change in gene expression is relative to that of controls (<italic>Hbs1l</italic><sup>+/+</sup>) from each cross. Data represent mean + SEM. (<bold>G</bold>) Bright field images of control (<italic>Hbs1l</italic><sup>+/+</sup> and <italic>Pelo</italic><sup>+/+</sup>), <italic>Hbs1l</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> embryos at E7.5, E8.5, and E10.5. Scale bars: 500 μm and 200 μm (higher magnification), 50 μm (immunofluorescence image) (<bold>C</bold>); 500 μm (<bold>D</bold>); 100 μm (E7.5), 200 μm (E8.5), and 2 mm (E10.5) (<bold>G</bold>). PTC, premature termination codon; Frt, flippase-mediated recombination site; loxP, <italic>Cre</italic> recombinase-mediated recombination site; En2(SA), splice acceptor of mouse <italic>Engrailed-2</italic> exon 2; SC, spermatocytes; SG, spermatogonia; St, spermatids; LC, Leydig cells. t-tests were corrected for multiple comparisons using Holm-Sidak method (F). ns, not significant; **p≤0.01; ***p≤0.001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title><italic>Hbs1l</italic> is required for embryogenesis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig1-v1.tif"/></fig><p>To study the neurological function of <italic>Hbs1l</italic> in mice, we first examined an <italic>Hbs1l</italic> allele (<italic>Hbs1l</italic><sup>tm1a</sup>) with a gene trap cassette inserted between ‘exon 5a’ and exon 5 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). As previously reported, homozygous <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> mice were viable, but male mice were infertile (<xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>). Histological analysis of the <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> testis at postnatal day P45 revealed a dramatic loss of mitotically active (PCNA<sup>+</sup>) spermatogonia, as well as spermatocytes and spermatids that normally differentiate from these cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). However, no overt defects were observed in the <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> brain (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>Residual levels of <italic>Hbs1l</italic> were still present in various tissues from <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> mice (<xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>). In agreement, <italic>Hbs1l</italic> transcripts spliced into the gene trap cassette in all tested tissues; however, correctly spliced <italic>Hbs1l</italic> transcripts were still detected in several tissues (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Thus, to completely eliminate expression of <italic>Hbs1l</italic>, we ubiquitously deleted exon five in <italic>Hbs1l</italic><sup>tm1a</sup> mice to generate <italic>Hbs1l</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In contrast to embryonic day (E) 8.5 <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> embryos, which still expressed 9% of the wild-type levels of <italic>Hbs1l</italic> mRNA, expression of <italic>Hbs1l</italic> was not detected in E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Expression of <italic>Hbsl1</italic> isoform II was not significantly changed in homozygous embryos of either allele, as predicted (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). In contrast to hypomorphic <italic>Hbs1l</italic><sup>tm1a/tm1a</sup> mice, <italic>Hbs1l</italic><sup>-/-</sup> embryos failed to develop after E8.5 and could not be recovered at E11.5 from heterozygous matings (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). These results demonstrate that <italic>Hbs1l</italic> is necessary for embryonic development; however, embryos lacking <italic>Hbs1l</italic> develop longer than embryos deficient for <italic>Pelo</italic>, the binding partner of HBS1L, which die by E7.5 (<xref ref-type="bibr" rid="bib2">Adham et al., 2003</xref>; <xref ref-type="fig" rid="fig1">Figure 1G</xref>).</p><p>To determine if isoform II of <italic>Hbs1l</italic> is also necessary for embryonic viability, we utilized an additional allele (<italic>Hbs1l</italic><sup>GTC</sup>) with a gene trap cassette located in intron 2 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Expression of <italic>Hbs1l</italic> and isoform II transcripts in E8.5 heterozygous <italic>Hbs1l</italic><sup>GTC/+</sup> embryos was reduced by 51% and 41%, respectively (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Homozygous <italic>Hbs1l</italic><sup>GTC/GTC</sup> embryos were not recovered at E6.5 from heterozygous matings (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) demonstrating that they died even before <italic>Pelo</italic><sup>-/-</sup> or <italic>Hbs1l</italic><sup>-/-</sup> embryos. The early embryonic lethality of <italic>Hbs1l</italic><sup>GTC/GTC</sup> embryos suggests that the <italic>Hbs1l</italic> isoforms are likely functionally distinct, and that their loss causes additive or synergistic defects during embryogenesis.</p></sec><sec id="s2-2"><title><italic>Hbs1l</italic> is required for cerebellar development</title><p>Consistent with transcriptome data from a brain RNA sequencing database (<xref ref-type="bibr" rid="bib148">Zhang et al., 2014</xref>), we observed expression of <italic>Hbs1l</italic> in multiple cell types of the brain (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Expression of HBS1L and its binding partner PELO was observed throughout and after cerebellar development (<xref ref-type="fig" rid="fig2">Figure 2A,B and C</xref>). However, levels of HBS1L and PELO decreased in the postnatal (P)14 cerebellum after the completion of development, a similar decrease was observed in the whole brain (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). To begin to investigate the role of <italic>Hbs1l</italic> in the brain, we deleted this gene in the developing cerebellum and midbrain by crossing the floxed allele to <italic>En1<sup>Cre</sup></italic> mice (<xref ref-type="bibr" rid="bib67">Kimmel et al., 2000</xref>). Differences in cerebellar size between mutant and control embryos were already apparent by E13.5 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Although the trilaminar structure of the cerebellum appeared normal in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO mice at postnatal day P21, cerebellar foliation was delayed in P0 mutant mice, and secondary fissures failed to form compared to control mice (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Consistent with previous studies no cerebellar abnormalities were observed in <italic>En1<sup>Cre</sup></italic> mice (<xref ref-type="bibr" rid="bib26">Dong and Kwan, 2020</xref>; <xref ref-type="bibr" rid="bib38">Guo et al., 2010</xref>; <xref ref-type="bibr" rid="bib76">Li et al., 2002</xref>; <xref ref-type="bibr" rid="bib117">Sgaier et al., 2007</xref>; <xref ref-type="bibr" rid="bib133">Tripathi et al., 2008</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Hbs1l</italic> is required for cerebellar development.</title><p>(<bold>A</bold>) In situ hybridization of <italic>Hbs1l</italic> mRNA (red) on cerebellar sections from E13.5 and P28 control (B6J) mice. Sections were counterstained with DAPI. (<bold>B</bold>) Western blot analysis using cerebellar lysates from B6J mice. Vinculin was used as a loading control. (<bold>C</bold>) The relative protein levels of HBS1L and PELO were normalized to levels of vinculin and protein levels are relative to those of E16.5 B6J cerebella. (<bold>D</bold>) Parasagittal (E13.5) and sagittal (P0 and P21) cerebellar sections from control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO mice stained with cresyl violet. Higher magnification images of lobules IV/V at P21 are shown below each genotype. Cerebellar lobules are indicated by Roman numerals. (<bold>E</bold>) Immunofluorescence using antibodies to Ki67 (red) on cerebellar section from E14.5 control (<italic>Hbs1l</italic><sup>+/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Sections were counterstained with DAPI and higher magnification images of boxed area are shown. (<bold>F</bold>) Number of cerebellar VZ-progenitors (Ki67<sup>+</sup> cells) from control (<italic>Hbs1l</italic><sup>+/+</sup> or <italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Data represent mean + SD. (<bold>G</bold>) Immunofluorescence using antibodies to BrdU (green) and Ki67 (red) on cerebellar sections from E14.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos to determine the fraction of cells that exited the cell cycle. Embryos were injected with BrdU 24 hr prior to harvest. (<bold>H</bold>) Percentage of cerebellar VZ-progenitors that exited the cell cycle (BrdU<sup>+</sup>, Ki67<sup>-</sup> cells). Data represent mean + SD. (<bold>I</bold>) Immunofluorescence using antibodies to Lhx1/5 on cerebellar sections from E13.5 control (<italic>Hbs1l</italic><sup>+/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Sections were counterstained with DAPI and higher magnification images of boxed areas are shown. (<bold>J</bold>) Number of cerebellar Purkinje cell precursors (Lhx1/5<sup>+</sup> cells). Data represent mean + SD. Scale bars: 100 μm and 20 μm (higher magnifications) (<bold>A</bold>); 200 μm (E13.5 and P0), 500 μm and 50 μm (higher magnification) (P21) (<bold>D</bold>); 100 μm and 20 μm (higher magnification) (<bold>E</bold>); 20 μm (<bold>G</bold>); 100 μm and 50 μm (higher magnification) (<bold>I</bold>). VZ, ventricular zone; NTZ, nuclear transitory zone; RL, rhombic lip; EGL, external granule cell layer; ML, molecular cell layer; PL, Purkinje cell layer; GCL, granule cell layer; IC, inferior colliculus. t-tests were corrected for multiple comparisons using Holm-Sidak method (<bold>C, F, H, J</bold>). ns, not significant; *p≤0.05; **p≤0.01; ***p≤0.001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title><italic>Hbs1l</italic> is required for cerebellar development.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>Hbs1l</italic> is required for the development of multiple cerebellar linages.</title><p>(<bold>A</bold>) Western blot analysis using brain lysates from B6J mice. Vinculin was used a loading control. (<bold>B</bold>) Immunofluorescence using antibodies to BrdU (green) and Ki67 (red) from cerebellar sections of E13.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos to determine the fraction of cells in S-phase. Embryos were injected with BrdU 30 min prior to harvest. Sections were counterstained with DAPI. (<bold>C</bold>) Percentage of cerebellar VZ-progenitors in S-phase (BrdU<sup>+</sup>, Ki67<sup>+</sup> cells). Data represent mean + SD. (<bold>D</bold>) Percentage of cerebellar VZ-progenitors in M-phase (pH3<sup>+</sup>, PCNA<sup>+</sup> cells). Data represent mean + SD. (<bold>E</bold>) Immunofluorescence using antibodies to Pax2 (red) on cerebellar sections from E13.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Sections were counterstained with DAPI. (<bold>F</bold>) Number of cerebellar VZ-derived interneuron precursors (Pax2<sup>+</sup> cells). Data represent mean + SD. (<bold>G</bold>) Immunofluorescence using antibodies to Tbr1 (green) on cerebellar sections from E14.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Sections were counterstained with DAPI. (<bold>H</bold>) Immunofluorescence using antibodies to Ki67 (green) on cerebellar sections from E14.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos to identify granule cell precursors in the EGL. Sections were counterstained with DAPI. (<bold>I</bold>) Number of RL-derived granule cell precursors in the EGL (Ki67<sup>+</sup> cells). Data represent mean + SD. (<bold>J</bold>) Immunofluorescence using antibodies to BrdU (green) and Ki67 (red) on cerebellar sections from E14.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Embryos were injected with BrdU 24 hr prior to harvest. (K) Number of RL-derived granule cell precursors (BrdU<sup>+</sup> cells). Data represent mean + SD. (<bold>L</bold>) Percentage of RL-derived granule cell precursors that exited the cell cycle (BrdU<sup>+</sup>, Ki67<sup>-</sup> cells). Data represent mean + SD. (<bold>M</bold>) Percentage of RL-derived granule cell precursors in S-phase (BrdU<sup>+</sup>, Ki67<sup>+</sup> cells). Embryos were injected with BrdU 30 min prior to harvest. Data represent mean + SD. (<bold>N</bold>) Percentage of RL-derived granule cell precursors in M-phase (pH3<sup>+</sup>, PCNA<sup>+</sup> cells). Data represent mean + SD. (<bold>O</bold>) Number of oligodendroglial progenitors (Olig2<sup>+</sup> cells) from E14.5 control (<italic>Hbs1l</italic><sup>fl/+</sup>) and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO cerebella. Scale bars: 20 μm (<bold>C</bold>); 50 μm (<bold>E, G, H, J</bold>). VZ, ventricular zone; NTZ; nuclear transitory zone; EGL, external granule cell layer; RL, rhombic lip. t-tests were corrected for multiple comparisons using Holm-Sidak method (<bold>C, D, F, I, K, L, M, N</bold>); Student’s t-test (<bold>O</bold>). ns, not significant; *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title><italic>Hbs1l</italic> is required for the development of multiple cerebellar linages.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title><italic>Hbs1l</italic><sup>-/-</sup><italic>-</italic>mediated cerebellar defects are independent of the B6J-associated mutation in <italic>n-Tr20</italic>.</title><p>(<bold>A</bold>) Cresyl violet staining of sagittal sections of <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO cerebellum expressing wild-type levels of <italic>n-Tr20</italic> (<italic>n-Tr20</italic><sup>B6N/B6N</sup>) or reduced levels of <italic>n-Tr20</italic> (<italic>n-Tr20</italic><sup>B6J/B6J</sup>) and Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella with reduced levels of <italic>n-Tr20</italic> (<italic>n-Tr20</italic><sup>B6J/B6J</sup>) or that completely lack <italic>n-Tr20</italic> (<italic>n-Tr20</italic><sup>-/-</sup>). Cerebellar lobules are indicated by Roman numerals. (<bold>B</bold>) Sagittal sections from 35-week-old control (Tg(Gabra6-Cre); <italic>Pelo</italic><sup>fl/+</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup>), Tg(Gabra6-Cre); <italic>Pelo</italic> cKO; <italic>n-Tr20</italic><sup>B6J/B6J</sup> and Tg(Gabra6-Cre); <italic>Hbs1l</italic> cKO; <italic>n-Tr20</italic><sup>B6J/B6J</sup> cerebella stained with hematoxylin and eosin. Higher magnification images of lobule IX are shown below. Cerebellar lobules are indicated by Roman numerals. (<bold>C</bold>) Number of cerebellar granule cells in lobule IX shown in B. Data represent mean + SD. (<bold>D</bold>) Western blot analysis using cerebellar lysates from P28 control (<italic>Hbs1l</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup> or <italic>Pelo</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup>), Tg(Gabra6-Cre); <italic>Pelo</italic> cKO; <italic>n-Tr20</italic><sup>B6J/B6J</sup> and Tg(Gabra6-Cre); <italic>Hbs1l</italic> cKO; <italic>n-Tr20</italic><sup>B6J/B6J</sup> mice. GAPDH was used a loading control. (<bold>E</bold>) Quantification of HBS1L and PELO protein levels shown in D. Levelswere normalized to levels of GAPDH. Protein levels are relative to those of controls (<italic>Hbs1l</italic><sup>fl/fl</sup> or <italic>Pelo</italic><sup>fl/fl</sup>) from each cross. Scale bars: 500 μm (<bold>A</bold>); 500 μm and 50 μm (higher magnification) (<bold>B</bold>). One-way ANOVA (<bold>C</bold>) and two-way ANOVA (<bold>E</bold>) were corrected for multiple comparisons using Tukey method. ns, not significant; **p≤0.01; ***p≤0.001.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title><italic>Hbs1l</italic><sup>-/-</sup>-mediated cerebellar defects are independent of the B6J-associated mutation in <italic>n-Tr20</italic>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig2-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Lineage-restricted GABAergic precursors are generated beginning at ~E10.5 from progenitors in the ventricular zone (VZ) of the developing cerebellum (<xref ref-type="bibr" rid="bib60">Ju et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Leto et al., 2012</xref>). The pool of progenitors declines as progenitors either exit the cell cycle to generate precursors or retract from the VZ to form a secondary germinal zone in the prospective white matter to transition from neurogenesis to gliogenesis (<xref ref-type="bibr" rid="bib75">Leto et al., 2012</xref>; <xref ref-type="bibr" rid="bib135">Vong et al., 2015</xref>; <xref ref-type="bibr" rid="bib139">Wizeman et al., 2019</xref>). Immunofluorescence with antibodies to the cell-cycle-associated protein Ki67 demonstrated a loss of progenitors between E12.5 to E16.5 in both the control and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO cerebella. However, the number of progenitors remained higher in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO compared to control cerebella (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>), suggesting that <italic>Hbs1l</italic>-deficient progenitors may aberrantly proliferate. In agreement, we observed a higher fraction of VZ-progenitors in S-phase in the E12.5 and E13.5 mutant cerebella by pulse labeling with BrdU for 30 min and performing co-immunofluorescence with BrdU and Ki67 antibodies (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>). Immunofluorescence with antibodies to the M-Phase marker phospho-histone 3 (pH3) and the general cell cycle marker PCNA demonstrated an increase of VZ-progenitors in M-phase in the mutant cerebellum (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>).</p><p>To test if <italic>Hbs1l</italic>-deficient progenitors are able to exit the cell cycle, which is necessary to generate lineage-restricted precursors, we labeled control and mutant embryos at E12.5 or E13.5 with BrdU and then determined the fraction of BrdU<sup>+</sup> cells that had left the cell cycle (do not express Ki67) 24 hr after labeling. Fewer VZ-progenitors exited the cell cycle in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO relative to control cerebella (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>). Concordantly, the number of VZ-derived Lhx1/5<sup>+</sup> Purkinje cells and Pax2<sup>+</sup> interneuron precursors was reduced to ~32% and~34% in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO between E12.5 to E16.5 compared to control cerebella (<xref ref-type="fig" rid="fig2">Figure 2I and J</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E and F</xref>), suggesting that <italic>Hbs1l</italic>-deficient VZ-progenitors remain proliferative at the expense of differentiation.</p><p>Cerebellar glutamatergic precursors are generated beginning at ~E10.5 from the rhombic lip (RL), a germinal zone located in the caudal region of the cerebellar primordia. Between E10.5–12.5 the RL gives rise to Tbr1<sup>+</sup> cells that migrate subpially to take up residence in the nuclear transitory zone and will develop into deep cerebellar neurons (<xref ref-type="bibr" rid="bib30">Fink et al., 2006</xref>). Following Tbr1<sup>+</sup> cell production, proliferating granule cell precursors emerge from the RL and form the external granule cell layer (EGL) (<xref ref-type="bibr" rid="bib18">Chung et al., 2010</xref>). As observed for VZ-derived neuronal precursors, deletion of <italic>Hbs1l</italic> also decreased progeny generated from the RL. Immunofluorescence with antibodies to Tbr1, revealed fewer Tbr1<sup>+</sup> cells in the E14.5 mutant cerebella compared to controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G</xref>). In addition, the EGL of <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO at E13.5 to E16.5 contained only ~45% of the granule cell precursors compared to controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H and I</xref>).</p><p>Granule cell precursors that derive from the RL continue to proliferate in the EGL to generate additional precursors that exit the cell cycle postnatally prior to migrating to the internal granule cell layer (IGL). To determine if the decrease in granule cell precursors was due to a failure of progenitors in the RL to generate sufficient numbers of granule cell precursors, or a failure of granule cell precursors to proliferate, we labeled E12.5 and E13.5 wild type and mutant embryos with BrdU and then determined the number of BrdU<sup>+</sup> cells in the EGL 24 hr after labeling. Fewer BrdU<sup>+</sup> cells were present in the <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO EGL compared to that of controls indicating that the mutant rhombic lip generates fewer granule cell precursors (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1J and K</xref>). However, cell cycle exit of these precursors did not vary between mutant and control cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1L</xref>). Furthermore, no difference in proliferation (S- and M-phase) was observed when granule cell precursors were analyzed at E16.5 or P5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1M and N</xref>). Together, these data suggest that while <italic>Hbs1l</italic> is required for the initial production of granule cell precursors, it is dispensable for the subsequent cell cycle progression of these precursors in the EGL. In agreement, genetic ablation of <italic>Hbs1l</italic> by Tg(Atoh1<italic>-</italic>Cre) which specifically deletes in cerebellar granule cell precursors in the EGL beginning at ~E16.5 (<xref ref-type="bibr" rid="bib85">Lorenz et al., 2011</xref>; <xref ref-type="bibr" rid="bib104">Pan et al., 2009</xref>; <xref ref-type="bibr" rid="bib108">Qiu et al., 2010</xref>; <xref ref-type="bibr" rid="bib140">Wojcinski et al., 2019</xref>), did not impair development of these cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>).</p><p><italic>Hbs1l</italic> was also required for gliogenesis in the developing cerebellum. Cerebellar gliogenesis starts at ~E18 and continues during postnatal development during which time progenitors that have retracted from the VZ switch from a neurogenic to gliogenic fate and produce oligodendrocytes and astrocytes (<xref ref-type="bibr" rid="bib37">Götz and Huttner, 2005</xref>; <xref ref-type="bibr" rid="bib135">Vong et al., 2015</xref>). Immunofluorescence with antibodies to Olig2, a marker of oligodendroglial progenitors which give rise to oligodendrocytes and astrocytes (<xref ref-type="bibr" rid="bib19">Chung et al., 2013</xref>; <xref ref-type="bibr" rid="bib130">Tatsumi et al., 2018</xref>), revealed the number of these cells was reduced in P5 <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO cerebella (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1O</xref>). Together these data indicate that <italic>Hbs1l</italic> is required for the generation of multiple cell types in the developing cerebellum.</p><p>We have previously identified a mutation in the common C57BL/6J (B6J) strain that partially disrupts processing of the brain-specific arginine tRNA, <italic>n-Tr20</italic> (<italic>n-Tr20</italic><sup>B6J/B6J</sup>; <italic>n-Tr20</italic> is also known as <italic>n-TRtct5</italic>). This processing defect in turn reduces the pool of available tRNA<sup>Arg</sup><sub>UCU</sub>, leading to ribosome pausing at the A-site at AGA codons in cerebellar mRNAs (<xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>). <italic>Hbs1l</italic> cKO mice were generated with the B6J-associated mutation in <italic>n-Tr20</italic>. To test if the <italic>n-Tr20</italic> deficiency influenced the developmental defects observed in the absence of <italic>Hbs1l</italic>, we either restored <italic>n-Tr20</italic> to wild type levels or completely deleted <italic>n-Tr20</italic> in <italic>Hbs1l</italic> cKO mice. Wild-type expression of the tRNA (<italic>n-Tr20</italic><sup>B6N/B6N</sup>) did not rescue defects in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO cerebella, nor did complete loss of <italic>n-Tr20</italic> (<italic>n-Tr20</italic><sup>-/-</sup>) cause developmental defects in Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). In addition, neither loss of <italic>Hbs1l</italic> or <italic>Pelo</italic> affected cell survival of terminally differentiated granule cells in 9-month-old mice even in the presence of the <italic>n-Tr20</italic> deficiency (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B,C,D and E</xref>), indicating that <italic>Hbs1l</italic> and <italic>Pelo</italic> do not respond to AGA pausing.</p></sec><sec id="s2-3"><title>Ribosome pausing correlates with pathology in <italic>Hbs1l</italic>-deficient mice</title><p>To determine if the developmental defects that occur upon loss of <italic>Hbs1l</italic> are accompanied by alterations in translation elongation, we performed ribosome profiling on wild type and <italic>Hbs1l</italic><sup>-/-</sup> embryos at E8.5. Ribosome protected fragments (RPF) mapped primarily to the protein coding sequence of genes in both wild-type and mutant embryos (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Using the previously described methodology (<xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>), we found a total of ~1300 sites with significant (z-score ≥10) increases in local ribosome occupancy (‘ribosome pauses’) in wild-type and mutant embryos (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). About 40% of the ribosome pauses, which mapped to 319 genes, were shared between genotypes suggesting they occurred independently of the loss of <italic>Hbs1l</italic>. Ten percent of ribosome pauses (mapped to 107 genes) were found only in wild-type embryos. The ribosome density derived from the total number of ribosome-protected fragments (RPF) serves as proxy for gene expression at the level of the translatome. Differential expression analysis of the translatome (DE RPF, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) indicated translation of genes with wild type-specific pauses was decreased in mutant embryos (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), which may contribute to the apparent specificity of these pauses to wild-type embryos. Strikingly, 50% of ribosome pauses (mapped to 459 genes) were uniquely observed in <italic>Hbs1l</italic><sup>-/-</sup> embryos and like other pauses, occurred primarily in protein coding sequences (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Similar to the metagene analysis (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), we didn’t observe genotype-dependent differences in the ribosome occupancy in different gene regions (i.e. untranslated 5’ or 3’ region). Only 9% of genes associated with <italic>Hbs1l</italic><sup>-/-</sup>-specific ribosome pauses were differentially translated in <italic>Hbs1l</italic><sup>-/-</sup> embryos (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>) and translation of 26 genes and 15 genes was decreased and increased, respectively (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Ribosome pausing correlates with pathology in <italic>Hbs1l</italic>-deficient mice.</title><p>(<bold>A</bold>) Metagene profiles of RPFs from E8.5 control (<italic>Hbs1l</italic><sup>+/+</sup>, gray traces) and <italic>Hbs1l</italic><sup>-/-</sup> (red traces) embryos. (<bold>B</bold>) Analysis of significantly increased local ribosome occupancy (z-score ≥10, pause site detected in all three replicates) from E8.5 wild type (<italic>Hbs1l</italic><sup>+/+</sup>) and <italic>Hbs1l</italic><sup>-/-</sup> embryos (left) or P14 control (Tg(Atoh1-Cre); <italic>Hbs1l</italic><sup>+/+</sup>) and Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella (right). The number of genes that pause sites map to is shown below for each genotype. (<bold>C</bold>) All translated genes (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>) from E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos were compared to the translation of genes which contained pauses specific to either <italic>Hbs1l</italic><sup>-/-</sup> or wild-type embryos. Downward direction of arrows indicates significant reduction in translation of pausing genes in E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos relative to wild-type embryos. (<bold>D</bold>) Identification of upstream regulators using Ingenuity Pathway Analysis (IPA) of differentially translated genes of E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>). Transcription factors that are involved in heart development are shown in red. Downward direction of arrows indicates predicated activity (downregulation) of transcription factors. RPFs, ribosome-protected fragments; nts, nucleotides. Wilcoxon rank-sum test was used to determine statistical significance (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Hbs1l</italic> deficiency in embryos alters translation of pathways associated with heart function.</title><p>(<bold>A</bold>) Analysis of differentially translated genes (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05) of E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos (421 genes, gray). Genes that have ribosome pauses specific to <italic>Hbs1l</italic><sup>-/-</sup> embryos with significant (adj. p≤0.05) changes in translation are shown in green (47 genes). (<bold>B</bold>) Comparison of z-scores of <italic>Hbs1l</italic><sup>-/-</sup>-specific pause sites detected in E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos and P14 Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella. Downward direction of the arrow indicates significant lower z-scores of these pauses in P14 Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella. (<bold>C</bold>) Comparison of differentially translated genes (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05) of E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos and P14 Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella. Downward direction of the arrow indicates significant lower fold changes in translation in P14 Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella. (<bold>D</bold>) KEGG pathway analysis of differentially translated genes (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05) of E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos. Top five significantly (p≤0.05) enriched pathways are shown and the heatmap indicates relative changes in genes associated with the respective pathway. (<bold>E</bold>) Ingenuity Pathway Analysis (IPA) of differentially translated genes (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>) from E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos. Pathways that are involved in heart, muscle contraction, cardiomyocyte, and cytoskeleton function are in italics. The red dashed line indicates the significance threshold (p=0.05). Up- or downward direction of arrows indicates predicated up- or downregulated activity of the pathway, respectively. RPF, ribosome protected fragments. Wilcoxon rank-sum test was used to determine statistical significance (<bold>B, C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Loss of <italic>Hbs1l</italic> did not affect survival of granule cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B and C</xref>), which constitute the vast majority of the cellular content of the cerebellum. Thus, to determine if elongation defects correlate with pathogenesis in <italic>Hbs1l</italic> mutant tissues, we also performed ribosome profiling on the cerebellum of P14 control and Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO mice (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). We observed more ribosome pausing sites (~2700) in the cerebellum than in embryos, likely due to the higher amount of input RNA and sequencing depth. Consistent with the lack of a genetic interaction between the <italic>Hbs1l</italic> and the <italic>n-Tr20</italic> mutation, no significant increase in ribosome occupancy on A-site AGA codons was observed in <italic>Hbs1l</italic><sup>-/-</sup> cerebella (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Unlike the high percentage of pauses that were unique to <italic>Hbs1l</italic><sup>-/-</sup> embryos, only 2% of ribosome pauses (mapped to 69 genes) were unique to the mutant cerebellum (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In addition, the z-scores (<italic>‘</italic>pause scores’) for <italic>Hbs1l</italic>-specific pauses were significantly higher in mutant embryos than the mutant cerebellum (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>).</p><p>Mutant embryos also exhibited larger changes in the translatome (DE RPF) than the mutant cerebellum (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), indicating that defects in translation also correlate with pathology. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Ingenuity Pathway Analysis (IPA) of differentially translated genes (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05) in <italic>Hbs1l<sup>-/-</sup></italic> embryos revealed that downregulated genes were significantly enriched for heart/cardiac muscle contraction and calcium signaling (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D and E</xref>). In agreement, upstream regulator analysis predicted downregulation of multiple transcription factors required for heart development (<xref ref-type="bibr" rid="bib21">Cui et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Molkentin et al., 1997</xref>; <xref ref-type="bibr" rid="bib100">Muñoz-Martín et al., 2019</xref>; <xref ref-type="bibr" rid="bib127">Steimle and Moskowitz, 2017</xref>; <xref ref-type="fig" rid="fig3">Figure 3D</xref>). Together these data suggest that HBS1L deficiency may cause defects in the embryonic heart, one of the first organs to begin developing in the mouse embryo.</p></sec><sec id="s2-4"><title>Loss of <italic>Pelo/Hbs1l</italic> alters translation regulation and reprograms the translatome</title><p>Our embryonic data suggested that defects in translation modulate the translatome. Because <italic>Pelo</italic><sup>-/-</sup> embryos could not be profiled due to their early embryonic lethality, we conditionally deleted <italic>Pelo</italic> or <italic>Hbs1l</italic> in primary mouse embryonic fibroblasts (MEFs) using a tamoxifen-inducible <italic>Cre</italic> transgene (TgCAG-Cre<sup>ER</sup>) to compare changes in translation upon loss of <italic>Pelo</italic> and <italic>Hbs1l</italic> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Consistent with previous studies (<xref ref-type="bibr" rid="bib61">Juszkiewicz et al., 2020</xref>; <xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>), deletion of <italic>Hbs1l</italic> was accompanied by decreased levels of PELO protein, but not its mRNA (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A,B and C</xref>). In addition, we found deletion of <italic>Pelo</italic> also led to the loss of HBS1L without altering <italic>Hbs1l</italic> mRNA levels, suggesting degradation of PELO or HBS1L protein occurs in the absence of either interacting partner (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A,B and C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of <italic>Pelo</italic> induces greater defects in translation elongation then loss of <italic>Hbs1l</italic>.</title><p>(<bold>A</bold>) Experimental strategy for in vitro studies using tamoxifen (4-OHT) treatment of primary mouse embryonic fibroblasts (MEFs). (<bold>B</bold>) Western blot analysis of HBS1L and PELO using MEF lysates from tamoxifen-treated control (<italic>Hbs1l</italic><sup>fl/+</sup> or <italic>Pelo</italic><sup>fl/fl</sup>), <italic>Hbs1l</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> cells. Vinculin was used as a loading control. (<bold>C</bold>) Analysis of significantly increased local ribosome occupancy (z-score ≥10, pause site detected in all three replicates) from tamoxifen-treated control (TgCAG-Cre<sup>ER</sup>) and <italic>Pelo</italic><sup>-/-</sup> (left), or control and <italic>Hbs1l</italic><sup>-/-</sup> cells (right). The number of genes that pause sites map to is shown below for each genotype. (<bold>D</bold>) Comparison of the z-scores (‘pause score’) for pauses observed in <italic>Pelo</italic><sup>-/-</sup> (blue) and <italic>Hbs1l</italic><sup>-/-</sup> (red) cells. Downward direction of the arrow indicates significant lower pause scores of <italic>Hbs1l</italic><sup>-/-</sup>- compared to <italic>Pelo</italic><sup>-/-</sup>-specific pauses. (<bold>E</bold>) Examples of mapped footprints (27–34 nucleotides) on genes from tamoxifen-treated control (TgCAG-Cre<sup>ER</sup>, gray) and <italic>Pelo</italic><sup>-/-</sup> (blue), or control and <italic>Hbs1l</italic><sup>-/-</sup> (red) cells. Upward direction of arrows indicates significant increase in local ribosome occupancy and the dashed line indicates the pause site. 4-OHT, 4-hydroxytamoxifin; nts, nucleotides; rpm, reads per million. Wilcoxon rank-sum test was used to determine statistical significance (<bold>D</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Loss of <italic>Hbs1l</italic> and <italic>Pelo</italic> control protein levels of their respective binding partner.</title><p>(<bold>A</bold>) Quantitative RT-PCR analysis of <italic>Hbs1l</italic> and <italic>Pelo</italic> transcripts using cDNA from MEFs of tamoxifen-treated control (<italic>Hbs1l</italic><sup>fl/+</sup> or <italic>Pelo</italic><sup>fl/+</sup>), <italic>Hbs1l</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> cells at Day 2 (Passage P1). Data were normalized to <italic>Gapdh</italic> and fold change in expression is relative to those of control (<italic>Hbs1l</italic><sup>fl/+</sup> or <italic>Pelo</italic><sup>fl/+</sup>) cells. Data represent mean + SEM. (<bold>B</bold>) Western blot analysis of HBS1L and PELO using MEF lysates of tamoxifen-treated control (<italic>Hbs1l</italic><sup>fl/+</sup> or <italic>Pelo</italic><sup>fl/fl</sup>), <italic>Hbs1l</italic><sup>-/-</sup> or <italic>Pelo</italic><sup>-/-</sup> cells at Day 2 and 4 (Passage P1). Vinculin was used as a loading control. (<bold>C</bold>) Quantification of HBS1L and PELO protein levels shown in B. Levels were normalized to levels of vinculin. Protein levels are relative to those of control (<italic>Hbs1l</italic><sup>fl/+</sup> or <italic>Pelo</italic><sup>fl/fl</sup>) cells at Day 2 (Passage P1). Data represent mean + SD. (<bold>D</bold>) Location of pause sites. (<bold>E</bold>) Histogram of A count on the 3’end of ribosome footprints that mapped after removal of the 3’end A’s. (<bold>F</bold>) Fraction of 3’ end A ribosome footprints that mapped after removal of the 3’ end A’s relative to the total number of ribosome footprints from tamoxifen-treated control (TgCAG-Cre<sup>ER</sup>) and <italic>Hbs1l</italic><sup>-/-</sup>, or control (TgCAG-Cre<sup>ER</sup>) and <italic>Pelo</italic><sup>-/-</sup> cells. (<bold>G</bold>) Percent of unique pausing transcripts that are protein-coding or NMD transcripts. P1, Passage 1; MEFs, primary mouse embryonic fibroblasts; 4-OHT, 4-hydroxytamoxifin; PTC, premature termination codon; nd, not detected; A, adenosines; nts, nucleotides; CDS, coding sequence; UTR, untranslated region; NMD, nonsense-mediated decay. Two-way ANOVA was corrected for multiple comparisons using Tukey method (<bold>A, C</bold>); Fisher’s exact test (<bold>D, G</bold>); Student’s t-test (<bold>F</bold>). ns, not significant; **p≤0.01; ***p≤0.001; ****p≤0.0001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Loss of <italic>Hbs1l</italic> and <italic>Pelo</italic> control protein levels of their respective binding partner.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To analyze defects in translation elongation, we performed ribosome profiling of tamoxifen-treated control (TgCAG-Cre<sup>ER</sup>), <italic>Pelo<sup>-/-</sup></italic> (TgCAG-Cre<sup>ER</sup>; <italic>Pelo</italic> cKO), and <italic>Hbs1l<sup>-/-</sup></italic> (TgCAG-Cre<sup>ER</sup>; <italic>Hbs1l</italic> cKO) cells. Analyzing the ribosome occupancy in <italic>Pelo</italic><sup>-/-</sup> and control cells revealed ~10,000 sites with significant (z-score ≥10) increases in local ribosome occupancy which mapped to 4693 genes (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). One percent of these ribosome pauses were only observed in control cells (‘control-pauses’), 57% were shared between control and <italic>Pelo<sup>-/-</sup></italic> cells, and 42% were specific to <italic>Pelo</italic><sup>-/-</sup> cells (‘<italic>Pelo</italic><sup>-/-</sup>-pauses’). In contrast, analysis of <italic>Hbs1l</italic><sup>-/-</sup> and control cells revealed fewer ribosome pauses (~4200 - mapping to 1807 genes) and only 5% were specific to <italic>Hbs1l</italic><sup>-/-</sup> cells (‘<italic>Hbs1l</italic><sup>-/-</sup>-pauses’) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In addition to the fewer ribosome pause sites, the z-scores (‘pause scores’) for <italic>Hbs1l<sup>-/-</sup></italic>-pauses were also significantly lower than those of <italic>Pelo</italic><sup>-/-</sup>-pauses (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Approximately 80% of the <italic>Hbs1l<sup>-/-</sup></italic>-pausing genes also had pauses in <italic>Pelo</italic><sup>-/-</sup> cells; however, only 30% of the ribosome pauses occurred at the same pause site (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Together, these data suggest that the loss of <italic>Pelo</italic> or <italic>Hbs1l</italic> leads to translation elongation defects, but particularly severe defects are observed in the absence of <italic>Pelo</italic>.</p><p>The Dom34:Hbs1 complex has been implicated in multiple translation-dependent quality control pathways including non-stop decay (NSD) (<xref ref-type="bibr" rid="bib20">Collart and Weiss, 2020</xref>; <xref ref-type="bibr" rid="bib123">Simms et al., 2017a</xref>). This pathway rescues ribosomes stalled at the ends of truncated mRNAs, ribosomes in polyA-sequences on prematurely polyadenylated mRNAs that lack a termination codon, or ribosomes in the 3’UTR of mRNAs that were not recycled at canonical stop codons (<xref ref-type="bibr" rid="bib4">Arribere and Fire, 2018</xref>; <xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib40">Guydosh and Green, 2014</xref>; <xref ref-type="bibr" rid="bib98">Mills et al., 2017</xref>; <xref ref-type="bibr" rid="bib146">Young et al., 2015</xref>). Examination of <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l</italic><sup>-/-</sup>-pauses revealed that ~92% of pauses mapped to the protein-coding region of transcripts (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). The remaining local increases in ribosome occupancy were similarly split between the 5’ and 3’UTRs. Although the frequency of pauses in the 3’UTR was similar for mutant-specific, control-specific and shared pauses, the frequency of control-specific pauses that mapped to the 5’UTR was increased and those in the coding region were decreased (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Thus, consistent with our observations in <italic>Hbs1l</italic><sup>-/-</sup> embryos, these data suggest that neither loss of <italic>Hbs1l</italic> nor <italic>Pelo</italic> in MEFs led to enrichment of ribosomes in the 5’ or 3’UTR.</p><p>We also searched for RPFs containing untemplated stretches of adenosines (A) at the 3’end indicative of ribosomes extending into the poly(A) tail of premature polyadenylated mRNAs. Ribosomes did not protect more then 15 consecutive A’s (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>) suggesting that like in yeast, the poly(A) tract does not extend beyond the P-site of the ribosome (<xref ref-type="bibr" rid="bib40">Guydosh and Green, 2014</xref>). Interestingly, we observed a significantly higher fraction of these 3’end A reads in <italic>Pelo</italic><sup>-/-</sup> compared to control cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>), supporting a role for <italic>Pelo</italic> in rescuing ribosomes in polyA tails (<xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Guydosh and Green, 2017</xref>; <xref ref-type="bibr" rid="bib40">Guydosh and Green, 2014</xref>). However, the fraction of those reads did not significantly increase in <italic>Hbs1l</italic><sup>-/-</sup> MEFs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>), <italic>Hbs1l</italic><sup>-/-</sup> embryos (Student’s t-test, p=0.4621) or <italic>Hbs1l</italic><sup>-/-</sup> cerebella (Student’s t-test, p=0.3269).</p><p>In addition to NSD, Dom34:Hbs1 is implicated in ribosome rescue during No-Go decay (NGD), a quality control pathway in which ribosome stalling is evoked due to stretches of rare codons, secondary mRNA structures, amino acid starvation, or tRNA deficiency. NGD may trigger endonucleolytic cleavage of mRNAs due to ribosome collision, leading to 5’RNA intermediates that lack a stop codon and are then targeted by Dom34:Hbs1 via NSD (<xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Doma and Parker, 2006</xref>; <xref ref-type="bibr" rid="bib35">Glover et al., 2020</xref>). Studies in <italic>Drosophila</italic> and <italic>C. elegans</italic> revealed that RNA intermediates that converge onto NSD may also be generated through additional mechanisms including RNA interference (RNAi) and nonsense-mediated decay (NMD) (<xref ref-type="bibr" rid="bib4">Arribere and Fire, 2018</xref>; <xref ref-type="bibr" rid="bib44">Hashimoto et al., 2017</xref>).</p><p>To determine if loss of <italic>Pelo</italic> or <italic>Hbs1l</italic> alters the frequency of ribosome pauses that are associated with potential targets such as NMD targets, we mapped pauses to unique coding transcripts, which is generally difficult due to the short nature of RPFs. Indeed, only a fraction (~30%) of <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l<sup>-/-</sup></italic>-pauses could be assigned to unique coding transcripts (1518 and 95, respectively) (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Of these transcripts, ~8% were classified as NMD transcripts and ~92% were protein-coding transcripts. A similar percentage of pauses mapping to NMD transcripts (~6.5%) was observed when we analyzed transcripts that contained ribosome pauses shared between either control and <italic>Pelo</italic><sup>-/-</sup> cells, control and <italic>Hbs1l</italic><sup>-/-</sup> cells, or control-specific pausing transcripts (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>). In addition, transcriptome analysis of MEFs revealed that NMD transcripts represented ~6% of expressed transcripts (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). These data suggest that loss of <italic>Pelo</italic> or <italic>Hbs1l</italic> did not lead to enrichment of ribosome pauses on transcripts predicted to undergo NMD.</p><p>Our observation that ribosome pausing is more dramatic in <italic>Pelo</italic><sup>-/-</sup> than <italic>Hbs1l</italic><sup>-/-</sup> cells correlates with the earlier lethality of <italic>Pelo</italic><sup>-/-</sup> embryos. To get a broader perspective of whether the loss of <italic>Pelo</italic> impacts other aspects of translation more than the <italic>Hbs1l</italic> deficiency, we analyzed at first the translational efficiency (TE, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>) of genes by normalizing the abundance of ribosomal footprint reads to that of the RNA sequencing reads. In <italic>Pelo</italic><sup>-/-</sup> cells about 35% (4884) of genes displayed significant (adj. p≤0.05) alterations in TE compared to control cells. The TE of 57% of these genes was increased and for 43% it was decreased. In contrast, the TE of only 4% of genes (314, 60% up- and 40% downregulated) was significantly changed in <italic>Hbs1l</italic><sup>-/-</sup> cells and genes with differential translational efficiency showed only a moderate correlation between <italic>Hbs1l</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> cells (Pearson’s correlation<italic>, r</italic> = 0.3739). The TE of <italic>Pelo</italic><sup>-/-</sup>-specific pausing genes increased, but this effect was less for <italic>Hbs1l<sup>-/-</sup></italic>-specific pausing genes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), suggesting that elongation defects maybe more dramatic in <italic>Pelo</italic><sup>-/-</sup> cells as a result of the increase in translation of these genes.</p><p>In addition to its greater impact on the TE of genes, the loss of <italic>Pelo</italic> also had a stronger impact on gene translation in general as evidenced by the differential expression of ribosome-protected fragments (DE RPF, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). While <italic>Hbs1l</italic> deficiency altered translation of 26% (3445) of genes, the loss of <italic>Pelo</italic> affected translation of 34% (4965) of genes and led to significantly greater fold changes in gene expression in <italic>Pelo</italic><sup>-/-</sup> cells (Wilcoxon test, p&lt;2.2e-16). However, differentially translated genes between <italic>Pelo</italic><sup>-/-</sup> (DE RPF <italic>Pelo</italic><sup>-/-</sup>) and <italic>Hbs1l<sup>-/-</sup></italic> (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>) cells were strongly correlated (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), indicating that, although loss of <italic>Hbs1l</italic> may lead to smaller alterations in translation, most of the changes occur in the same direction.</p><p>In addition, 20% (1060) and 2% (70) of the differentially translated genes in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l<sup>-/-</sup></italic> cells also contained ribosome pauses specifically found in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l<sup>-/-</sup></italic> cells, respectively, and translation of these pausing genes was both increased and decreased (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). However, changes in expression were under 2-fold for the majority of <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l<sup>-/-</sup>-</italic>pausing genes (88% of <italic>Pelo</italic><sup>-/-</sup>- and 93% of <italic>Hbs1l</italic><sup>-/-</sup>-pausing genes) and these changes were significantly lower compared to those in genes without mutant-specific pauses (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and D</xref>). Thus, similar to <italic>Hbs1l</italic><sup>-/-</sup> embryos, these data suggest that most of the translational changes in gene expression are not due to an increase in the ribosome occupancy but are likely a response to changes in mRNA expression and/or translation regulation.</p><p>Interestingly, we observed an opposing relationship between transcriptional expression changes (DE mRNA) and changes in translational efficiency (TE) of many genes in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l<sup>-/-</sup></italic> cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). KEGG pathway analysis of genes with this opposing behavior revealed enrichment of several pathways (ribosome, ribosome biogenesis, RNA transport, spliceosome, cell cycle, and lysosome) that overlapped with those of differently translated genes (DE RPF) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>), suggesting that expression of genes in these pathways is translationally regulated, perhaps to restore homeostasis between the transcriptome and translatome.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Pelo</italic>/<italic>Hbs1l</italic> deficiency alters translation regulation and reprograms the translatome.</title><p>(<bold>A</bold>) Translational efficiency (TE) of genes that are transcriptionally upregulated or downregulated was compared to the remaining (‘other’) genes from <italic>Pelo</italic><sup>-/-</sup> (blue) and <italic>Hbs1l</italic><sup>-/-</sup> (red) MEFs, respectively. Downward direction of arrows indicates significant decrease in translational efficiency of transcriptionally upregulated genes in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l</italic><sup>-/-</sup> MEFs. Upward direction of arrows indicates significant increase in translational efficiency of transcriptionally downregulated genes in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l</italic><sup>-/-</sup> MEFs. (<bold>B</bold>) KEGG pathway analysis of genes from <italic>Pelo</italic><sup>-/-</sup> MEFs in which the translational efficiency (TE <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05) is opposite to their transcriptional expression (DE mRNA <italic>Pelo</italic><sup>-/-</sup>, <italic>q</italic>-value ≤0.05). Italicized pathways indicate pathways that overlapped with enriched pathways of differentially translated genes in <italic>Pelo</italic><sup>-/-</sup> MEFs (DE RPF <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). The red dashed line indicates the significance threshold (p=0.05). (<bold>C</bold>) Ingenuity pathway analysis (IPA) of genes with differential translational efficiency from <italic>Pelo</italic><sup>-/-</sup> (TE <italic>Pelo</italic><sup>-/-</sup>) and <italic>Hbs1l</italic><sup>-/-</sup> (TE <italic>Hbs1l</italic><sup>-/-</sup>) MEFs. EIF2 and mTOR/p70S6K signaling are in italics. The red dashed line indicates the significance threshold (p=0.05). (<bold>D</bold>) Western blot analysis of p-eIF2α<sup>S51</sup> and p-p70S6K<sup>T389</sup> using lysates of tamoxifen-treated control (<italic>Pelo</italic><sup>fl/fl</sup>) and <italic>Pelo</italic><sup>-/-</sup> MEFs at Day 2 (Passage P1). Vinculin was used as a loading control. (<bold>E</bold>) Levels of p-eIF2α<sup>S51</sup> or p-p70S6K<sup>T389</sup> were normalized to total level of eIF2α or p70S6K, and phosphorylation levels are relative to those of control (<italic>Pelo</italic><sup>fl/fl</sup>). Data represent mean + SD. (<bold>F</bold>) Translational efficiency (TE) of genes with translational regulation by mTOR via their 5’TOP motif was compared to the remaining (‘other’) genes from <italic>Pelo</italic><sup>-/-</sup> (blue) and <italic>Hbs1l</italic><sup>-/-</sup> (red) MEFs. Upward direction of arrows indicates significant increase in translational efficiency of 5’TOP genes. 4-OHT, 4-hydroxytamoxifin; 5’TOP, 5’terminal oligopyrimidine motif. Student’s t-test (<bold>E</bold>); Wilcoxon rank-sum test was used to determine statistical significance (<bold>A, F</bold>). ns, not significant; **p≤0.01.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title><italic>Pelo/Hbs1l</italic> deficiency alters translation regulation and reprograms the translatome.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>Pelo</italic>/<italic>Hbs1l</italic> deficiency alters translational gene expression of multiple pathways.</title><p>(<bold>A</bold>) Translational efficiency (TE) of <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l</italic><sup>-/-</sup>-pausing genes was compared to the TE of the remaining (‘other’) genes from <italic>Pelo</italic><sup>-/-</sup> (blue) and <italic>Hbs1l</italic><sup>-/-</sup> (red) MEFs. Upward direction of arrows indicates significant increase in translational efficiency of <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l</italic><sup>-/-</sup>-pausing genes. (<bold>B</bold>) Analysis of differentially translated genes in <italic>Pelo</italic><sup>-/-</sup> (DE RPF <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05, left) and <italic>Hbs1l</italic><sup>-/-</sup> (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05, right) MEFs are shown in gray. <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l</italic><sup>-/-</sup>-specific pausing genes (z-score ≥10, detected in all three biological replicates) that are differentially translated are highlighted. Twofold changes in expression are indicated by the black dashed lines. (<bold>C</bold>) Differentially translated genes in <italic>Hbs1l</italic><sup>-/-</sup> MEFs (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05, x-axis, red) were plotted against genes that are differentially translated in <italic>Pelo</italic><sup>-/-</sup> MEFs (DE RPF <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05, y-axis, blue). Genes those translation was significantly different in both <italic>Hbs1l</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> MEFs are shown in purple. (<bold>D</bold>) Differential translation of genes in <italic>Pelo</italic> (DE RPF <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05) and <italic>Hbs1l</italic> (DE RPF <italic>Hbs1l</italic><sup>-/-</sup>, adj. p≤0.05) was compared to that of <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l</italic><sup>-/-</sup>-specific pausing genes. Downward direction of arrows indicates significantly reduced changes in RPFs from the pausing genes compared to non-pausing (‘other’) genes. (<bold>E</bold>) KEGG pathway analysis of differentially translated (up- and downregulated) genes (DE RPF <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05) in <italic>Pelo</italic><sup>-/-</sup> MEFs. Top nine of the significantly enriched pathways are shown. The red dashed line indicates the significance threshold (p=0.05). Pathways that are positively (ribosome, ribosome biogenesis) and negatively (lysosome, autophagy) regulated by mTORC1 are in italics. (<bold>F</bold>) Ingenuity pathway analysis (IPA) of differentially transcribed genes in <italic>Pelo</italic> (DE mRNA <italic>Pelo</italic><sup>-/-</sup>) and <italic>Hbs1l</italic> (DE mRNA <italic>Hbs1l</italic><sup>-/-</sup>). EIF2 and mTOR/p70S6K signaling are in italics. The red dashed line indicates the significance threshold (p=0.05). RPF, ribosome protected fragments. Wilcoxon rank-sum test was used to determine statistical significance (<bold>A, D</bold>); Pearson coefficient (r) was determined to analyze linearity of gene expression changes (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To identify signaling pathways that might control these changes in translation regulation upon loss of <italic>Pelo</italic>/<italic>Hbs1l</italic>, we performed IPA analysis on differentially transcribed (DE mRNA) genes and genes with altered translation efficiency (TE). EIF2 and mTOR/p70S6K signaling, both of which are known to regulate translation, were highly enriched in <italic>Pelo</italic><sup>-/-</sup> cells but less enriched in <italic>Hbs1l</italic><sup>-/-</sup> cells (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). Phosphorylation of eIF2α decreases translation initiation, while the activity of mTOR, in particular mTORC1 (mechanistic target of rapamycin complex 1), increases translation initiation and elongation. About 50% of the differentially regulated genes identified by IPA overlapped between the two pathways and therefore, we assessed the phosphorylation status of p-eIF2α<sup>S51</sup> and p-p70S6<sup>T389</sup>, a known target of mTORC1, to determine if one or both signaling pathways were affected. Levels of p-eIF2α<sup>S51</sup> in <italic>Pelo</italic><sup>-/-</sup> cells were unchanged from those of control cells (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). However, levels of p-p70S6<sup>T389</sup> were significantly increased in <italic>Pelo</italic><sup>-/-</sup> cells, indicating activation of mTOR signaling (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). In agreement, the TE of genes that are known to be translationally regulated by mTORC1 via their 5’terminal oligopyrimidine motifs (5’TOP) (<xref ref-type="bibr" rid="bib144">Yamashita et al., 2008</xref>) was significantly increased in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l</italic><sup>-/-</sup> cells, although this increase was less pronounced in the latter (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Activation of mTORC1 may underlie some of the observed gene expression changes (DE RPF) given its role as a positive regulator for ribosome biogenesis and translation of ribosomal genes and a negative regulator of lysosomal biogenesis and autophagy (<xref ref-type="bibr" rid="bib65">Kim et al., 2011</xref>; <xref ref-type="bibr" rid="bib93">Mayer and Grummt, 2006</xref>; <xref ref-type="bibr" rid="bib107">Puertollano, 2014</xref>; <xref ref-type="bibr" rid="bib109">Rabanal-Ruiz et al., 2018</xref>; <xref ref-type="bibr" rid="bib112">Roczniak-Ferguson et al., 2012</xref>), which parallels the directionality of the changes in these pathways (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>).</p></sec><sec id="s2-5"><title>Convergent modulation of the translatome in cells with defects in translation-dependent quality control pathways</title><p>Our findings suggest that translational reprogramming occurs upon loss of <italic>Pelo/Hbs1l</italic>. However, whether these changes are unique to <italic>Pelo/Hbs1l</italic> or reflect a more general cellular response upon impairment of translation-dependent quality control pathways is unclear. To investigate this possibility, we conditionally deleted the core NMD component, <italic>Upf2</italic>, in MEFs (<xref ref-type="bibr" rid="bib74">Lelivelt and Culbertson, 1999</xref>; <xref ref-type="bibr" rid="bib116">Serin et al., 2001</xref>). In contrast to NGD and NSD that resolve ribosomes on mRNAs impeding translation elongation, nonsense-mediated decay (NMD) targets aberrant mRNAs (e.g. mRNAs containing a premature termination codon) for degradation during translation (<xref ref-type="bibr" rid="bib64">Karousis and Mühlemann, 2019</xref>; <xref ref-type="bibr" rid="bib115">Schuller and Green, 2018</xref>). Consistent with the function of <italic>Upf2</italic> in NMD, about 20% and 13% of upregulated transcripts (DE mRNA <italic>Upf2</italic>, <italic>q-value</italic> ≤0.05) were NMD transcripts or transcripts with retained introns, respectively (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). Although the accumulation of these transcripts was specific to <italic>Upf2</italic> <sup>-/-</sup> cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>), we observed an inverse relationship between transcriptional gene expression changes (DE mRNA <italic>Upf2</italic>) and changes in translational efficiency (TE <italic>Upf2</italic>) in <italic>Upf2<sup>-/-</sup></italic> cells as we did in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l<sup>-/-</sup></italic> cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Surprisingly, IPA analysis on differentially transcribed (DE mRNA <italic>Upf2</italic><sup>-/-</sup>) genes and genes with altered translation efficiency (TE <italic>Upf2</italic><sup>-/-</sup>) revealed enrichment for EIF2 and mTOR signaling in <italic>Upf2<sup>-/-</sup></italic> as observed in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l<sup>-/-</sup></italic> cells (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>). Western blot analysis revealed the level of p-eIF2α<sup>S51</sup> in <italic>Upf2<sup>-/-</sup></italic> cells was unchanged from that of controls, but p-p70S6<sup>T389</sup> levels and translation of 5’TOP genes were significantly increased (<xref ref-type="fig" rid="fig6">Figure 6C,D and E</xref>), indicating that mTORC1 is activated in <italic>Upf2<sup>-/-</sup></italic> cells. Although translation of ribosomal genes was increased, transcriptional levels of ribosomal genes were decreased in <italic>Upf2</italic><sup>-/-</sup> similar to <italic>Pelo</italic><sup>-/-</sup> cells (<xref ref-type="fig" rid="fig6">Figure 6F</xref>), further supporting that mTORC1 activation may be a general response in an attempt to restore cellular homeostasis in <italic>Upf2</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> cells.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Defects in different translation-dependent quality control pathways similarly alter translation regulation and the translatome.</title><p>(<bold>A</bold>) Translational efficiency (TE) of genes that are transcriptionally upregulated or downregulated was compared to the remaining (‘other’) genes from <italic>Upf2</italic><sup>-/-</sup> (green) MEFs. Downward direction of the arrow indicates significant decrease in translational efficiency of transcriptionally upregulated genes in <italic>Upf2</italic><sup>-/-</sup> MEFs. Upward direction of the arrow indicates significant increase in translational efficiency of transcriptionally downregulated genes in <italic>Upf2</italic><sup>-/-</sup> MEFs. (<bold>B</bold>) Ingenuity pathway analysis (IPA) of differentially transcribed genes from <italic>Upf2</italic><sup>-/-</sup> MEFs (DE mRNA <italic>Upf2</italic><sup>-/-</sup>). EIF2 and mTOR/p70S6K signaling are in italics. The red dashed line indicates the significance threshold (p=0.05). (<bold>C</bold>) Western blot analysis of p-eIF2α<sup>S51</sup> and p-p70S6K<sup>T389</sup> of lysates from tamoxifen-treated control (<italic>Upf2</italic><sup>fl/+</sup>) and <italic>Upf2</italic><sup>-/-</sup> MEFs at Day 2 (Passage P1). Vinculin was used as a loading control. (D) Levels of p-eIF2α<sup>S51</sup> or p-p70S6K<sup>T389</sup> were normalized to total level of eIF2α or p70S6K, and phosphorylation levels are relative to those of control (<italic>Upf2</italic><sup>fl/+</sup>) MEFs. Data represent mean + SD. (<bold>E</bold>) Translational efficiency (TE) of genes those translation is regulated by mTOR via their 5’TOP motif was compared to the remaining (‘other’) genes from <italic>Upf2</italic><sup>-/-</sup> (green) MEFs. Upward direction of the arrow indicates significant increase in translational efficiency of 5’TOP genes. (<bold>F</bold>) Differential transcription (DE mRNA) or translational efficiency (TE) of ribosomal protein genes (small and large ribosomal subunit) was compared to the remaining (‘other’) genes from <italic>Pelo</italic><sup>-/-</sup> (blue), <italic>Upf2</italic><sup>-/-</sup> (green), and <italic>Hbs1l</italic><sup>-/-</sup> (red) MEFs. Up- and downward direction of arrows indicates significant up- and downregulation of ribosomal protein genes, respectively. The heatmap indicates the gene expression changes of ribosomal protein genes. (<bold>G</bold>) Identification of upstream regulators of genes with differential translational efficiency in <italic>Upf2</italic><sup>-/-</sup> (TE <italic>Upf2</italic><sup>-/-</sup>) and <italic>Pelo</italic><sup>-/-</sup> (TE <italic>Pelo</italic><sup>-/-</sup>) MEFs. Top ten transcription factors are shown. Those enriched in both <italic>Upf2</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> MEFs and shown in red. Up- or downward direction of arrows indicates predicted up- or downregulation of transcription factors, respectively. (<bold>H</bold>) Differentially translated genes in <italic>Upf2</italic><sup>-/-</sup> MEFs (DE RPF <italic>Upf2</italic><sup>-/-</sup>, adj. p≤0.05, x-axis, green) were plotted against genes that are differentially translated in <italic>Pelo</italic><sup>-/-</sup> MEFs (DE RPF <italic>Pelo</italic><sup>-/-</sup>, adj. p≤0.05, y-axis, blue). Genes those translation was significantly different in both <italic>Upf2</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> MEFs are shown in purple. (<bold>I</bold>) KEGG pathway analysis of differentially translated (up- and downregulated) genes (DE RPF, adj. p≤0.05) in <italic>Upf2</italic><sup>-/-</sup> (green), <italic>Pelo</italic><sup>-/-</sup> (blue) and <italic>Hbs1l</italic><sup>-/-</sup> (red) MEFs. Significantly (p≤0.05) enriched pathways are shown and pathways in bold indicate pathways that are shared between any of the mutant MEFs. Pathways known to be positively or negatively regulated by mTORC1 are in red. 4-OHT, 4-hydroxytamoxifin; 5’TOP, 5’terminal oligopyrimidine motif. Student’s t-test (<bold>D</bold>); Wilcoxon rank-sum test was used to determine statistical significance (<bold>A, E, F</bold>); Pearson coefficient (r) was determined to analyze linearity of gene expression changes (<bold>H</bold>). ns, not significant; **p≤0.01.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Defects in different translation-dependent quality control pathways similarly alter translation regulation and the translatome.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Loss of <italic>Upf2</italic> leads to an increase of NMD targets.</title><p>(<bold>A</bold>) Ensembl-annotated transcript biotypes of differentially transcribed mRNAs in <italic>Upf2</italic><sup>-/-</sup> (DE mRNA <italic>Upf2</italic><sup>-/-</sup>, <italic>q</italic>-value ≤0.05) and <italic>Pelo</italic><sup>-/-</sup> (DE mRNA <italic>Pelo</italic><sup>-/-</sup>, <italic>q</italic>-value ≤0.05) MEFs. (<bold>B</bold>) Transcriptional expression of NMD transcripts with significant (<italic>q</italic>-value ≤0.05) changes in expression in <italic>Upf2</italic><sup>-/-</sup> (DE mRNA <italic>Upf2</italic><sup>-/-</sup>) and <italic>Pelo</italic><sup>-/-</sup> (DE mRNA <italic>Pelo</italic><sup>-/-</sup>) was compared to expression of the remaining (‘other’) transcripts. The effect size (<italic>beta</italic>) is analogous to the natural log fold change in expression. Up- or downward direction of arrows indicates significant increase or decrease in expression of NMD transcripts in <italic>Upf2</italic><sup>-/-</sup> or <italic>Pelo</italic><sup>-/-</sup> MEFs. (<bold>C</bold>) Ingenuity pathway analysis (IPA) of genes with differential translational efficiency (TE) in <italic>Upf2</italic><sup>-/-</sup> MEFs (TE <italic>Upf2</italic><sup>-/-</sup>). EIF2 and mTOR signaling are in italics. The red dashed line indicates the significance threshold (p=0.05). (<bold>D</bold>) Comparison of z-scores (‘pause score’) of specific pauses observed in <italic>Pelo</italic><sup>-/-</sup> (blue) and <italic>Upf2</italic><sup>-/-</sup> (green) MEFs. Downward direction of the arrow indicates significantly lower pause scores specific to <italic>Upf2</italic><sup>-/-</sup> compared to <italic>Pelo</italic><sup>-/-</sup> MEFs. (<bold>E</bold>) Transcriptional expression of either <italic>Pelo</italic>- or <italic>Hbs1l</italic>-specific pausing transcripts (unique protein-coding pausing transcripts) was compared to the remaining (‘other’) transcripts in <italic>Upf2</italic><sup>-/-</sup> (DE mRNA <italic>Upf2</italic><sup>-/-</sup>) MEFs. The effect size (<italic>beta</italic>) is analogous to the natural log fold change in expression. Downward direction of arrows indicates a significant decrease in expression of <italic>Pelo</italic>- or <italic>Hbs1l</italic>-specific pausing transcripts in <italic>Upf2</italic><sup>-/-</sup> MEFs. NMD, nonsense-mediated transcript; lncRNA, long noncoding RNA. Wilcoxon rank-sum test was used to determine statistical significance (<bold>B, D, E</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Surprisingly, most of the top upstream regulators predicted by IPA analysis that may govern the observed gene expression changes were shared between <italic>Upf2</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> cells and included <italic>Trp53</italic>, <italic>Myc</italic>, <italic>Tgfb1</italic>, <italic>Errb2</italic>, <italic>Cdkn1a</italic>, <italic>Hras</italic>, and <italic>Nfkbia</italic> (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). In agreement, genes with differential translational efficiency were strongly correlated between <italic>Upf2</italic><sup>-/-</sup> and <italic>Pelo</italic><sup>-/-</sup> cells (Pearson’s correlation<italic>, r</italic> = 0.6576). Furthermore, differentially translated genes in <italic>Upf2</italic><sup>-/-</sup> (32% of genes, DE RPF <italic>Upf2</italic><sup>-/-</sup>) and <italic>Pelo</italic><sup>-/-</sup> (34% of genes, DE RPF <italic>Pelo</italic><sup>-/-</sup>) cells also showed a strong linear correlation (<xref ref-type="fig" rid="fig6">Figure 6H</xref>), indicating that defects in these quality control pathways may not only lead to similar changes in translation regulation (TE) but also in global gene translation (DE RPF). Consistent with the similar changes in translation, KEGG pathway analysis of differentially translated genes (DE RPF, adj. p≤0.05) revealed similar enrichment of multiple pathways in <italic>Upf2</italic><sup>-/-</sup>, <italic>Pelo</italic><sup>-/-</sup>, and <italic>Hbs1</italic><sup>-/-</sup> cells (<xref ref-type="fig" rid="fig6">Figure 6I</xref>).</p><p>In contrast with the many ribosome pauses we observed specifically in <italic>Pelo</italic><sup>-/-</sup> cells, only 4% of all ribosome pausing events observed in <italic>Upf2</italic><sup>-/-</sup> and control cells were uniquely found in <italic>Upf2</italic><sup>-/-</sup> cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). Although only a small fraction (8%) of <italic>Pelo-</italic> and <italic>Hbs1l</italic>-specific pausing transcripts corresponded to NMD transcripts, we considered the possibility that some of the protein-coding transcripts with ribosome pauses in <italic>Pelo</italic><sup>-/-</sup> and <italic>Hbs1l</italic><sup>-/-</sup> cells may also be NMD sensitive given that 5–10% of mRNAs without premature termination codons are thought to be degraded by the NMD pathway (<xref ref-type="bibr" rid="bib45">He et al., 2003</xref>; <xref ref-type="bibr" rid="bib56">Jaffrey and Wilkinson, 2018</xref>; <xref ref-type="bibr" rid="bib74">Lelivelt and Culbertson, 1999</xref>; <xref ref-type="bibr" rid="bib94">Mendell et al., 2004</xref>). However, upregulation of these protein-coding pausing transcripts was not observed in <italic>Upf2</italic><sup>-/-</sup> cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>), suggesting that these pausing transcripts are not NMD sensitive. Together, these findings suggest that while <italic>Pelo/Hbs1l</italic> and <italic>Upf2</italic> largely function in distinct quality control pathways, disruption of either pathway results in similar translational gene expression changes.</p></sec><sec id="s2-6"><title>Deletion of <italic>Upf2</italic> or <italic>Pelo</italic> cause similar cerebellar developmental defects</title><p>Intrigued by the similar changes in translation upon impairment of <italic>Upf2</italic> and <italic>Pelo/Hbs1l</italic> in MEFs, we conditionally deleted <italic>Upf2</italic> during cerebellar development to determine if phenotypic similarities exist upon loss of these different translation-dependent quality control pathways. Surprisingly, deletion of <italic>Upf2</italic> (<italic>En1<sup>Cre</sup>; Upf2</italic> cKO) or <italic>Pelo</italic> (<italic>En1<sup>Cre</sup>; Pelo</italic> cKO) using <italic>En1<sup>Cre</sup></italic> resulted in largely indistinguishable defects with a grossly hypoplastic cerebellum and regions of the midbrain (superior and inferior colliculus) being nearly absent unlike in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO mice (<xref ref-type="fig" rid="fig7">Figures 7A</xref> and <xref ref-type="fig" rid="fig2">2D</xref>). Both <italic>Upf2</italic> and <italic>Pelo</italic> mutant pups died shortly after birth, perhaps due to <italic>En1<sup>Cre</sup></italic> deletion of these genes in other cell types (<xref ref-type="bibr" rid="bib9">Britz et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Kimmel et al., 2000</xref>; <xref ref-type="bibr" rid="bib114">Sapir et al., 2004</xref>; <xref ref-type="bibr" rid="bib117">Sgaier et al., 2007</xref>; <xref ref-type="bibr" rid="bib142">Wurst et al., 1994</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Loss of <italic>Upf2</italic> and <italic>Pelo</italic> cause similar cerebellar developmental defects.</title><p>(<bold>A</bold>) Parasagittal (E13.5) and sagittal (P0) cerebellar sections of control (<italic>Pelo</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO mice stained with cresyl violet. (<bold>B</bold>) Sagittal cerebellar sections of P21 control (<italic>Pelo</italic><sup>fl/fl</sup>), Tg(Atoh1-Cre); <italic>Upf2</italic> cKO and Tg(Atoh1-Cre); <italic>Pelo</italic> cKO mice stained with cresyl violet. Higher magnification images of lobule VI are shown below for each genotype. Cerebellar lobules are indicated by Roman numerals. (<bold>C</bold>) Immunofluorescence with antibodies to BrdU (green) and Ki67 (red) on sections of P6 control (Tg(Atoh1-Cre); <italic>Upf2</italic><sup>fl/+</sup>), Tg(Atoh1-Cre); <italic>Upf2</italic> cKO and Tg(Atoh1-Cre); <italic>Pelo</italic> cKO cerebellum. Mice were injected with BrdU 24 hr prior to harvest to determine the fraction of granule cell precursors in the EGL that exited the cell cycle. Images are shown for anterior (IV/V) and posterior (IX) lobules. (<bold>D</bold>) Quantification of the fraction of granule cell precursors in the EGL (lobules IV/V and IX) that exited the cell cycle (BrdU<sup>+</sup>, Ki67<sup>-</sup> cells) of control (Tg(Atoh1-Cre); <italic>Upf2</italic><sup>fl/+</sup>), Tg(Atoh1-Cre); <italic>Upf2</italic> cKO, Tg(Atoh1-Cre); <italic>Pelo</italic> cKO and Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO mice. Data represent mean + SD. (<bold>E</bold>) Quantification of terminally differentiated granule cells (NeuN<sup>+</sup> cells) in the IGL in lobules IV/V and IX of control (Tg(Atoh1-Cre); <italic>Upf2</italic><sup>fl/+</sup>), Tg(Atoh1-Cre); <italic>Upf2</italic> cKO, Tg(Atoh1-Cre); <italic>Pelo</italic> cKO and Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO mice. Data represent mean + SD. Scale bars: 200 μm (E13.5) and 500 μm (P0) (<bold>A</bold>); 500 μm and 20 μm (higher magnification) (<bold>B</bold>); 50 μm (<bold>C</bold>). VZ, ventricular zone, EGL, external granule cell layer; NTZ, nuclear transitory zone; SC, superior colliculus; IC, inferior colliculus; ML, molecular cell layer; PL, Purkinje cell layer; GCL, granule cell layer; oEGL, outer external granule cell layer; iEGL, inner external granule cell layer; IGL, internal granule cell layer. Two-way ANOVA was corrected for multiple comparisons using Tukey method (<bold>D, E</bold>). ns, not significant; ***p≤0.001; ****p≤0.0001.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Loss of <italic>Upf2</italic> and <italic>Pelo</italic> cause similar cerebellar developmental defects.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title><italic>Upf2</italic> and <italic>Pelo</italic> are required for the development of multiple cerebellar linages.</title><p>(<bold>A</bold>) Immunofluorescence using antibodies to BrdU (green) and Ki67 (red) on cerebellar sections from E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO embryos to determine the fraction of cells in VZ that exited the cell cycle. Embryos were injected with BrdU 24 hr prior to harvest. (<bold>B</bold>) Percentage of cerebellar VZ-progenitors that exited the cell cycle (BrdU<sup>+</sup>, Ki67<sup>-</sup> cells). Data represent mean + SD. (<bold>C</bold>) Number of cerebellar Purkinje cell precursors (Lhx1/5<sup>+</sup> cells). Data represent mean + SD. (<bold>D</bold>) Immunofluorescence using antibodies to Lhx1/5 on cerebellar sections from E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO embryos. Sections were counterstained with DAPI and higher magnification images of boxed areas are shown. (<bold>E</bold>) Immunofluorescence using antibodies to Pax2 (red) on cerebellar sections from E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO embryos. Sections were counterstained with DAPI. Arrowheads denote occasional Pax2<sup>+</sup> cells. (<bold>F</bold>) Number of cerebellar VZ-derived interneuron precursors (Pax2<sup>+</sup> cells). Data represent mean + SD. (<bold>G</bold>) Immunofluorescence using antibodies to Tbr1 (red) on cerebellar sections from E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO embryos. Sections were counterstained with DAPI. Arrowheads denote occasional Tbr1<sup>+</sup> cells. (<bold>H</bold>) Number of RL-derived Tbr1<sup>+</sup> deep cerebellar neurons. Data represent mean + SD. (<bold>I</bold>) Quantification of newborn granule cell precursors (BrdU<sup>+</sup> cells) in E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO EGL. Data represent mean + SD. Embryos were injected with BrdU 24 hr prior to harvest. (J) Immunofluorescence using antibodies to cleaved caspase 3 (Casp3, red) on cerebellar sections from E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO, <italic>En1<sup>Cre</sup>; Pelo</italic> cKO and <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos. Sections were counterstained with DAPI. Note: Because the number of apoptotic cells was noticeably higher in <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebella, arrowheads (magenta) to indicate these cells were not included. (K) Number of Casp3<sup>+</sup> cells. Data represent mean + SD. (<bold>L</bold>) Immunofluorescence on sections of E13.5 control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebellum with antibodies to p-S6<sup>S240/244</sup> (red) and PCNA (green). (<bold>M</bold>) Relative fluorescence intensity (FI) of p-S6<sup>S240/244</sup> of control (<italic>Upf2</italic><sup>fl/fl</sup>), <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO embryos. Levels of p-S6<sup>S240/244</sup> are relative to those of control (<italic>Upf2</italic><sup>fl/fl</sup>). Data represent mean + SD. Scale bars: 100 μm and 20 μm (higher magnification) (<bold>A</bold>); 100 μm and 50 μm (higher magnification) (<bold>D</bold>); 50 μm (<bold>E, G</bold>); 20 μm (<bold>J</bold>); 25 μm (<bold>L</bold>). VZ, ventricular zone; RL, rhombic lip; NTZ; nuclear transitory zone; EGL, external granule cell layer. One-way ANOVA was corrected for multiple comparisons using Tukey method (<bold>B, C, F, H, I, K, M</bold>). ns, not significant; **p≤0.01; ***p≤0.001; ****p≤0.0001.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title><italic>Upf2</italic> and <italic>Pelo</italic> are required for the development of multiple cerebellar linages.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-fig7-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66904-fig7-figsupp1-v1.tif"/></fig></fig-group><p>Similar neurogenesis defects were observed in the <italic>Upf2</italic> and <italic>Pelo</italic> mutant cerebellum. The fraction of ventricular zone (VZ) progenitors that remained in the cell cycle was higher in E13.5 <italic>Upf2</italic>- or <italic>Pelo</italic>-deficient cerebella compared to controls (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A and B</xref>), indicating that like <italic>Hbs1l</italic>, loss of <italic>Upf2</italic> or <italic>Pelo</italic> impairs cell cycle exit of VZ-progenitors. Inversely, the number of VZ-derived precursors, for example Purkinje cells (Lhx1/5<sup>+</sup> cells) and Pax2<sup>+</sup> interneurons were reduced by ~83% and~90% in the <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebellum (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C,D,E and F</xref>). Glutamatergic deep cerebellar neurons (Tbr1<sup>+</sup>) were nearly absent in the E13.5 <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebellum (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1G and H</xref>). In addition, the EGL was missing in <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebella at both E13.5 and P0 (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1I</xref>), indicating that neurogenesis defects are particularly more severe in the absence of <italic>Upf2</italic> or <italic>Pelo</italic> relative to those observed upon <italic>Hbs1l</italic> loss.</p><p>Thus, we considered that in addition to cell cycle exit abnormalities, cell death might also contribute to impaired cerebellar development. Indeed, the number of apoptotic cells (Casp3<sup>+</sup> cells) was significantly increased in the <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebellum compared to that of controls or <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO embryos, and apoptotic cells were observed in both the ventricular zone and the prospective white matter where progenitor-derived progeny reside (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1J and K</xref>). Together, these data suggest that defects in cell cycle exit and increased cell death likely impair cerebellar development in <italic>Upf2</italic> and <italic>Pelo</italic> mutant mice. To determine if loss of <italic>Upf2</italic> or <italic>Pelo</italic> also increased mTORC1 signaling in the developing cerebellum as it did in MEFs, we analyzed levels of p-S6<sup>S240/244</sup>, a known downstream target of mTORC1. In agreement, levels of p-S6<sup>S240/244</sup> were significantly increased in the <italic>En1<sup>Cre</sup>; Upf2</italic> cKO and <italic>En1<sup>Cre</sup>; Pelo</italic> cKO cerebellum, including the VZ (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1L and M</xref>).</p><p>Because loss of <italic>Upf2</italic> or <italic>Pelo</italic> severely impaired early granule cell neurogenesis, we investigated if these genes are also required later in the development of these cells. Conditional deletion of either <italic>Upf2</italic> or <italic>Pelo</italic> using Tg(Atoh1<italic>-</italic>Cre) resulted in abnormalities of the anterior lobes of the cerebellum in P21 mice (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). These lobes were reduced in length and Purkinje cells failed to form a monolayer. In contrast, the posterior lobes appeared unaffected, possibly due to the anterior-to-posterior gradient of <italic>Cre</italic> expression in granule cell precursors in the developing cerebellum (<xref ref-type="bibr" rid="bib104">Pan et al., 2009</xref>; <xref ref-type="bibr" rid="bib108">Qiu et al., 2010</xref>; <xref ref-type="bibr" rid="bib140">Wojcinski et al., 2019</xref>).</p><p>During postnatal cerebellar development, granule cell precursors in the outer region of the EGL (oEGL) exit the cell cycle and transiently reside in the inner EGL (iEGL) before migrating to the internal granule cell layer (IGL). To determine if granule cell precursors in postnatal Tg(Atoh1-Cre); <italic>Upf2</italic> cKO or Tg(Atoh1-Cre); <italic>Pelo</italic> cKO cerebellum properly exited the cell cycle, we labeled granule cell precursors with BrdU to determine the fraction of precursors that exited the cell cycle twenty-four hours later (BrdU<sup>+</sup>; Ki67<sup>-</sup> cells). In P6 control cerebella, BrdU-labeled granule cell precursors that were negative for Ki67 formed a distinct layer on the ventral surface of the EGL consistent with the appearance and location of the iEGL (<xref ref-type="bibr" rid="bib73">Legué et al., 2016</xref>; <xref ref-type="fig" rid="fig7">Figure 7C</xref>). However, no clear separation between the oEGL and iEGL was observed in the anterior lobes in Tg(Atoh1-Cre); <italic>Upf2</italic> cKO or Tg(Atoh1-Cre); <italic>Pelo</italic> cKO cerebella (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), and the fraction of granule cell precursors that exited the cell cycle (BrdU<sup>+</sup>; Ki67<sup>-</sup> cells) in these lobes, but not posterior lobes, was significantly lower compared to control or Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO cerebella (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Correspondingly, the number of terminally differentiated granule cells in the IGL (NeuN<sup>+</sup> cells) of the anterior, but not posterior, lobes was reduced by ~45% in P6 Tg(Atoh1-Cre); <italic>Upf2</italic> cKO or Tg(Atoh1-Cre); <italic>Pelo</italic> cKO cerebella (<xref ref-type="fig" rid="fig7">Figure 7E</xref>), indicating that both of these genes are necessary for differentiation of granule cell precursors.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Translation-dependent quality control pathways govern protein synthesis and proteostasis by degrading aberrant mRNAs that result in potentially toxic peptide products. However, little is known about the in vivo defects or how translation is altered in the absence of these pathways. To interrogate these questions, we investigated the translational and phenotypic alterations from different translation-dependent quality control pathways including the NSD/NGD (<italic>Pelo</italic>/<italic>Hbs1l</italic>) and the NMD (<italic>Upf2</italic>) pathways.</p><p>Here, we show that <italic>Pelo </italic>and <italic>Hbs1l</italic> are both critical for mouse embryonic and cerebellar development but dispensable for granule cells after cerebellar development. In addition, loss of <italic>Pelo</italic> or <italic>Hbs1l</italic> locally increase the ribosome occupancy (‘ribosome pauses’) of genes. Interestingly, the number and strength of these pauses were higher in E8.5 <italic>Hbs1l</italic><sup>-/-</sup> embryos, just prior to the time when these embryos cease developing, compared to the postnatal cerebellum, where loss of <italic>Hbs1l</italic> had no effect on cerebellar granule cells. Together these data suggest that this translation-dependent quality control pathway may be needed in cell- and/or tissue-specific manner.</p><p>In agreement with the differential severity between <italic>Pelo</italic><sup>-/-</sup><italic>-</italic> and <italic>Hbs1l</italic><sup>-/-</sup>-mediated defects during embryonic and cerebellar development, pauses were stronger and more frequent in <italic>Pelo</italic><sup>-/-</sup> MEFs and coincided with greater changes in gene expression than in <italic>Hbs1l</italic><sup>-/-</sup> MEFs. Loss of <italic>Pelo</italic> induced greater translation elongation defects compared to its binding partner <italic>Hbs1l</italic>, which may be in part be influenced by differences in gene expression and translational efficiency between <italic>Pelo-</italic> and <italic>Hbs1l-</italic>deficient cells. However, additional factors may also play a role. For example, while deletion of either <italic>Pelo</italic> or <italic>Hbs1l</italic> led to a reduction of their respective binding partners, the kinetics of this decrease upon deletion of <italic>Pelo</italic> or <italic>Hbs1l</italic> is unknown and may not be equal. In addition, Dom34 (<italic>Pelo</italic>) promotes dissociation of ribosomes by Rli1 (<italic>Abce1</italic>) and this activity increased in the presence of Hbs1 (<italic>Hbs1l</italic>) (<xref ref-type="bibr" rid="bib106">Pisareva et al., 2011</xref>; <xref ref-type="bibr" rid="bib119">Shoemaker and Green, 2011</xref>). Hence, we cannot rule out a scenario in which the remaining levels of PELO in <italic>Hbs1l</italic><sup>-/-</sup> cells might be able to mitigate and/or delay elongation defects even in the absence of <italic>Hbs1l</italic>.</p><p>Most of the ribosome pauses in <italic>Pelo</italic>- and <italic>Hbs1l-</italic>deficient tissues or cells were located in the coding sequence. Although these pauses with a footprint length of 27–34 nucleotides could indicate ribosomes that paused during translation, phenotypes in <italic>Hbs1l</italic> and <italic>Pelo</italic> mutant mice were not dependent on the B6J-associated mutation in <italic>n-Tr20</italic> that introduces genome-wide AGA pausing within mRNAs. Instead, these pauses may reflect pausing of the ‘trailing’ ribosomes upstream of the ‘lead’ ribosome that reached the 3’end of truncated mRNAs (<xref ref-type="bibr" rid="bib39">Guydosh et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Guydosh and Green, 2014</xref>). Footprints of the ‘lead’ ribosome have been analyzed on an exosome-deficient background (<xref ref-type="bibr" rid="bib4">Arribere and Fire, 2018</xref>; <xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Glover et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Guydosh and Green, 2014</xref>), and their short length of 15–18 nucleotides makes it difficult to uniquely map these footprints in mammals with their larger genomes. Regardless, recent biochemical studies have demonstrated that the <italic>Pelo</italic>/<italic>Hbs1l</italic> complex rescues trapped ribosomes near the 3’end of truncated mRNAs but is not necessary for the resolution of internally stalled ribosomes within the mRNA (<xref ref-type="bibr" rid="bib61">Juszkiewicz et al., 2020</xref>), which is consistent with early biochemical and structural studies demonstrating that Dom34:Hbs1 preferentially rescues ribosomes arrested at sites of truncation (<xref ref-type="bibr" rid="bib46">Hilal et al., 2016</xref>; <xref ref-type="bibr" rid="bib106">Pisareva et al., 2011</xref>; <xref ref-type="bibr" rid="bib119">Shoemaker and Green, 2011</xref>).</p><p>RNA intermediates that converge on <italic>Pelo</italic>/<italic>Hbs1l</italic> may derive from endonucleolytic cleavage for example during NMD, RNAi, or NGD (<xref ref-type="bibr" rid="bib4">Arribere and Fire, 2018</xref>; <xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Doma and Parker, 2006</xref>; <xref ref-type="bibr" rid="bib29">Eberle et al., 2009</xref>; <xref ref-type="bibr" rid="bib44">Hashimoto et al., 2017</xref>). However, most of the <italic>Pelo</italic><sup>-/-</sup>- and <italic>Hbs1l</italic><sup>-/-</sup>-pausing transcripts were not NMD sensitive, suggesting that if pausing occurred on truncated mRNAs, many of the RNA intermediates likely derived from additional mechanisms. Endonucleolytic cleavage of mRNAs may occur upon persistent ribosome collision during NGD (<xref ref-type="bibr" rid="bib22">D'Orazio et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Doma and Parker, 2006</xref>; <xref ref-type="bibr" rid="bib120">Shoemaker and Green, 2012</xref>). Intriguingly, widespread ribosome collision has been observed under normal conditions and may represent 10% of the pool of translating ribosomes (<xref ref-type="bibr" rid="bib3">Arpat et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Diament et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Han et al., 2020</xref>; <xref ref-type="bibr" rid="bib96">Meydan and Guydosh, 2020</xref>). Numerous human mRNAs are subject to repeated, co-translational endonucleolytic cleavage and occur independent of NMD-associated nucleases (<xref ref-type="bibr" rid="bib49">Ibrahim et al., 2018</xref>). Because translation changes during development and varies between cell types (<xref ref-type="bibr" rid="bib5">Blair et al., 2017</xref>; <xref ref-type="bibr" rid="bib13">Buszczak et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Castelo-Szekely et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Gonzalez et al., 2014</xref>; <xref ref-type="bibr" rid="bib128">Sudmant et al., 2018</xref>), RNA intermediates that are generated during translation may also vary and thereby, could introduce a need for quality control pathways in a tissue- and/or cell-type-specific manner.</p><p>We also observed that loss of <italic>Pelo/Hbs1l</italic> was associated with the activation of mTORC1 signaling. mTORC1 activation was previously observed in <italic>Hbs1l</italic> patient derived fibroblasts (<xref ref-type="bibr" rid="bib103">O'Connell et al., 2019</xref>) and upon deletion of <italic>Pelo</italic> during epidermal development (<xref ref-type="bibr" rid="bib79">Liakath-Ali et al., 2018</xref>). Interestingly, inhibition of translation/mTORC1 partially prevented <italic>Pelo</italic><sup>-/-</sup>-mediated epidermal defects (<xref ref-type="bibr" rid="bib79">Liakath-Ali et al., 2018</xref>). How mTORC1 responds to loss of <italic>Pelo</italic>/<italic>Hbs1l</italic> is unknown. Multiple mTOR-dependent phosphorylation sites on the surface of the ribosome have been observed, suggesting that mTORC1 and/or mTORC1-associated kinases interact with the ribosomes and might provide a mechanism to detect changes in translation elongation (<xref ref-type="bibr" rid="bib58">Jiang et al., 2016</xref>). However, changes in levels of ribosomal mRNAs and/or impaired ribosomal biogenesis also activate mTORC1 signaling (<xref ref-type="bibr" rid="bib82">Liu et al., 2014</xref>). Indeed, deletion of <italic>Pelo/Hbs1l</italic> led to decreased transcript levels but increased translation of ribosomal genes. Thus, mTORC1 may be activated to compensate for decreases in expression of these genes rather than directly sensing defects in translation elongation. To test whether mTORC1 activation was specific to <italic>Pelo</italic>/<italic>Hbs1l</italic> deficiency or was generally associated with defects in translation-dependent quality control pathways, we examined MEFs deficient for <italic>Upf2</italic>, an essential component of the NMD pathway. Loss of <italic>Upf2</italic> also led to decreased expression and increased translation of ribosomal genes and mTORC1 activation, supporting that changes in mTORC1 signaling are not a direct consequence of the elongation defects, but likely occurs as a compensatory response.</p><p>In general, impairment of either translation-dependent quality control pathway led to strikingly similar alterations in gene expression with <italic>Pelo</italic> and <italic>Upf2</italic> showing the most changes compared to <italic>Hbs1l</italic>. Reminiscent of these changes, loss of <italic>Pelo</italic> or <italic>Upf2</italic> had remarkably similar effects on multiple cerebellar neuronal populations during early embryonic and late postnatal neurogenesis, causing comparable morphological defects in the cerebellum (e.g. inhibition of differentiation and an increase in cell death). Growing evidence highlights the role of mTOR in the decision of stem cells to self-renew or differentiate (<xref ref-type="bibr" rid="bib95">Meng et al., 2018</xref>; <xref ref-type="bibr" rid="bib143">Xiang et al., 2011</xref>). However, increased mTOR activity generally reduces self-renewal and promotes differentiation of neuronal stem/progenitor cells (<xref ref-type="bibr" rid="bib43">Hartman et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">LiCausi and Hartman, 2018</xref>; <xref ref-type="bibr" rid="bib89">Magri et al., 2011</xref>; <xref ref-type="bibr" rid="bib136">Way et al., 2009</xref>), suggesting that other molecular changes contributed to the observed defects in neurogenesis.</p><p>The similarities in gene expression and developmental alterations in mice deficient for these translation-dependent quality control pathways suggest a convergence of molecular and cellular pathology. In fact, several changes in gene expression and signaling pathways were altered in the same direction in mutant cells. Thus, phenotypic changes could be due to either a change in a single molecular pathway or interactions of multiple pathways. For example, <italic>Myc</italic> activation was predicted as an upstream regulator of gene expression in both <italic>Pelo</italic><sup>-/-</sup> and <italic>Upf2</italic><sup>-/-</sup> but less in <italic>Hbs1l</italic><sup>-/-</sup> MEFs. <italic>Myc</italic> functions as a switch between proliferation and differentiation during cerebellar development (<xref ref-type="bibr" rid="bib68">Knoepfler et al., 2002</xref>; <xref ref-type="bibr" rid="bib88">Ma et al., 2015</xref>; <xref ref-type="bibr" rid="bib138">Wey et al., 2010</xref>), in which loss of <italic>Myc</italic> allows precursors to exit the cell cycle and undergo differentiation, while maintained <italic>Myc</italic> expression retains cells in the proliferation cycle. Intriguingly, previous studies revealed that depletion of NMD factors inhibited differentiation of embryonic stem cells, which coincided with sustained <italic>Myc</italic> expression and its downregulation released the differentiation blockage in NMD-deficient cells (<xref ref-type="bibr" rid="bib77">Li et al., 2015</xref>).</p><p>How different translation-dependent quality control pathways can lead to similar changes in translation and cellular defects is unclear. Recent studies in yeast demonstrated that impairment of these quality control mechanisms (<italic>Hbs1</italic>, <italic>Dom34</italic>, <italic>Upf1</italic>, <italic>Upf2</italic>, <italic>Ski7</italic> and <italic>Ski8</italic>) caused protein aggregation (<xref ref-type="bibr" rid="bib57">Jamar et al., 2018</xref>). Protein misfolding occurred co-translationally on highly translated genes and the aggregated proteins overlapped between the different mutant strains. These data suggest that increased translation and protein aggregation may be common properties among different quality control mutants (<xref ref-type="bibr" rid="bib57">Jamar et al., 2018</xref>). Perhaps, regardless of specific targets of various quality control pathways, defects in protein folding, clearance of defective peptide products, and/or defects in mRNA decay may trigger similar cellular responses leading to similar phenotypes.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top"><italic>Hbs1l</italic><sup>GTC</sup></td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">MMRRC #007694-UCD; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC007694-UCD">MMRRC007694-UCD</ext-link></td><td valign="top">International Gene Trap Consortium, IGTC, cell line ID: XE494</td></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top"><italic>Hbs1l</italic><sup>tm1a</sup>(C57BL/6N-<italic>A<sup>tm1Brd</sup>Hbs1l<sup>tm1a(KOMP)Wtsi</sup></italic>)</td><td valign="top"><xref ref-type="bibr" rid="bib125">Skarnes et al., 2011</xref></td><td valign="top">MMRRC #048037-UCD, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC048037-UCD">MMRRC048037-UCD</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6N.129S4-Gt(ROSA)26Sor<sup>tm1(FLP1)Dym</sup>/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX:016226; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSRJAX:016226">IMSRJAX:016226</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6N.Cg-Edil3Tg(Sox2-Cre)1Amc/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX:014094; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSRJAX:014094">IMSRJAX:014094</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6.FVB-Tg(EIIa-Cre)C5379Lmgd/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX:003724; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSRJAX:003724">IMSRJAX:003724</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">En1<sup>tm2(Cre)Wrst</sup>/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX:007916; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSRJAX:007916">IMSRJAX:007916</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6.Cg-Tg(Atoh1-Cre)1Bfri/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">JAX:011104; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSRJAX:011104">IMSRJAX:011104</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6.Cg-Tg(CAG-Cre/Esr1*)5Amc/J</td><td valign="top"/><td valign="top">JAX:004682; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSRJAX:004682">IMSRJAX:004682</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6.Tg(Gabra6-Cre)B1Lfr</td><td valign="top"><xref ref-type="bibr" rid="bib32">Fünfschilling and Reichardt, 2002</xref></td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6J-<italic>Pelo</italic><sup>fl/fl</sup></td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top"><italic>Upf2</italic><sup>fl/fl</sup></td><td valign="top"><xref ref-type="bibr" rid="bib137">Weischenfeldt et al., 2008</xref></td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>mouse</italic>)</td><td valign="top">B6J.B6N<italic><sup>n-Tr20</sup></italic></td><td valign="top"><xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref></td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background (<italic>mouse</italic>)</td><td valign="top">B6J-<italic>n-Tr20</italic><sup>-/-</sup></td><td valign="top"><xref ref-type="bibr" rid="bib55">Ishimura et al., 2016</xref></td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-phospho-eIF2alpha<sup>S51</sup> <break/>(Rabbit polyclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #9721; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330951">AB_330951</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-eIF2alpha <break/>(Rabbit polyclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #9722; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2230924">AB_2230924</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-phospho-p70S6K<sup>T389</sup> <break/>(Rabbit monoclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #9234; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2269803">AB_2269803</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-p70S6K <break/>(Rabbit monoclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #2708; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_390722">AB_390722</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-phospho-S6<sup>S240/244</sup> <break/>(Rabbit monoclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #5364; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694233">AB_10694233</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-cleaved caspase 3 <break/>(Rabbit polyclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #9661; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2341188">AB_2341188</ext-link></td><td valign="top">IF (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-BrdU <break/>(Mouse monoclonal)</td><td valign="top">Dako/Agilent</td><td valign="top">M0744; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10013660">AB_10013660</ext-link></td><td valign="top">IF (1:50)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Hbs1l <break/>(Rabbit polyclonal)</td><td valign="top">Proteintech</td><td valign="top">#10359–1-AP; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2114730">AB_2114730</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Pelo <break/>(Rabbit polyclonal)</td><td valign="top">Proteintech</td><td valign="top">#10582–1-AP; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2236833">AB_2236833</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Vinculin <break/>(Mouse monoclonal)</td><td valign="top">Sigma-Aldrich</td><td valign="top">V9131; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477629">AB_477629</ext-link></td><td valign="top">WB (1:20,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-GAPDH <break/>(Rabbit monoclonal)</td><td valign="top">Cell Signaling Technology</td><td valign="top">CST #2118; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_561053">AB_561053</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Ki67 <break/>(Rabbit Polyclonal)</td><td valign="top">Abcam</td><td valign="top">ab15580; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_443209">AB_443209</ext-link></td><td valign="top">IF (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Olig2 <break/>(Rabbit monoclonal)</td><td valign="top">Abcam</td><td valign="top">ab109186; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10861310">AB_10861310</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Lhx1/5 <break/>(Mouse monoclonal)</td><td valign="top">DSHB</td><td valign="top">#4F2-c; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_531784">AB_531784</ext-link></td><td valign="top">IF (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-NeuN <break/>(Mouse monoclonal)</td><td valign="top">Millipore</td><td valign="top">MAB377; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2298772">AB_2298772</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Tbr1 <break/>(Rabbit polyclonal)</td><td valign="top">Millipore</td><td valign="top">AB9616; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2200223">AB_2200223</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Pax2 <break/>(Rabbit polyclonal)</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">#71–6000; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2533990">AB_2533990</ext-link></td><td valign="top">IF (1:50)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-pH3 (Rabbit polyclonal)</td><td valign="top">Upstate, Millipore</td><td valign="top">#06–570; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_310177">AB_310177</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-PCNA <break/>(Mouse monoclonal)</td><td valign="top">Invitrogen, Thermo Fisher Scientific</td><td valign="top">MA5-11358; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10982348">AB_10982348</ext-link></td><td valign="top">IF (1:100)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DNase I</td><td valign="top">Worthington</td><td valign="top">LS002139</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Bromodeoxyuridine (BrdU)</td><td valign="top">Sigma-Aldrich</td><td valign="top">B9285</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal)</td><td valign="top">Sigma-Aldrich</td><td valign="top">B4252</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Z-4-hydroxytamoxifin (4OHT)</td><td valign="top">Sigma-Aldrich</td><td valign="top">H7905</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNAscope Multiplex Fluorescent Reagent Kit v2</td><td valign="top">Advanced Cell Diagnostics</td><td valign="top">#323100</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">KAPA Stranded mRNA-seq. Kit</td><td valign="top">Roche</td><td valign="top">KR0960</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">iQ SYBR Green Supermix</td><td valign="top">Bio-Rad</td><td valign="top">#1708880</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">SuperScript III First-Strand Synthesis System</td><td valign="top">Invitrogen</td><td valign="top">#18080051</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">DNA-free DNA Removal Kit</td><td valign="top">Life Technologies</td><td valign="top">AM1906</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">TSA Plus Cyanine 3</td><td valign="top">PerkinElmer</td><td valign="top">NEL744001KT</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">RNA-seq. and ribosome profiling data</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">GSE162556</td><td valign="top">Deposited Data</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hbs1l GTC (Genotyping)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Common Forward:5’AGTCCAGGTGTTTCCTCACG3’; Wild type Reverse:5’CCCTGGCCTATTTTTGGTTT3’; <break/>GTC Reverse:5’TGTCCTCCAGTCTCCTCCAC3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Hbs1l cKO (Genotyping)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Forward I: 5’CATGGCCTCCTATGGGTTGA3’; Forward II: 5’GCCTACAGTGAGCACAGAGT3’; <break/>Reverse: 5’TAGGTGCTGGGATTTGAACC3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Pelo cKO (Genotyping)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Forward:5’TGTAACTGAACCCTGCAGTATCT3’; Reverse I: 5’GTGGAGCATGAAATGAAATTCGG3’; <break/>Reverse II: 5’ATCCAAGGCTTTTACTTCGCC3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RNAscope probe <italic>Hbs1l-</italic>C2</td><td valign="top">Advanced Cell Diagnostics</td><td valign="top">#527471-C2</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Hbs1l Exon 3–6</italic> (RT-PCR)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Forward Primer:5’GAAATTGACCAAGCTCGCCTGTA3’; Reverse Primer:5’CTCAGAAGTTAAGCCAGGCACT3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>β</italic>-<italic>actin</italic> (RT-PCR)</td><td valign="top"><xref ref-type="bibr" rid="bib131">Terrey et al., 2020</xref></td><td valign="top">N/A</td><td valign="top">Forward Primer:5’GGCTGTATTCCCCTCCATCG3’; Reverse Primer:5’CCAGTTGGTAACAATGCCATGT3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Hbs1l</italic> Isoform I (quantitative RT-PCR)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Forward Primer:5’AGACCATGGGATTTGAAGTGC3’; Reverse Primer:5’CCGGTCTCAGGAATGTTAGGA3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Hbs1l</italic> Isoform II (quantitative RT-PCR)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Forward Primer:5’TGAAGTTGAACAAAGTGCCAAG 3’; Reverse Primer:5’CTGCTTCCTCTGTGTTCCTC3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Pelo</italic> (quantitative RT-PCR)</td><td valign="top">This study <break/>(see Materials and methods)</td><td valign="top">N/A</td><td valign="top">Forward Primer:5’CCCCAGGAAACGGAAAGGC3’; Reverse Primer:5’ACGCACTTTACAACCTCGAAG3’</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Gapdh</italic> (quantitative RT-PCR)</td><td valign="top"><xref ref-type="bibr" rid="bib55">Ishimura et al., 2016</xref></td><td valign="top">N/A</td><td valign="top">Forward Primer:5’CATTGTCATACCAGGAAATG3’; Reverse Primer:5’GGAGAAACCTGCCAAGTATG3’</td></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">Image J</td><td valign="bottom">NIH</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij">https://imagej.nih.gov/ij</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">GraphPad Prism 7</td><td valign="bottom">GraphPad Prism</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">Pause site identification algorithm</td><td valign="bottom"><xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref></td><td valign="bottom">N/A</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">biomaRt version 2.42.1</td><td valign="bottom"><xref ref-type="bibr" rid="bib28">Durinck et al., 2005</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019214">SCR_019214</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/biomaRt.html">https://bioconductor.org/packages/release/bioc/html/biomaRt.html</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">ShinyGO v0.61 (KEGG pathway)</td><td valign="bottom"><xref ref-type="bibr" rid="bib34">Ge et al., 2020</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019213">SCR_019213</ext-link>; <ext-link ext-link-type="uri" xlink:href="http://bioinformatics.sdstate.edu/go">http://bioinformatics.sdstate.edu/go</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">Ingenuity Pathway Analysis (IPA)</td><td valign="bottom">QIAGEN Inc</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008653">SCR_008653</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis">https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">DESeq2 v1.26.0</td><td valign="bottom"><xref ref-type="bibr" rid="bib86">Love et al., 2014</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015687">SCR_015687</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">ensembldb v2.6.8</td><td valign="bottom"><xref ref-type="bibr" rid="bib111">Rainer et al., 2019</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019103">SCR_019103</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/ensembldb.html">https://www.bioconductor.org/packages/release/bioc/html/ensembldb.html</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">riborex v2.3.4</td><td valign="bottom"><xref ref-type="bibr" rid="bib78">Li et al., 2017</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019104">SCR_019104</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://github.com/smithlabcode/riborex">https://github.com/smithlabcode/riborex</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">RiboWaltz v1.0.1</td><td valign="bottom"><xref ref-type="bibr" rid="bib72">Lauria et al., 2018</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016948">SCR_016948</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://github.com/LabTranslationalArchitectomics/RiboWaltz">https://github.com/LabTranslationalArchitectomics/RiboWaltz</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">bowtie2 v 2.2.3</td><td valign="bottom"><xref ref-type="bibr" rid="bib71">Langmead and Salzberg, 2012</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_005476">SCR_005476</ext-link>; <ext-link ext-link-type="uri" xlink:href="http://bowtie-bio.sourceforge.net/bowtie2/index.shtml">http://bowtie-bio.sourceforge.net/bowtie2/index.shtml</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">fastx_trimmer</td><td valign="bottom">Hannon Lab</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">fastx_clipper</td><td valign="bottom">Hannon Lab</td><td valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">hisat2 v2.1.0</td><td valign="bottom"><xref ref-type="bibr" rid="bib66">Kim et al., 2019</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015530">SCR_015530</ext-link>;<ext-link ext-link-type="uri" xlink:href="https://daehwankimlab.github.io/hisat2/">https://daehwankimlab.github.io/hisat2/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">featureCounts</td><td valign="bottom"><xref ref-type="bibr" rid="bib80">Liao et al., 2014</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_012919">SCR_012919</ext-link>; <ext-link ext-link-type="uri" xlink:href="http://bioinf.wehi.edu.au/featureCounts">http://bioinf.wehi.edu.au/featureCounts</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">sleuth v0.30.0</td><td valign="bottom"><xref ref-type="bibr" rid="bib105">Pimentel et al., 2017</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016883">SCR_016883</ext-link>;<ext-link ext-link-type="uri" xlink:href="https://pachterlab.github.io/sleuth/about">https://pachterlab.github.io/sleuth/about</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="bottom">kallisto v0.42.4</td><td valign="bottom"><xref ref-type="bibr" rid="bib8">Bray et al., 2016</xref></td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016582">SCR_016582</ext-link>;<ext-link ext-link-type="uri" xlink:href="https://pachterlab.github.io/kallisto/about">https://pachterlab.github.io/kallisto/about</ext-link></td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse strains</title><p>Generation of <italic>Hbs1l</italic><sup>GTC</sup> mice was performed by injection of targeted ES cells (International Gene Trap Consortium, IGTC, cell line ID: XE494) into C57BL/6J (B6J) blastocysts. B6N-<italic>Hbs1l</italic><sup>tm1a</sup> (C57BL/6N-<italic>A<sup>tm1Brd</sup>Hbs1l<sup>tm1a(KOMP)Wtsi</sup></italic>, MMRRC:048037) mice were produced at the Wellcome Trust Sanger Institute Mouse Genetics Project as part of the International Mouse Phenotype Consortium (IMPC). In order to generate the conditional <italic>Hbs1l</italic> knock out allele, heterozygous B6N-<italic>Hbs1l</italic><sup>tm1a/+</sup> mice were crossed to B6N.129S4-Gt(ROSA)26Sor<sup>tm1(FLP1)Dym</sup>/J (The Jackson Laboratory, #016226, MGI:5425632) to remove the gene trap cassette and generate B6N-<italic>Hbs1l</italic><sup>fl/+</sup> mice. Generation of the constitutive B6N-<italic>Hbs1l</italic><sup>+/-</sup> knock out allele was accomplished by crossing homozygous B6N-<italic>Hbs1l</italic><sup>fl/fl</sup> mice to B6N.Cg-Edil3Tg(Sox2-Cre)1Amc/J mice (The Jackson Laboratory, #014094, MGI:4943744). The B6N-<italic>Hbs1l</italic><sup>+/-</sup> or B6N-<italic>Hbs1l</italic><sup>fl/fl</sup> mice were backcrossed to congenic B6N.B6J<sup>n-Tr20</sup> mice (n = 2 backcross generations) to introduce the B6J-associated <italic>n-Tr20</italic> mutation. The conditional knock out <italic>Pelo</italic> allele was generated by placing the 5’loxP site 117 bp upstream of exon 2 and the 3’loxP site 302 bp downstream of exon2. Targeted B6J ES cells were injected into B6J blastocysts to generate heterozygous B6J-<italic>Pelo</italic><sup>fl/+</sup> mice. Generation of the ubiquitous B6J-<italic>Pelo</italic><sup>+/-</sup> knock out allele was accomplished by crossing homozygous B6J-<italic>Pelo</italic><sup>fl/fl</sup> mice to B6.FVB-Tg(EIIa-Cre)C5379Lmgd/J mice (The Jackson Laboratory, #003724, MGI:2174520). The conditional <italic>Upf2</italic> knock out allele (<italic>Upf2</italic><sup>fl/fl</sup> mice) was kindly provided from Drs. Bo Torben Porse and Miles Wilkinson. Genotyping primers are listed below and for the conditional knock out alleles of <italic>Hbs1l</italic> and <italic>Pelo,</italic> genotyping primers were multiplexed to simultaneously detect the wild type, flox (fl) and delta (-) allele. Genotyping for the conditional knock out allele of <italic>Upf2</italic>, was performed as previously described (<xref ref-type="bibr" rid="bib137">Weischenfeldt et al., 2008</xref>).</p><list list-type="simple"><list-item><p><italic>Hbs1l common</italic> Forward: 5’<named-content content-type="sequence">AGTCCAGGTGTTTCCTCACG</named-content>3'</p></list-item><list-item><p><italic>Hbs1l wild type</italic> Reverse: 5’<named-content content-type="sequence">CCCTGGCCTATTTTTGGTTT</named-content>3'</p></list-item><list-item><p><italic>Hbs1l GTC</italic> Reverse: 5’<named-content content-type="sequence">TGTCCTCCAGTCTCCTCCAC</named-content>3'</p></list-item><list-item><p><italic>Hbs1l cKO</italic> Forward I: 5’<named-content content-type="sequence">CATGGCCTCCTATGGGTTGA</named-content>3'</p></list-item><list-item><p><italic>Hbs1l cKO</italic> Forward II: 5’<named-content content-type="sequence">GCCTACAGTGAGCACAGAGT</named-content>3'</p></list-item><list-item><p><italic>Hbs1l cKO</italic> Reverse: 5’<named-content content-type="sequence">TAGGTGCTGGGATTTGAACC</named-content>3'</p></list-item><list-item><p><italic>Pelo cKO</italic> Forward: 5’<named-content content-type="sequence">TGTAACTGAACCCTGCAGTATCT</named-content>3'</p></list-item><list-item><p><italic>Pelo cKO</italic> Reverse I: 5’<named-content content-type="sequence">GTGGAGCATGAAATGAAATTCGG</named-content>3'</p></list-item><list-item><p><italic>Pelo cKO</italic> Reverse II: 5’<named-content content-type="sequence">ATCCAAGGCTTTTACTTCGCC</named-content>3'</p></list-item></list><p>For conditional knock out experiments, the following <italic>Cre</italic>-lines were used and the <italic>Cre</italic> allele was maternally inherited to generate mutant mice (F<sub>2</sub> generation): En1<sup>tm2(Cre)Wrst</sup>/J (<italic>En1<sup>Cre</sup></italic>, The Jackson Laboratory, #007916, MGI:3815003), B6.Cg-Tg(Atoh1-Cre)1Bfri/J (Tg(Atoh1-Cre), The Jackson Laboratory, #011104, MGI:4415810) and B6.Tg(Gabra6-Cre)B1Lfr (Tg(Gabra6-Cre), MGI:4358481, <xref ref-type="bibr" rid="bib32">Fünfschilling and Reichardt, 2002</xref>). In order to avoid the introduction of the B6J-associated <italic>n-Tr20</italic> mutation in <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO mice, En1<sup>tm2(Cre)Wrst</sup>/J mice were backcrossed to congenic B6J.B6N<sup>n-Tr20</sup> mice (<xref ref-type="bibr" rid="bib55">Ishimura et al., 2016</xref>) to generate En1<sup>tm2(Cre)Wrst</sup>/J mice that no longer carry the mutation. Subsequently, B6J.B6N<sup>n-Tr20</sup>; <italic>En1<sup>Cre</sup></italic> mice were intercrossed with B6N-<italic>Hbs1l</italic><sup>+/-</sup> to produce F1 mice, then these mice were crossed to B6N-<italic>Hbs1l</italic><sup>fl/fl</sup> mice to generate <italic>En1<sup>Cre</sup>; Hbs1l</italic> cKO; <italic>n-Tr20</italic><sup>B6N/B6N</sup> without the B6J-associated tRNA mutation. To generate Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO mice lacking <italic>n-Tr20</italic>, B6.Cg-Tg(Atoh1-Cre)1Bfri/J, B6N-<italic>Hbs1l</italic><sup>+/-</sup>, and B6N-<italic>Hbs1l</italic><sup>fl/fl</sup> mice were crossed to B6J-<italic>n-Tr20</italic><sup>-/-</sup> mice. Subsequently, these strains were intercrossed to generate Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO; <italic>n-Tr20</italic><sup>-/-</sup> mice. For BrdU experiments, pregnant females or pups were injected with BrdU (0.05 mg/g, Sigma-Aldrich, B9285) and collected 30 min (S-phase analysis) or 24 hr (cell cycle exit analysis) post injection. For the isolation of MEFs or embryos, the day that a vaginal plug was detected was defined as embryonic day 0.5 (E0.5).</p><p>For conditional knock out experiments in primary mouse embryonic fibroblasts (MEFs), we crossed mice to the tamoxifen inducible <italic>Cre</italic>-line B6.Cg-Tg(CAG-Cre/Esr1*)5Amc/J (CAG-Cre<sup>ER</sup>, The Jackson Laboratory, #004682, MGI:2680708). The <italic>Cre</italic> allele was paternally inherited to generate embryos (F<sub>2</sub> generation) because <italic>Cre</italic>-mediated recombination (‘<italic>leaky Cre expression</italic>’) was occasionally observed even in the absence of tamoxifen (4-OHT) treatment of MEFs when the <italic>Cre</italic> allele was maternally inherited (F<sub>2</sub> generation).</p><p>All experiments and quantifications were performed with at least three mice/embryos of each genotype and time point using mice of either sex (embryos were not sexed). The Jackson Laboratory Animal Care and Use Committee and The University of California San Diego Animal Care and Use Committee approved all mouse protocols.</p></sec><sec id="s4-2"><title>Strain abbreviation</title><p>For conditional knock out (cKO) experiments, animals were given a simplified abbreviation throughout the article. The complete genotype is shown below.</p><p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Abbreviation</th><th valign="top">Genotype</th></tr></thead><tbody><tr><td valign="top"><italic>En1<sup>Cre</sup></italic>, <italic>Hbs1l</italic> cKO</td><td valign="top"><italic>En1<sup>Cre/+</sup></italic>; <italic>Hbs1l</italic><sup>fl/-</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top"><italic>En1<sup>Cre</sup></italic>, <italic>Pelo</italic> cKO</td><td valign="top"><italic>En1<sup>Cre/+</sup></italic>; <italic>Pelo</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top"><italic>En1<sup>Cre</sup></italic>, <italic>Upf2</italic> cKO</td><td valign="top"><italic>En1<sup>Cre/+</sup></italic>; <italic>Upf2</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">Tg(Atoh1-Cre), <italic>Hbs1l</italic> cKO</td><td valign="top">Tg(Atoh1-Cre); <italic>Hbs1l</italic><sup>fl/-</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">Tg(Atoh1-Cre), <italic>Pelo</italic> cKO</td><td valign="top">Tg(Atoh1-Cre); <italic>Pelo</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">Tg(Atoh1-Cre), <italic>Upf2</italic> cKO</td><td valign="top">Tg(Atoh1-Cre); <italic>Upf2</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">Tg(Gabra6-Cre), <italic>Hbs1l</italic> cKO</td><td valign="top">Tg(Gabra6-Cre); <italic>Hbs1l</italic><sup>fl/-</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">Tg(Gabra6-Cre), <italic>Pelo</italic> cKO</td><td valign="top">Tg(Gabra6-Cre); <italic>Pelo</italic><sup>fl/-</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">TgCAG-Cre<sup>ER</sup> (control MEFs)</td><td valign="top">Tg(CAG-Cre/Esr1); <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">TgCAG-Cre<sup>ER</sup>, <italic>Hbs1l</italic> cKO (<italic>Hbs1l</italic><sup>-/-</sup> MEFs)</td><td valign="top">Tg(CAG-Cre/Esr1); <italic>Hbs1l</italic><sup>fl/-</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">TgCAG-Cre<sup>ER</sup>, <italic>Pelo</italic> cKO (<italic>Pelo</italic><sup>-/-</sup> MEFs)</td><td valign="top">Tg(CAG-Cre/Esr1); <italic>Pelo</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr><tr><td valign="top">TgCAG-Cre<sup>ER</sup>, <italic>Upf2</italic> cKO (<italic>Upf2</italic><sup>-/-</sup> MEFs)</td><td valign="top">Tg(CAG-Cre/Esr1); <italic>Upf2</italic><sup>fl/fl</sup>; <italic>n-Tr20</italic><sup>B6J/B6J</sup></td></tr></tbody></table></table-wrap></p></sec><sec id="s4-3"><title>Cell culture</title><p>Primary mouse embryonic fibroblasts (MEFs) were isolated on embryonic day E13.0 and prepared by standard procedures (<xref ref-type="bibr" rid="bib101">Nagy et al., 2014</xref>). MEFs were maintained in Dulbecco’s modified Eagle’s medium (Gibco, #41965039) with GlutaMAX (Gibco, #35050061), PSN (Gibco, # 15640055), and 10% embryonic stem cell fetal bovine serum (Gibco, #10439024) at 37°C in 5% CO<sub>2</sub>. Two days post-isolation (Passage P0), the cell culture media was replaced with fresh media and supplemented with 1 μM 4-OHT (4-hydroxytamoxifen, Sigma, H7904) for both control and mutant cells. After 48 hr, cells were washed, trypsinized, and seeded on a 10 cm dish (Passage P1). For RNA sequencing and ribosome footprint profiling experiments, cells were collected 48 hr (Passage P1, Day 2) later when cells reached ~80% confluency. For western blotting experiments, cells of Passage P1 were collected 48 hr (Day 2) and 96 hr (Day 4) post-seeding.</p></sec><sec id="s4-4"><title>Histology and immunofluorescence</title><p>Anesthetized mice were transcardially perfused with 4% paraformaldehyde (PFA, for immunofluorescence and histology), Bouins fixative (for histology) or 10% neutral buffered formalin (NBF, for in situ hybridization). Tissues were post-fixed overnight and embedded in paraffin. For histological analysis, sections were deparaffinized, rehydrated, and were stained with cresyl violet according to standard procedures. Histological slides were imaged using a digital slide scanner (Hamamatsu).</p><p>All quantifications were performed with three mice or embryos of each genotype and time point using animals of either sex (embryos were not sexed). For cell quantification in embryos at E12.5 to E16.5 and pups at P5 (Olig2<sup>+</sup> cells), cells were counted from the entire section and values were averaged from three parasagittal (embryos) or sagittal (pups) sections (spaced 35 μm apart) per mouse. For the analysis of granule cell precursors or granule cells in P5 or P6 pups, the total number of cells was determined within lobule IV/V or IX, and values were averaged from three sagittal sections (spaced 50 μm apart) per mouse. For the analysis of granule cells in adult mice (35 weeks of age), granule cells were counted in a 0.025 mm<sup>2</sup> area of lobule IX and values were averaged from three midline sections per mouse spaced 100 μm apart.</p><p>For immunofluorescence, antigen retrieval on deparaffinized PFA-fixed sections was performed by microwaving sections in 0.01M sodium citrate buffer (pH 6.0, 0.05% Tween-20) for three times with 3 min each or three times for 3 min, followed by two times for 9 min. PFA-fixed sections were incubated with the following primary antibodies overnight at 4°C: rabbit anti-cleaved caspase 3 (Cell signaling, #9661, 1:100), mouse anti-BrdU (Dako, M0744, 1:50), rabbit anti-Ki67 (Abcam, ab15580, 1:100), mouse anti-Lhx1/5 (DSHB, 4F2-c, 1:100), mouse anti-NeuN (Millipore, MAB377, 1:500), mouse anti-PCNA (Invitrogen, MA5-11358, 1:100), rabbit anti-p-S6<sup>240/244</sup> (Cell Signaling, #5364, 1:1000), rabbit anti-Pax2 (ThermoFisher, 71–6000, 1:50), rabbit anti-Olig2 (Abcam, ab109186, 1:200), rabbit anti-Tbr1 (Chemicon, AB9616, 1:1000), and rabbit anti-pH3 (Upstate, 06–570, 1:1000). Immunofluorescence with antibodies to BrdU was performed on sections treated with DNase I (5mU/µl, Worthington, LS002139) for 45 min at 37°C after antigen retrieval. Detection of primary antibodies was performed with goat anti-mouse Alexa Fluor-488 or −555, goat anti-rabbit Alexa Fluor-488 or −555, and donkey anti-rabbit Alexa Fluor-555 secondary antibodies (Invitrogen). Sections were counterstained with DAPI and Sudan Black to quench autofluorescence.</p><p>For immunofluorescence quantification, the fluorescence intensity was measured in an area of 60 × 125 μm using ImageJ, averaged from three sections (spaced 35 μm apart) per embryo and expressed as the fold change relative to control.</p></sec><sec id="s4-5"><title>RNAscope (in situ hybridization)</title><p>In situ hybridization of <italic>Hbs1l-C2</italic> probes (ACD, #527471-C2) was performed with the ACD RNAscope Multiplex Fluorescent Reagent Kit v2 (ACD, #323100) using the manufacturer’s protocol. Briefly, deparaffinized NBF-fixed sections were treated for 15 min with Target Retrieval Reagent at 100°C and subsequently, treated with Protease Plus for 20 min (E13.5 embryos) or 30 min (P28 mice) at 40°C. RNAScope probes were hybridized for 2 hr; TSA Plus Cyanine 3 (PerkinElmer, 1:1,500) was used as a secondary fluorophore for <italic>Hbs1l-C2</italic> probes.</p></sec><sec id="s4-6"><title>Reverse transcription and quantitative PCR (qPCR) analysis</title><p>Whole mouse embryos, primary mouse embryonic fibroblasts, or adult mouse tissues were isolated and immediately frozen in liquid nitrogen. Total RNA was extracted with Trizol reagent (Life Technologies). cDNA synthesis was performed on DNase-treated (DNA-free DNA Removal Kit, Life Technologies AM1906) total RNA using oligo(dT) primers and SuperScript III First-Strand Synthesis System (Life Technologies). Quantitative RT-PCR reactions were performed using iQ SYBR Green Supermix (Bio-Rad) and an CFX96 Real-Time PCR Detection System (Bio-Rad). Expression levels of <italic>β-actin</italic> were used as input control for semi-quantitative RT-PCR. For quantitative RT-PCR (qPCR) analysis, expression levels of the genes of interest were normalized to <italic>Gapdh</italic> using the 2<sup>-ΔΔCT</sup> method (<xref ref-type="bibr" rid="bib84">Livak and Schmittgen, 2001</xref>) and expressed as the fold change + standard error of the mean (SEM) relative to control.</p><p>Semi-quantitative RT-PCR Primers (F, Forward; R, Reverse):</p><list list-type="simple"><list-item><p><italic>Hbs1l Exon 3</italic> F: 5’<named-content content-type="sequence">GAAATTGACCAAGCTCGCCTGTA3</named-content>’</p></list-item><list-item><p><italic>Hbs1l Exon 6</italic> R: 5’<named-content content-type="sequence">CTCAGAAGTTAAGCCAGGCACT3</named-content>’</p></list-item><list-item><p><italic>β-actin F: </italic>5’<named-content content-type="sequence">GGCTGTATTCCCCTCCATCG3</named-content>’</p></list-item><list-item><p><italic>β-actin</italic> R: 5’<named-content content-type="sequence">CCAGTTGGTAACAATGCCATGT3</named-content>’</p></list-item></list><p>Quantitative RT-PCR Primers (F, Forward; R, Reverse):</p><list list-type="simple"><list-item><p><italic>Hbs1l</italic> F: 5’<named-content content-type="sequence">AGACCATGGGATTTGAAGTGC3</named-content>’</p></list-item><list-item><p><italic>Hbs1l</italic> R: 5’<named-content content-type="sequence">CCGGTCTCAGGAATGTTAGGA3</named-content>’</p></list-item><list-item><p><italic>Hbs1l II</italic> F: 5’<named-content content-type="sequence">TGAAGTTGAACAAAGTGCCAAG3</named-content>’</p></list-item><list-item><p><italic>Hbs1l II</italic> R: 5’<named-content content-type="sequence">CTGCTTCCTCTGTGTTCCTC3</named-content>’</p></list-item><list-item><p><italic>Pelo</italic> F: 5’<named-content content-type="sequence">CCCCAGGAAACGGAAAGGC3</named-content>’</p></list-item><list-item><p><italic>Pelo</italic> R: 5’<named-content content-type="sequence">ACGCACTTTACAACCTCGAAG3</named-content>’</p></list-item><list-item><p><italic>Gapdh</italic> F: 5’<named-content content-type="sequence">CATTGTCATACCAGGAAATG3</named-content>’,</p></list-item><list-item><p><italic>Gapdh</italic> R: 5’<named-content content-type="sequence">GGAGAAACCTGCCAAGTATG3</named-content>’</p></list-item></list></sec><sec id="s4-7"><title>Western blotting</title><p>MEFs or tissues were immediately frozen in liquid nitrogen. Proteins were extracted by homogenizing frozen tissue or cell samples in five volumes of RIPA buffer with cOmplete Mini, EDTA-free Protease inhibitor Cocktail (Roche), sonicating tissues two times for 10 s (Branson, 35% amplitude) or triturating cells 10 times using a 26G needle. Lysates were incubated for 30 min at 4°C, centrifuged at 16,000xg for 25 min, and 25 µg of whole protein lysate were resolved on SDS-PAGE gels prior to transfer to PVDF membranes (GE Healthcare Life Sciences, #10600023) using a tank blotting apparatus (BioRad).</p><p>For detection of phosphoproteins, frozen tissue samples were homogenized in 5 volumes of homogenization buffer (50 mM Hepes/KOH, pH 7.5, 140 mM potassium acetate, 4 mM magnesium acetate, 2.5 mM dithiothreitol, 0.32M sucrose, 1 mM EDTA, 2 mM EGTA) (<xref ref-type="bibr" rid="bib14">Carnevalli et al., 2004</xref>), supplemented with phosphatase and protease inhibitors (PhosStop and cOmplete Mini, EDTA-free Protease inhibitor Cocktail, Roche). Frozen cell samples were homogenized by using a 26G needle (five times) in homogenization buffer (see above). Lysate samples were immediately centrifuged at 12,000xg for 7 min and whole protein lysate were resolved on SDS-PAGE gels prior to transfer to PVDF membranes.</p><p>After blocking in 5% nonfat dry milk (Cell Signaling, #9999S), blots were probed with primary antibodies at 4°C overnight: rabbit anti-phospho-eIF2α<sup>S51</sup> (Cell Signaling, #9721, 1:1000), rabbit anti-eIF2α (Cell Signaling, #9722, 1:2000), rabbit anti-Hbs1l (Proteintech, 10359–1-AP, 1;1000), rabbit anti-Pelo (Proteintech, 10582–1-AP, 1:2000), rabbit anti-GAPDH (Cell Signaling, #2118, 1:10,000), rabbit anti-phospho-p70S6K<sup>T389</sup> (Cell Signaling, #9234, 1:1000), rabbit anti-phospho-p70S6K (Cell Signaling, #2708, 1:1000), mouse anti-vinculin (Sigma, V-9131, 1:20,000). Primary antibodies were detected by incubation with HRP-conjugated secondary antibodies for 2 hr at room temperature: goat anti-rabbit IgG (BioRad, #170–6515) or goat anti-mouse IgG (BioRad, #170–6516). Signals were detected with SuperSignal West Pico Chemiluminescent substrate (ThermoScientific, #34080) or ProSignal Femto ECL Reagent (Genesee Scientific, #20–302).</p></sec><sec id="s4-8"><title>RNA sequencing library construction</title><p>For RNA sequencing of primary mouse embryonic fibroblasts (MEFs), one 10 cm dish of tamoxifen (4-OHT) treated MEFs at Day 2 (Passage P1) from TgCAG-Cre<sup>ER</sup> (control), TgCAG-Cre<sup>ER</sup>; <italic>Hbs1l</italic> cKO (<italic>Hbs1l</italic><sup>-/-</sup>), TgCAG-Cre<sup>ER</sup>; <italic>Pelo</italic> cKO (<italic>Pelo</italic><sup>-/-</sup>) and TgCAG-Cre<sup>ER</sup>; <italic>Upf2</italic> cKO (<italic>Upf2</italic><sup>-/-</sup>) were collected. One 10 cm dish from one individual embryo was used as one biological replicate, and either two (<italic>Pelo</italic>) or three (control, <italic>Hbs1</italic>, <italic>Upf2</italic>) biological replicates were used per genotype. Two micrograms of DNase-treated (DNA-free DNA Removal Kit, Life Technologies AM1906) total RNA were used for the RNA library construction, performed as per the manufacturer’s protocol (KAPA Stranded mRNA-Seq Kit, KR0960) and the adapter ligation was performed for 3 hr at room temperature. Library quality and concentration was assessed using D1000 screen tape on the Agilent TapeStation and Qubit 2.0 Fluorometer. All libraries were pooled, and the pool of libraries was sequenced on two lanes using HiSeq4000 (PE100).</p></sec><sec id="s4-9"><title>Analysis of RNA sequencing data</title><p>Reads were quantified using kallisto version 0.42.4 (<xref ref-type="bibr" rid="bib8">Bray et al., 2016</xref>) and pseudo-aligned to a Gencode M24 transcriptome reference with parameters –bias and -b 100. Differential expression was performed using sleuth version 0.30.0 (<xref ref-type="bibr" rid="bib105">Pimentel et al., 2017</xref>). Pairwise comparisons were performed to identify differentially expressed transcripts and genes: TgCAG-Cre<sup>ER</sup> vs. TgCAG-Cre<sup>ER</sup>; <italic>Pelo</italic> cKO, TgCAG-Cre<sup>ER</sup> vs. TgCAG-Cre<sup>ER</sup>; <italic>Hbs1l</italic> cKO, and TgCAG-Cre<sup>ER</sup> vs. TgCAG-Cre<sup>ER</sup>; <italic>Upf2</italic> cKO. We used functions within sleuth to perform differential transcript and gene expression. Briefly, we fit null models and models corresponding to the genotype of the samples for each transcript and performed Wald tests on the models for each transcript to identify differentially expressed transcripts. Differential gene expression was performed by aggregating transcript expression on Ensembl gene identifiers. Multiple hypotheses testing was corrected using Benjamini-Hochberg correction, referred to as q-value. Transcript biotypes were identified using biomaRt version 2.42.1 (<xref ref-type="bibr" rid="bib28">Durinck et al., 2005</xref>). For downstream TE analysis, mapping to mm10 using a Gencode M24 transcript annotation was performed using hisat2 version 2.1.0 (<xref ref-type="bibr" rid="bib66">Kim et al., 2019</xref>) using default parameters.</p></sec><sec id="s4-10"><title>Ribosome profiling library construction</title><p>Ribosome profiling libraries were generated as previously described (<xref ref-type="bibr" rid="bib53">Ingolia et al., 2012</xref>; <xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>) with some modifications. Cerebella were dissected and immediately frozen in liquid nitrogen. One cerebellum from P14 mice was used for each biological replicate, and three biological replicates were prepared for each control (Tg(Atoh1-Cre); <italic>Hbs1l</italic><sup>+/+</sup>) and mutant (Tg(Atoh1-Cre); <italic>Hbs1l</italic> cKO) genotype. For profiling of mouse embryos, embryos from timed mating were dissected at embryonic day E8.5, frozen in a drop of nuclease free water on dry ice, and then flash frozen in liquid nitrogen. Five embryos were pooled for each biological replicate, and three biological replicates were prepared for each control (<italic>Hbs1l</italic><sup>+/+</sup>) and mutant (<italic>Hbs1l</italic><sup>-/-</sup>) genotype. For profiling of primary mouse embryonic fibroblasts (MEFs), tamoxifen (4-OHT) treated MEFs at Day 2 (Passage P1) from TgCAG-Cre<sup>ER</sup> (control), TgCAG-Cre<sup>ER</sup>; <italic>Hbs1l</italic> cKO (<italic>Hbs1l</italic><sup>-/-</sup>), TgCAG-Cre<sup>ER</sup>; <italic>Pelo</italic> cKO (<italic>Pelo</italic><sup>-/-</sup>) and TgCAG-Cre<sup>ER</sup>; <italic>Upf2</italic> cKO (<italic>Upf2</italic><sup>-/-</sup>) were collected. Two 10 cm dishes from one individual embryo were pooled as one biological replicate, and three biological replicates (three individual embryos) were used for each genotype. The tissue and embryo homogenization were performed with a mixer mill (Retsch MM400) in lysis buffer (20 mM Tris-Cl, pH 8.0, 150 mM NaCl, 5 mM MgCl<sub>2</sub>, 1 mM DTT, 100 µg/ml CHX, 1% (v/v) TritonX-100, 25units/ml Turbo DNase I). The cell homogenization was performed by triturating the cells in lysis buffer (20 mM Tris-Cl, pH 8.0, 150 mM NaCl, 5 mM MgCl<sub>2</sub>, 1 mM DTT, 100 µg/ml CHX, 1% (v/v) TritonX-100, 25units/ml Turbo DNase I) ten times through a 26G needle. RNase I-treated lysates were overlaid on top of a sucrose cushion in 5 ml Beckman Ultraclear tubes and centrifuged in an SW55Ti rotor for 4 hr at 4°C at 46,700 rpm. Pellets were resuspended and RNA was extracted using the miRNeasy kit (Qiagen) according to manufacturer’s instructions. 26–34 nts (cerebella samples) or 15–34 nts (embryo and MEF samples) RNA fragments were purified by electrophoresis on a denaturing 15% gel. Linker addition, cDNA generation (first-strand synthesis was performed at 50°C for 1 hr), circularization, rRNA depletion, and amplification of cDNAs with indexing primers were performed. Library quality and concentration was assessed using high sensitivity D1000 screen tape on the Agilent TapeStation and Qubit 2.0 Fluorometer. All libraries were pooled as set of six samples consisting of three control and mutant samples. Libraries were run on HiSeq4000 (SR75) and either three lanes (cerebella samples) or two lanes (embryo and MEF samples) per set of samples were sequenced.</p></sec><sec id="s4-11"><title>Analysis of ribosome profiling data</title><p>Reads were clipped to remove adaptor sequences (<named-content content-type="sequence">CTGTAGGCACCATCAAT</named-content>) using fastx_clipper and trimmed so that reads start on the second base using fastx_trimmer (<ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link>). Reads containing ribosomal RNAs, snoRNAs, and tRNAs were then filtered out by mapping to a ribosomal RNA reference using bowtie2 version 2.2.3 using parameters -L 13 (<xref ref-type="bibr" rid="bib71">Langmead and Salzberg, 2012</xref>). Remaining reads were mapped to an mm10 mouse reference using a Gencode M24 annotation, or a Gencode M24 protein-coding transcript reference using hisat2 version 2.1.0 (<xref ref-type="bibr" rid="bib66">Kim et al., 2019</xref>). Ribosomal A-sites were identified using RiboWaltz version 1.0.1 (<xref ref-type="bibr" rid="bib72">Lauria et al., 2018</xref>), and reads with lengths of 27–34 nucleotides were retained for further analysis.</p><p>To identify potential codon bias in the A-site, observed/expected reads were calculated for each transcript with alignments with the expected reads being the read density expected at a given site with a given codon, assuming that reads are uniformly distributed across the coding part of the transcript. Differences in codon usage were then tested with a student’s t-test followed by Benjamini-Hochberg multiple hypothesis testing correction.</p><p>Pauses were identified using previous methodology (<xref ref-type="bibr" rid="bib54">Ishimura et al., 2014</xref>). Reads with lengths of 27–34 nucleotides were analyzed using a 0.5 reads/codon threshold in all samples to analyze pausing on transcripts. Additionally, pauses with P-sites nearby start and stop codons (P-sites at the −3, 0, 1, 2, 3, and 4 positions for start codons and P-sites at the −1 and −2 positions for stop codons) in any isoform of the gene were excluded from the analysis. To identify pauses overlapping start and stop codons in other isoforms, we used ensembldb v.2.6.8 (<xref ref-type="bibr" rid="bib111">Rainer et al., 2019</xref>) to map transcript coordinates back to the genome and analyzed whether pauses with identical genome coordinates overlapped start/stop codons.</p><p>To extend this approach to identify pauses at the gene level, we removed start/stop overlapping pauses (in any gene-matched transcript) and collapsed pauses based on the genomic location of the A-site, which was also identified with ensembldb v.2.6.8. Mean pause score across transcripts of genomically identical pauses for each sample was the reported pause score (excluding transcripts without a reported pause in a sample). If genomically identical pauses were in multiple transcript regions (i.e. 3’UTR or CDS depending on the isoform), all were reported.</p><p>Pauses were further filtered such that the pause locus appeared in all three replicates of the genotype and thereby, pauses that were only detected in one or two of three replicates of the genotype were removed from the analysis. Pauses were compared between the 4-OHT-treated knock out (TgCAG-Cre<sup>ER</sup>; <italic>Hbs1l</italic> cKO, TgCAG-Cre<sup>ER</sup>; <italic>Pelo</italic> cKO and TgCAG-Cre<sup>ER</sup>; <italic>Upf2</italic> cKO) and the control (TgCAG-Cre<sup>ER</sup>) sample that each mutant sample was pooled with for sequencing.</p><p>To identify ribosome footprint reads with 3’end As (untemplated reads), we extracted at first reads from a genome mapped bam file with six or more As at the 3’end of the read (3’end As were soft-clipped). Mapped reads were only considered if the 3’end A reads were not matching the reference sequence, while all unmapped reads with six or more As at the 3’ end were considered. Afterwards, the 3’end As were then removed from these untemplated reads and they were mapped back to the transcriptome using parameters described above for ribosome footprint profiling mapping to the transcriptome. Only the untemplated reads that mapped after the removal of the 3’end As were considered as ribosome footprints that may derive from ribosomes translating premature polyadenylated transcripts.</p><p>For differential RPF and differential TE analysis, genome mapped reads were quantified using featureCounts (<xref ref-type="bibr" rid="bib80">Liao et al., 2014</xref>) with footprints overlapping CDS features. For TE analysis specifically, RNA-Seq read pairs overlapping gene exon features were also quantified using featureCounts. Differential RPF analysis was performed using DESeq2 (v1.26.0) (<xref ref-type="bibr" rid="bib86">Love et al., 2014</xref>) comparing 4-OHT-treated knock out (TgCAG-Cre<sup>ER</sup>; <italic>Hbs1l</italic> cKO, TgCAG-Cre<sup>ER</sup>; <italic>Pelo</italic> cKO and TgCAG-Cre<sup>ER</sup>; <italic>Upf2</italic> cKO) to control (TgCAG-Cre<sup>ER</sup>) cells using default parameters. Histone mRNAs were removed from the analysis by removing gene names with the prefixes ‘Hist’, ‘H1f’, ‘H2a’, ‘H2b’, ‘H3’, and ‘H4’. TE was quantified and tested for using riborex version 2.3.4 using the DESeq2 engine (<xref ref-type="bibr" rid="bib78">Li et al., 2017</xref>).</p></sec><sec id="s4-12"><title>Pathway analysis</title><p>Data were analyzed using Ingenuity Pathway Analysis (IPA, QIAGEN Inc, <ext-link ext-link-type="uri" xlink:href="https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis">https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis</ext-link>).</p><p>Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed using the ShinyGO v0.61 bioinformatics web server (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.sdstate.edu/go">http://bioinformatics.sdstate.edu/go</ext-link>) (<xref ref-type="bibr" rid="bib34">Ge et al., 2020</xref>) by uploading the gene lists from our RNA sequencing or ribosome profiling analysis. ﻿Pathway enrichment terms with a <italic>P</italic>-value cutoff (FDR) ≤ 0.05 were considered enriched.</p></sec><sec id="s4-13"><title>Statistics</title><p>For quantification of protein expression, RNA expression (quantitative RT-PCR), fluorescence intensity or histological quantifications, p-values were computed in GraphPad Prism using either student’s t-test, multiple t-tests, one-way ANOVA, or two-way ANOVA and statistical tests were corrected for multiple comparisons as indicated in the figure legends. All quantifications were performed with at least three mice/embryos of each genotype and time point using mice of either sex (embryos were not sexed).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank T Jucius and A Kano for technical assistance, Drs. Bo Torben Porse and Miles Wilkinson for providing the <italic>Upf2</italic><sup>fl/fl</sup> mice, the IGM Genomics Center at the University of California San Diego (UCSD) for support with sequencing and the UCSD School of Medicine Microcopy Core for providing access to microscopy equipment (Grant P30 NS047101). This work was supported in part by NIH R01 NS094637 (SLA). SLA is an investigator of the Howard Hughes Medical Institute.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Supervision, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: Animal Protocol number S15286.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Embryonic lethality.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Locus specific pausing genome level.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>DE RPF footprints.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp3-v1.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>A-site pausing.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp4-v1.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Locus-specific pausing transcript level.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp5-v1.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>TE MEFs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp6-v1.xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>DE mRNA MEFs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66904-supp7-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-66904-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE162556.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ackerman</surname><given-names>SL</given-names></name><name><surname>Terrey</surname><given-names>M</given-names></name><name><surname>Adamson</surname><given-names>SI</given-names></name><name><surname>Chuang</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Mutations in distinct translation-dependent quality control pathways lead to convergent molecular pathogenesis and neurodevelopmental defects.</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162556">GSE162556</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abreua R de</surname> <given-names>S</given-names></name><name><surname>Penalvaa</surname> <given-names>LO</given-names></name><name><surname>Marcotteb</surname> <given-names>EM</given-names></name><name><surname>Vogel</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Global signatures of protein and mRNA expression levels</article-title><source>Energy Conversion and Management</source><volume>5</volume><fpage>1512</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.1039/b908315d</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adham</surname> <given-names>IM</given-names></name><name><surname>Sallam</surname> <given-names>MA</given-names></name><name><surname>Steding</surname> <given-names>G</given-names></name><name><surname>Korabiowska</surname> <given-names>M</given-names></name><name><surname>Brinck</surname> <given-names>U</given-names></name><name><surname>Hoyer-Fender</surname> <given-names>S</given-names></name><name><surname>Oh</surname> <given-names>C</given-names></name><name><surname>Engel</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Disruption of the pelota gene causes early embryonic lethality and defects in cell cycle progression</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>1470</fpage><lpage>1476</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.4.1470-1476.2003</pub-id><pub-id pub-id-type="pmid">12556505</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arpat</surname> <given-names>AB</given-names></name><name><surname>Liechti</surname> <given-names>A</given-names></name><name><surname>De Matos</surname> <given-names>M</given-names></name><name><surname>Dreos</surname> <given-names>R</given-names></name><name><surname>Janich</surname> <given-names>P</given-names></name><name><surname>Gatfield</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptome-wide sites of collided ribosomes reveal principles of translational pausing</article-title><source>Genome Research</source><volume>30</volume><fpage>985</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1101/gr.257741.119</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arribere</surname> <given-names>JA</given-names></name><name><surname>Fire</surname> <given-names>AZ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nonsense mRNA suppression via nonstop decay</article-title><source>eLife</source><volume>7</volume><elocation-id>e33292</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.33292</pub-id><pub-id pub-id-type="pmid">29309033</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname> <given-names>JD</given-names></name><name><surname>Hockemeyer</surname> <given-names>D</given-names></name><name><surname>Doudna</surname> <given-names>JA</given-names></name><name><surname>Bateup</surname> <given-names>HS</given-names></name><name><surname>Floor</surname> <given-names>SN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Widespread translational remodeling during human neuronal differentiation</article-title><source>Cell Reports</source><volume>21</volume><fpage>2005</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.095</pub-id><pub-id pub-id-type="pmid">29141229</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname> <given-names>S</given-names></name><name><surname>Bandiera</surname> <given-names>R</given-names></name><name><surname>Popis</surname> <given-names>M</given-names></name><name><surname>Hussain</surname> <given-names>S</given-names></name><name><surname>Lombard</surname> <given-names>P</given-names></name><name><surname>Aleksic</surname> <given-names>J</given-names></name><name><surname>Sajini</surname> <given-names>A</given-names></name><name><surname>Tanna</surname> <given-names>H</given-names></name><name><surname>Cortés-Garrido</surname> <given-names>R</given-names></name><name><surname>Gkatza</surname> <given-names>N</given-names></name><name><surname>Dietmann</surname> <given-names>S</given-names></name><name><surname>Frye</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Stem cell function and stress response are controlled by protein synthesis</article-title><source>Nature</source><volume>534</volume><fpage>335</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1038/nature18282</pub-id><pub-id pub-id-type="pmid">27306184</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandman</surname> <given-names>O</given-names></name><name><surname>Hegde</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ribosome-associated protein quality control</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>23</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3147</pub-id><pub-id pub-id-type="pmid">26733220</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname> <given-names>NL</given-names></name><name><surname>Pimentel</surname> <given-names>H</given-names></name><name><surname>Melsted</surname> <given-names>P</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Near-optimal probabilistic RNA-seq quantification</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>525</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nbt.3519</pub-id><pub-id pub-id-type="pmid">27043002</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britz</surname> <given-names>O</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Grossmann</surname> <given-names>KS</given-names></name><name><surname>Dyck</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>JC</given-names></name><name><surname>Dymecki</surname> <given-names>S</given-names></name><name><surname>Gosgnach</surname> <given-names>S</given-names></name><name><surname>Goulding</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A genetically defined asymmetry underlies the inhibitory control of flexor–extensor locomotor movements</article-title><source>eLife</source><volume>4</volume><elocation-id>e04718</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.04718</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brule</surname> <given-names>CE</given-names></name><name><surname>Grayhack</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synonymous codons: choose wisely for expression</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>283</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.02.001</pub-id><pub-id pub-id-type="pmid">28292534</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunkard</surname> <given-names>JO</given-names></name><name><surname>Baker</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Two-Headed monster to avert disaster: Hbs1/SKI7 is alternatively spliced to build eukaryotic RNA surveillance complexes</article-title><source>Frontiers in Plant Science</source><volume>9</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3389/fpls.2018.01333</pub-id><pub-id pub-id-type="pmid">30258456</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buhr</surname> <given-names>F</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Thommen</surname> <given-names>M</given-names></name><name><surname>Mittelstaet</surname> <given-names>J</given-names></name><name><surname>Kutz</surname> <given-names>F</given-names></name><name><surname>Schwalbe</surname> <given-names>H</given-names></name><name><surname>Rodnina</surname> <given-names>MV</given-names></name><name><surname>Komar</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Synonymous codons direct cotranslational folding toward different protein conformations</article-title><source>Molecular Cell</source><volume>61</volume><fpage>341</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.01.008</pub-id><pub-id pub-id-type="pmid">26849192</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buszczak</surname> <given-names>M</given-names></name><name><surname>Signer</surname> <given-names>RA</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cellular differences in protein synthesis regulate tissue homeostasis</article-title><source>Cell</source><volume>159</volume><fpage>242</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.09.016</pub-id><pub-id pub-id-type="pmid">25303523</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnevalli</surname> <given-names>LS</given-names></name><name><surname>Pereira</surname> <given-names>CM</given-names></name><name><surname>Longo</surname> <given-names>BM</given-names></name><name><surname>Jaqueta</surname> <given-names>CB</given-names></name><name><surname>Avedissian</surname> <given-names>M</given-names></name><name><surname>Mello</surname> <given-names>LE</given-names></name><name><surname>Castilho</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Phosphorylation of translation initiation factor eIF2alpha in the brain during pilocarpine-induced status epilepticus in mice</article-title><source>Neuroscience Letters</source><volume>357</volume><fpage>191</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2003.12.093</pub-id><pub-id pub-id-type="pmid">15003282</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castelo-Szekely</surname> <given-names>V</given-names></name><name><surname>Arpat</surname> <given-names>AB</given-names></name><name><surname>Janich</surname> <given-names>P</given-names></name><name><surname>Gatfield</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Translational contributions to tissue specificity in rhythmic and constitutive gene expression</article-title><source>Genome Biology</source><volume>18</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1186/s13059-017-1222-2</pub-id><pub-id pub-id-type="pmid">28622766</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname> <given-names>YJ</given-names></name><name><surname>Park</surname> <given-names>SH</given-names></name><name><surname>Hassemer</surname> <given-names>T</given-names></name><name><surname>Körner</surname> <given-names>R</given-names></name><name><surname>Vincenz-Donnelly</surname> <given-names>L</given-names></name><name><surname>Hayer-Hartl</surname> <given-names>M</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Failure of RQC machinery causes protein aggregation and proteotoxic stress</article-title><source>Nature</source><volume>531</volume><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1038/nature16973</pub-id><pub-id pub-id-type="pmid">26934223</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>J</given-names></name><name><surname>Hong</surname> <given-names>NA</given-names></name><name><surname>Masuda</surname> <given-names>CA</given-names></name><name><surname>Jenkins</surname> <given-names>BV</given-names></name><name><surname>Nelms</surname> <given-names>KA</given-names></name><name><surname>Goodnow</surname> <given-names>CC</given-names></name><name><surname>Glynne</surname> <given-names>RJ</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Masliah</surname> <given-names>E</given-names></name><name><surname>Joazeiro</surname> <given-names>CA</given-names></name><name><surname>Kay</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration</article-title><source>PNAS</source><volume>106</volume><fpage>2097</fpage><lpage>2103</lpage><pub-id pub-id-type="doi">10.1073/pnas.0812819106</pub-id><pub-id pub-id-type="pmid">19196968</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>SH</given-names></name><name><surname>Kim</surname> <given-names>CT</given-names></name><name><surname>Jung</surname> <given-names>YH</given-names></name><name><surname>Lee</surname> <given-names>NS</given-names></name><name><surname>Jeong</surname> <given-names>YG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Early cerebellar granule cell migration in the mouse embryonic development</article-title><source>Anatomy &amp; Cell Biology</source><volume>43</volume><elocation-id>86</elocation-id><pub-id pub-id-type="doi">10.5115/acb.2010.43.1.86</pub-id><pub-id pub-id-type="pmid">21190009</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname> <given-names>SH</given-names></name><name><surname>Guo</surname> <given-names>F</given-names></name><name><surname>Jiang</surname> <given-names>P</given-names></name><name><surname>Pleasure</surname> <given-names>DE</given-names></name><name><surname>Deng</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Olig2/Plp-positive progenitor cells give rise to Bergmann glia in the cerebellum</article-title><source>Cell Death &amp; Disease</source><volume>4</volume><elocation-id>e546</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2013.74</pub-id><pub-id pub-id-type="pmid">23492777</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collart</surname> <given-names>MA</given-names></name><name><surname>Weiss</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ribosome pausing, a dangerous necessity for co-translational events</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>1043</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz763</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Bassel-Duby</surname> <given-names>R</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease</article-title><source>Development</source><volume>145</volume><elocation-id>dev171983</elocation-id><pub-id pub-id-type="doi">10.1242/dev.171983</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Orazio</surname> <given-names>KN</given-names></name><name><surname>Wu</surname> <given-names>CC</given-names></name><name><surname>Sinha</surname> <given-names>N</given-names></name><name><surname>Loll-Krippleber</surname> <given-names>R</given-names></name><name><surname>Brown</surname> <given-names>GW</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The endonuclease Cue2 cleaves mRNAs at stalled ribosomes during no go decay</article-title><source>eLife</source><volume>8</volume><elocation-id>e49117</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.49117</pub-id><pub-id pub-id-type="pmid">31219035</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dever</surname> <given-names>TE</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Phases of translation in eukaryotes</article-title><source>Cold Spring Harb Perspect Biol Perspect Biol</source><volume>4</volume><fpage>1</fpage><lpage>16</lpage></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diament</surname> <given-names>A</given-names></name><name><surname>Feldman</surname> <given-names>A</given-names></name><name><surname>Schochet</surname> <given-names>E</given-names></name><name><surname>Kupiec</surname> <given-names>M</given-names></name><name><surname>Arava</surname> <given-names>Y</given-names></name><name><surname>Tuller</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The extent of ribosome queuing in budding yeast</article-title><source>PLOS Computational Biology</source><volume>14</volume><elocation-id>e1005951-21</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005951</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doma</surname> <given-names>MK</given-names></name><name><surname>Parker</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation</article-title><source>Nature</source><volume>440</volume><fpage>561</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/nature04530</pub-id><pub-id pub-id-type="pmid">16554824</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>X</given-names></name><name><surname>Kwan</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Yin yang 1 is critical for mid-hindbrain neuroepithelium development and involved in cerebellar agenesis</article-title><source>Molecular Brain</source><volume>13</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s13041-020-00643-z</pub-id><pub-id pub-id-type="pmid">32703236</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname> <given-names>DA</given-names></name><name><surname>Wilke</surname> <given-names>CO</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolution</article-title><source>Cell</source><volume>134</volume><fpage>341</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.05.042</pub-id><pub-id pub-id-type="pmid">18662548</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durinck</surname> <given-names>S</given-names></name><name><surname>Moreau</surname> <given-names>Y</given-names></name><name><surname>Kasprzyk</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>De Moor</surname> <given-names>B</given-names></name><name><surname>Brazma</surname> <given-names>A</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BioMart and bioconductor: a powerful link between biological databases and microarray data analysis</article-title><source>Bioinformatics</source><volume>21</volume><fpage>3439</fpage><lpage>3440</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti525</pub-id><pub-id pub-id-type="pmid">16082012</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberle</surname> <given-names>AB</given-names></name><name><surname>Lykke-Andersen</surname> <given-names>S</given-names></name><name><surname>Mühlemann</surname> <given-names>O</given-names></name><name><surname>Jensen</surname> <given-names>TH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>16</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1530</pub-id><pub-id pub-id-type="pmid">19060897</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname> <given-names>AJ</given-names></name><name><surname>Englund</surname> <given-names>C</given-names></name><name><surname>Daza</surname> <given-names>RA</given-names></name><name><surname>Pham</surname> <given-names>D</given-names></name><name><surname>Lau</surname> <given-names>C</given-names></name><name><surname>Nivison</surname> <given-names>M</given-names></name><name><surname>Kowalczyk</surname> <given-names>T</given-names></name><name><surname>Hevner</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Development of the deep cerebellar nuclei: transcription factors and cell migration from the rhombic lip</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>3066</fpage><lpage>3076</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5203-05.2006</pub-id><pub-id pub-id-type="pmid">16540585</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname> <given-names>K</given-names></name><name><surname>Shi</surname> <given-names>Z</given-names></name><name><surname>Zhulyn</surname> <given-names>O</given-names></name><name><surname>Denans</surname> <given-names>N</given-names></name><name><surname>Barna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pervasive translational regulation of the cell signalling circuitry underlies mammalian development</article-title><source>Nature Communications</source><volume>8</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/ncomms14443</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fünfschilling</surname> <given-names>U</given-names></name><name><surname>Reichardt</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cre-mediated recombination in rhombic lip derivatives</article-title><source>Genesis</source><volume>33</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1002/gene.10104</pub-id><pub-id pub-id-type="pmid">12203913</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabut</surname> <given-names>M</given-names></name><name><surname>Bourdelais</surname> <given-names>F</given-names></name><name><surname>Durand</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ribosome and translational control in stem cells</article-title><source>Cells</source><volume>9</volume><elocation-id>497</elocation-id><pub-id pub-id-type="doi">10.3390/cells9020497</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname> <given-names>SX</given-names></name><name><surname>Jung</surname> <given-names>D</given-names></name><name><surname>Yao</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title><source>Bioinformatics</source><volume>36</volume><fpage>2628</fpage><lpage>2629</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz931</pub-id><pub-id pub-id-type="pmid">31882993</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname> <given-names>ML</given-names></name><name><surname>Burroughs</surname> <given-names>AM</given-names></name><name><surname>Monem</surname> <given-names>PC</given-names></name><name><surname>Egelhofer</surname> <given-names>TA</given-names></name><name><surname>Pule</surname> <given-names>MN</given-names></name><name><surname>Aravind</surname> <given-names>L</given-names></name><name><surname>Arribere</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NONU-1 encodes a conserved endonuclease required for mRNA translation surveillance</article-title><source>Cell Reports</source><volume>30</volume><fpage>4321</fpage><lpage>4331</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.023</pub-id><pub-id pub-id-type="pmid">32234470</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname> <given-names>C</given-names></name><name><surname>Sims</surname> <given-names>JS</given-names></name><name><surname>Hornstein</surname> <given-names>N</given-names></name><name><surname>Mela</surname> <given-names>A</given-names></name><name><surname>Garcia</surname> <given-names>F</given-names></name><name><surname>Lei</surname> <given-names>L</given-names></name><name><surname>Gass</surname> <given-names>DA</given-names></name><name><surname>Amendolara</surname> <given-names>B</given-names></name><name><surname>Bruce</surname> <given-names>JN</given-names></name><name><surname>Canoll</surname> <given-names>P</given-names></name><name><surname>Sims</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>10924</fpage><lpage>10936</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0084-14.2014</pub-id><pub-id pub-id-type="pmid">25122893</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Götz</surname> <given-names>M</given-names></name><name><surname>Huttner</surname> <given-names>WB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The cell biology of neurogenesis</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>6</volume><fpage>777</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1038/nrm1739</pub-id><pub-id pub-id-type="pmid">16314867</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Sunmonu</surname> <given-names>NA</given-names></name><name><surname>Li</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fgf8b-containing spliceforms, but not Fgf8a, are essential for Fgf8 function during development of the midbrain and cerebellum</article-title><source>Developmental Biology</source><volume>338</volume><fpage>183</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.11.034</pub-id><pub-id pub-id-type="pmid">19968985</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guydosh</surname> <given-names>NR</given-names></name><name><surname>Kimmig</surname> <given-names>P</given-names></name><name><surname>Walter</surname> <given-names>P</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulated Ire1-dependent mRNA decay requires no-go mRNA degradation to maintain endoplasmic reticulum homeostasis in <italic>S. pombe</italic></article-title><source>eLife</source><volume>6</volume><elocation-id>e29216</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.29216</pub-id><pub-id pub-id-type="pmid">28945192</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guydosh</surname> <given-names>NR</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dom34 rescues ribosomes in 3' untranslated regions</article-title><source>Cell</source><volume>156</volume><fpage>950</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.02.006</pub-id><pub-id pub-id-type="pmid">24581494</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guydosh</surname> <given-names>NR</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Translation of poly(A) tails leads to precise mRNA cleavage</article-title><source>RNA</source><volume>23</volume><fpage>749</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1261/rna.060418.116</pub-id><pub-id pub-id-type="pmid">28193672</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>P</given-names></name><name><surname>Shichino</surname> <given-names>Y</given-names></name><name><surname>Schneider-Poetsch</surname> <given-names>T</given-names></name><name><surname>Mito</surname> <given-names>M</given-names></name><name><surname>Hashimoto</surname> <given-names>S</given-names></name><name><surname>Udagawa</surname> <given-names>T</given-names></name><name><surname>Kohno</surname> <given-names>K</given-names></name><name><surname>Yoshida</surname> <given-names>M</given-names></name><name><surname>Mishima</surname> <given-names>Y</given-names></name><name><surname>Inada</surname> <given-names>T</given-names></name><name><surname>Iwasaki</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genome-wide survey of ribosome collision</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107610</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107610</pub-id><pub-id pub-id-type="pmid">32375038</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname> <given-names>NW</given-names></name><name><surname>Lin</surname> <given-names>TV</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Paquelet</surname> <given-names>GE</given-names></name><name><surname>Feliciano</surname> <given-names>DM</given-names></name><name><surname>Bordey</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1/2, to regulate neural stem cell self-renewal in vivo</article-title><source>Cell Reports</source><volume>5</volume><fpage>433</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.09.017</pub-id><pub-id pub-id-type="pmid">24139800</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname> <given-names>Y</given-names></name><name><surname>Takahashi</surname> <given-names>M</given-names></name><name><surname>Sakota</surname> <given-names>E</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nonstop-mRNA decay machinery is involved in the clearance of mRNA 5'-fragments produced by RNAi and NMD <italic>in</italic> Drosophila Melanogaster cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>484</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.01.092</pub-id><pub-id pub-id-type="pmid">28115162</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>F</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Spatrick</surname> <given-names>P</given-names></name><name><surname>Casillo</surname> <given-names>R</given-names></name><name><surname>Dong</surname> <given-names>S</given-names></name><name><surname>Jacobson</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genome-wide analysis of mRNAs regulated by the nonsense-mediated and 5' to 3' mRNA decay pathways in yeast</article-title><source>Molecular Cell</source><volume>12</volume><fpage>1439</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(03)00446-5</pub-id><pub-id pub-id-type="pmid">14690598</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilal</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>H</given-names></name><name><surname>Loerke</surname> <given-names>J</given-names></name><name><surname>Bürger</surname> <given-names>J</given-names></name><name><surname>Mielke</surname> <given-names>T</given-names></name><name><surname>Spahn</surname> <given-names>CMT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural insights into ribosomal rescue by Dom34 and Hbs1 at near-atomic resolution</article-title><source>Nature Communications</source><volume>7</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ncomms13521</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Sweet</surname> <given-names>TJ</given-names></name><name><surname>Chamnongpol</surname> <given-names>S</given-names></name><name><surname>Baker</surname> <given-names>KE</given-names></name><name><surname>Coller</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Co-translational mRNA decay in <italic>Saccharomyces cerevisiae</italic></article-title><source>Nature</source><volume>461</volume><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/nature08265</pub-id><pub-id pub-id-type="pmid">19701183</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Shum</surname> <given-names>EY</given-names></name><name><surname>Jones</surname> <given-names>SH</given-names></name><name><surname>Lou</surname> <given-names>CH</given-names></name><name><surname>Dumdie</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Roberts</surname> <given-names>AJ</given-names></name><name><surname>Jolly</surname> <given-names>LA</given-names></name><name><surname>Espinoza</surname> <given-names>JL</given-names></name><name><surname>Skarbrevik</surname> <given-names>DM</given-names></name><name><surname>Phan</surname> <given-names>MH</given-names></name><name><surname>Cook-Andersen</surname> <given-names>H</given-names></name><name><surname>Swerdlow</surname> <given-names>NR</given-names></name><name><surname>Gecz</surname> <given-names>J</given-names></name><name><surname>Wilkinson</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Upf3b-mutant mouse model with behavioral and neurogenesis defects</article-title><source>Molecular Psychiatry</source><volume>23</volume><fpage>1773</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1038/mp.2017.173</pub-id><pub-id pub-id-type="pmid">28948974</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname> <given-names>F</given-names></name><name><surname>Maragkakis</surname> <given-names>M</given-names></name><name><surname>Alexiou</surname> <given-names>P</given-names></name><name><surname>Mourelatos</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ribothrypsis, a novel process of canonical mRNA decay, mediates ribosome-phased mRNA endonucleolysis</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>25</volume><fpage>302</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1038/s41594-018-0042-8</pub-id><pub-id pub-id-type="pmid">29507394</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeuchi</surname> <given-names>K</given-names></name><name><surname>Yazaki</surname> <given-names>E</given-names></name><name><surname>Kudo</surname> <given-names>K</given-names></name><name><surname>Inada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Conserved functions of human pelota in mRNA quality control of nonstop mRNA</article-title><source>FEBS Letters</source><volume>590</volume><fpage>3254</fpage><lpage>3263</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12366</pub-id><pub-id pub-id-type="pmid">27543824</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeuchi</surname> <given-names>K</given-names></name><name><surname>Tesina</surname> <given-names>P</given-names></name><name><surname>Matsuo</surname> <given-names>Y</given-names></name><name><surname>Sugiyama</surname> <given-names>T</given-names></name><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Saeki</surname> <given-names>Y</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Becker</surname> <given-names>T</given-names></name><name><surname>Beckmann</surname> <given-names>R</given-names></name><name><surname>Inada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Collided ribosomes form a unique structural interface to induce Hel2‐driven quality control pathways</article-title><source>The EMBO Journal</source><volume>38</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.15252/embj.2018100276</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Quality controls induced by aberrant translation</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>1084</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz1201</pub-id><pub-id pub-id-type="pmid">31950154</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolia</surname> <given-names>NT</given-names></name><name><surname>Brar</surname> <given-names>GA</given-names></name><name><surname>Rouskin</surname> <given-names>S</given-names></name><name><surname>McGeachy</surname> <given-names>AM</given-names></name><name><surname>Weissman</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1534</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.086</pub-id><pub-id pub-id-type="pmid">22836135</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimura</surname> <given-names>R</given-names></name><name><surname>Nagy</surname> <given-names>G</given-names></name><name><surname>Dotu</surname> <given-names>I</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>XL</given-names></name><name><surname>Schimmel</surname> <given-names>P</given-names></name><name><surname>Senju</surname> <given-names>S</given-names></name><name><surname>Nishimura</surname> <given-names>Y</given-names></name><name><surname>Chuang</surname> <given-names>JH</given-names></name><name><surname>Ackerman</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RNA function. ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration</article-title><source>Science</source><volume>345</volume><fpage>455</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1126/science.1249749</pub-id><pub-id pub-id-type="pmid">25061210</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimura</surname> <given-names>R</given-names></name><name><surname>Nagy</surname> <given-names>G</given-names></name><name><surname>Dotu</surname> <given-names>I</given-names></name><name><surname>Chuang</surname> <given-names>JH</given-names></name><name><surname>Ackerman</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation</article-title><source>eLife</source><volume>5</volume><elocation-id>e14295</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.14295</pub-id><pub-id pub-id-type="pmid">27085088</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffrey</surname> <given-names>SR</given-names></name><name><surname>Wilkinson</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nonsense-mediated RNA decay in the brain: emerging modulator of neural development and disease</article-title><source>Nature Reviews Neuroscience</source><volume>19</volume><fpage>715</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1038/s41583-018-0079-z</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamar</surname> <given-names>NH</given-names></name><name><surname>Kritsiligkou</surname> <given-names>P</given-names></name><name><surname>Grant</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of mRNA surveillance pathways results in widespread protein aggregation</article-title><source>Scientific Reports</source><volume>8</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/s41598-018-22183-2</pub-id><pub-id pub-id-type="pmid">29497115</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Feng</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Deng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Proteomic analysis of mTOR inhibition-mediated phosphorylation changes in ribosomal proteins and eukaryotic translation initiation factors</article-title><source>Protein &amp; Cell</source><volume>7</volume><fpage>533</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1007/s13238-016-0279-0</pub-id><pub-id pub-id-type="pmid">27278278</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>JL</given-names></name><name><surname>Stoica</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>PJ</given-names></name><name><surname>Bhattacharya</surname> <given-names>A</given-names></name><name><surname>Buffington</surname> <given-names>SA</given-names></name><name><surname>Huq</surname> <given-names>R</given-names></name><name><surname>Eissa</surname> <given-names>NT</given-names></name><name><surname>Larsson</surname> <given-names>O</given-names></name><name><surname>Porse</surname> <given-names>BT</given-names></name><name><surname>Domingo</surname> <given-names>D</given-names></name><name><surname>Nawaz</surname> <given-names>U</given-names></name><name><surname>Carroll</surname> <given-names>R</given-names></name><name><surname>Jolly</surname> <given-names>L</given-names></name><name><surname>Scerri</surname> <given-names>TS</given-names></name><name><surname>Kim</surname> <given-names>HG</given-names></name><name><surname>Brignell</surname> <given-names>A</given-names></name><name><surname>Coleman</surname> <given-names>MJ</given-names></name><name><surname>Braden</surname> <given-names>R</given-names></name><name><surname>Kini</surname> <given-names>U</given-names></name><name><surname>Jackson</surname> <given-names>V</given-names></name><name><surname>Baxter</surname> <given-names>A</given-names></name><name><surname>Bahlo</surname> <given-names>M</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Amor</surname> <given-names>DJ</given-names></name><name><surname>Hildebrand</surname> <given-names>MS</given-names></name><name><surname>Bonnen</surname> <given-names>PE</given-names></name><name><surname>Beeton</surname> <given-names>C</given-names></name><name><surname>Gecz</surname> <given-names>J</given-names></name><name><surname>Morgan</surname> <given-names>AT</given-names></name><name><surname>Costa-Mattioli</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inhibition of Upf2-Dependent Nonsense-Mediated decay leads to behavioral and neurophysiological abnormalities by activating the immune response</article-title><source>Neuron</source><volume>104</volume><fpage>665</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.08.027</pub-id><pub-id pub-id-type="pmid">31585809</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>He</surname> <given-names>X</given-names></name><name><surname>Peng</surname> <given-names>C</given-names></name><name><surname>Zheng</surname> <given-names>T</given-names></name><name><surname>Lu</surname> <given-names>QR</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Olig2 regulates Purkinje cell generation in the early developing mouse cerebellum</article-title><source>Scientific Reports</source><volume>6</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/srep30711</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juszkiewicz</surname> <given-names>S</given-names></name><name><surname>Speldewinde</surname> <given-names>SH</given-names></name><name><surname>Wan</surname> <given-names>L</given-names></name><name><surname>Svejstrup</surname> <given-names>JQ</given-names></name><name><surname>Hegde</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The ASC-1 complex disassembles collided ribosomes</article-title><source>Molecular Cell</source><volume>79</volume><fpage>603</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.06.006</pub-id><pub-id pub-id-type="pmid">32579943</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalisiak</surname> <given-names>K</given-names></name><name><surname>Kuliński</surname> <given-names>TM</given-names></name><name><surname>Tomecki</surname> <given-names>R</given-names></name><name><surname>Cysewski</surname> <given-names>D</given-names></name><name><surname>Pietras</surname> <given-names>Z</given-names></name><name><surname>Chlebowski</surname> <given-names>A</given-names></name><name><surname>Kowalska</surname> <given-names>K</given-names></name><name><surname>Dziembowski</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A short splicing isoform of HBS1L links the cytoplasmic exosome and SKI complexes in humans</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>2068</fpage><lpage>2080</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw862</pub-id><pub-id pub-id-type="pmid">28204585</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname> <given-names>M</given-names></name><name><surname>Ganguly</surname> <given-names>A</given-names></name><name><surname>Nagy</surname> <given-names>G</given-names></name><name><surname>Adamson</surname> <given-names>SI</given-names></name><name><surname>Chuang</surname> <given-names>JH</given-names></name><name><surname>Frankel</surname> <given-names>WN</given-names></name><name><surname>Ackerman</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Expression of the neuronal tRNA n-Tr20 regulates synaptic transmission and seizure susceptibility</article-title><source>Neuron</source><volume>108</volume><fpage>193</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.07.023</pub-id><pub-id pub-id-type="pmid">32853550</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karousis</surname> <given-names>ED</given-names></name><name><surname>Mühlemann</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nonsense-Mediated mRNA decay begins where translation ends</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>11</volume><elocation-id>a032862</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a032862</pub-id><pub-id pub-id-type="pmid">29891560</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Kundu</surname> <given-names>M</given-names></name><name><surname>Viollet</surname> <given-names>B</given-names></name><name><surname>Guan</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</article-title><source>Nature Cell Biology</source><volume>13</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/ncb2152</pub-id><pub-id pub-id-type="pmid">21258367</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Paggi</surname> <given-names>JM</given-names></name><name><surname>Park</surname> <given-names>C</given-names></name><name><surname>Bennett</surname> <given-names>C</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>907</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id><pub-id pub-id-type="pmid">31375807</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname> <given-names>RA</given-names></name><name><surname>Turnbull</surname> <given-names>DH</given-names></name><name><surname>Blanquet</surname> <given-names>V</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Loomis</surname> <given-names>CA</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Two lineage boundaries coordinate vertebrate apical ectodermal ridge formation</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>1377</fpage><lpage>1389</lpage><pub-id pub-id-type="pmid">10837030</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoepfler</surname> <given-names>PS</given-names></name><name><surname>Cheng</surname> <given-names>PF</given-names></name><name><surname>Eisenman</surname> <given-names>RN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>2699</fpage><lpage>2712</lpage><pub-id pub-id-type="doi">10.1101/gad.1021202</pub-id><pub-id pub-id-type="pmid">12381668</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>J</given-names></name><name><surname>Lasko</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Translational control in cellular and developmental processes</article-title><source>Nature Reviews Genetics</source><volume>13</volume><fpage>383</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/nrg3184</pub-id><pub-id pub-id-type="pmid">22568971</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristensen</surname> <given-names>AR</given-names></name><name><surname>Gsponer</surname> <given-names>J</given-names></name><name><surname>Foster</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Protein synthesis rate is the predominant regulator of protein expression during differentiation</article-title><source>Molecular Systems Biology</source><volume>9</volume><elocation-id>689</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2013.47</pub-id><pub-id pub-id-type="pmid">24045637</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauria</surname> <given-names>F</given-names></name><name><surname>Tebaldi</surname> <given-names>T</given-names></name><name><surname>Bernabò</surname> <given-names>P</given-names></name><name><surname>Groen</surname> <given-names>EJN</given-names></name><name><surname>Gillingwater</surname> <given-names>TH</given-names></name><name><surname>Viero</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>riboWaltz: optimization of ribosome P-site positioning in ribosome profiling data</article-title><source>PLOS Computational Biology</source><volume>14</volume><elocation-id>e1006169</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006169</pub-id><pub-id pub-id-type="pmid">30102689</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legué</surname> <given-names>E</given-names></name><name><surname>Gottshall</surname> <given-names>JL</given-names></name><name><surname>Jaumouillé</surname> <given-names>E</given-names></name><name><surname>Roselló-Díez</surname> <given-names>A</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Barraza</surname> <given-names>LH</given-names></name><name><surname>Washington</surname> <given-names>S</given-names></name><name><surname>Grant</surname> <given-names>RL</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Differential timing of granule cell production during cerebellum development underlies generation of the foliation pattern</article-title><source>Neural Development</source><volume>11</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s13064-016-0072-z</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lelivelt</surname> <given-names>MJ</given-names></name><name><surname>Culbertson</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Yeast UPF proteins required for RNA surveillance affect global expression of the yeast transcriptome</article-title><source>Molecular and Cellular Biology</source><volume>19</volume><fpage>6710</fpage><lpage>6719</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.10.6710</pub-id><pub-id pub-id-type="pmid">10490610</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leto</surname> <given-names>K</given-names></name><name><surname>Rolando</surname> <given-names>C</given-names></name><name><surname>Rossi</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The genesis of cerebellar GABAergic neurons: fate potential and specification mechanisms</article-title><source>Frontiers in Neuroanatomy</source><volume>6</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.3389/fnana.2012.00006</pub-id><pub-id pub-id-type="pmid">22363268</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>JY</given-names></name><name><surname>Lao</surname> <given-names>Z</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Changing requirements for Gbx2 in development of the cerebellum and maintenance of the mid/hindbrain organizer</article-title><source>Neuron</source><volume>36</volume><fpage>31</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(02)00935-2</pub-id><pub-id pub-id-type="pmid">12367504</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Guachalla</surname> <given-names>LM</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name><name><surname>Joerss</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>YS</given-names></name><name><surname>Groth</surname> <given-names>M</given-names></name><name><surname>Krueger</surname> <given-names>A</given-names></name><name><surname>Platzer</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>YG</given-names></name><name><surname>Rudolph</surname> <given-names>KL</given-names></name><name><surname>Wang</surname> <given-names>ZQ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay</article-title><source>The EMBO Journal</source><volume>34</volume><fpage>1630</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.15252/embj.201489947</pub-id><pub-id pub-id-type="pmid">25770585</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Uren</surname> <given-names>PJ</given-names></name><name><surname>Penalva</surname> <given-names>LOF</given-names></name><name><surname>Smith</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Riborex: fast and flexible identification of differential translation from Ribo-seq data</article-title><source>Bioinformatics</source><volume>33</volume><fpage>1735</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx047</pub-id><pub-id pub-id-type="pmid">28158331</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liakath-Ali</surname> <given-names>K</given-names></name><name><surname>Mills</surname> <given-names>EW</given-names></name><name><surname>Sequeira</surname> <given-names>I</given-names></name><name><surname>Lichtenberger</surname> <given-names>BM</given-names></name><name><surname>Pisco</surname> <given-names>AO</given-names></name><name><surname>Sipilä</surname> <given-names>KH</given-names></name><name><surname>Mishra</surname> <given-names>A</given-names></name><name><surname>Yoshikawa</surname> <given-names>H</given-names></name><name><surname>Wu</surname> <given-names>CC</given-names></name><name><surname>Ly</surname> <given-names>T</given-names></name><name><surname>Lamond</surname> <given-names>AI</given-names></name><name><surname>Adham</surname> <given-names>IM</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name><name><surname>Watt</surname> <given-names>FM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An evolutionarily conserved ribosome-rescue pathway maintains epidermal homeostasis</article-title><source>Nature</source><volume>556</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0032-3</pub-id><pub-id pub-id-type="pmid">29643507</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LiCausi</surname> <given-names>F</given-names></name><name><surname>Hartman</surname> <given-names>NW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of mTOR complexes in neurogenesis</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>1544</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19051544</pub-id><pub-id pub-id-type="pmid">29789464</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Iadevaia</surname> <given-names>V</given-names></name><name><surname>Averous</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>PM</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Proud</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>5083</fpage><lpage>5096</lpage><pub-id pub-id-type="doi">10.1093/nar/gku130</pub-id><pub-id pub-id-type="pmid">24526220</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Beyer</surname> <given-names>A</given-names></name><name><surname>Aebersold</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>On the dependency of cellular protein levels on mRNA abundance</article-title><source>Cell</source><volume>165</volume><fpage>535</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.03.014</pub-id><pub-id pub-id-type="pmid">27104977</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>KJ</given-names></name><name><surname>Schmittgen</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) Method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname> <given-names>A</given-names></name><name><surname>Deutschmann</surname> <given-names>M</given-names></name><name><surname>Ahlfeld</surname> <given-names>J</given-names></name><name><surname>Prix</surname> <given-names>C</given-names></name><name><surname>Koch</surname> <given-names>A</given-names></name><name><surname>Smits</surname> <given-names>R</given-names></name><name><surname>Fodde</surname> <given-names>R</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Schüller</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Severe alterations of cerebellar cortical development after constitutive activation of Wnt signaling in granule neuron precursors</article-title><source>Molecular and Cellular Biology</source><volume>31</volume><fpage>3326</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.1128/MCB.05718-11</pub-id><pub-id pub-id-type="pmid">21690300</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lykke-Andersen</surname> <given-names>J</given-names></name><name><surname>Bennett</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Protecting the proteome: Eukaryotic cotranslational quality control pathways</article-title><source>Journal of Cell Biology</source><volume>204</volume><fpage>467</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1083/jcb.201311103</pub-id><pub-id pub-id-type="pmid">24535822</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Sheng</surname> <given-names>Z</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Sun</surname> <given-names>R</given-names></name><name><surname>Fei</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>N-myc is a key switch regulating the proliferation cycle of postnatal cerebellar granule cell progenitors</article-title><source>Scientific Reports</source><volume>5</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/srep12740</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magri</surname> <given-names>L</given-names></name><name><surname>Cambiaghi</surname> <given-names>M</given-names></name><name><surname>Cominelli</surname> <given-names>M</given-names></name><name><surname>Alfaro-Cervello</surname> <given-names>C</given-names></name><name><surname>Cursi</surname> <given-names>M</given-names></name><name><surname>Pala</surname> <given-names>M</given-names></name><name><surname>Bulfone</surname> <given-names>A</given-names></name><name><surname>Garcìa-Verdugo</surname> <given-names>JM</given-names></name><name><surname>Leocani</surname> <given-names>L</given-names></name><name><surname>Minicucci</surname> <given-names>F</given-names></name><name><surname>Poliani</surname> <given-names>PL</given-names></name><name><surname>Galli</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions</article-title><source>Cell Stem Cell</source><volume>9</volume><fpage>447</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2011.09.008</pub-id><pub-id pub-id-type="pmid">22056141</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname> <given-names>T</given-names></name><name><surname>Güell</surname> <given-names>M</given-names></name><name><surname>Serrano</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Correlation of mRNA and protein in complex biological samples</article-title><source>FEBS Letters</source><volume>583</volume><fpage>3966</fpage><lpage>3973</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2009.10.036</pub-id><pub-id pub-id-type="pmid">19850042</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname> <given-names>AN</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>van Hoof</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Conservation of mRNA quality control factor Ski7 and its diversification through changes in alternative splicing and gene duplication</article-title><source>PNAS</source><volume>115</volume><fpage>E6808</fpage><lpage>E6816</lpage><pub-id pub-id-type="doi">10.1073/pnas.1801997115</pub-id><pub-id pub-id-type="pmid">29967155</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>PB</given-names></name><name><surname>Kigoshi-Tansho</surname> <given-names>Y</given-names></name><name><surname>Sher</surname> <given-names>RB</given-names></name><name><surname>Ravenscroft</surname> <given-names>G</given-names></name><name><surname>Stauffer</surname> <given-names>JE</given-names></name><name><surname>Kumar</surname> <given-names>R</given-names></name><name><surname>Yonashiro</surname> <given-names>R</given-names></name><name><surname>Müller</surname> <given-names>T</given-names></name><name><surname>Griffith</surname> <given-names>C</given-names></name><name><surname>Allen</surname> <given-names>W</given-names></name><name><surname>Pehlivan</surname> <given-names>D</given-names></name><name><surname>Harel</surname> <given-names>T</given-names></name><name><surname>Zenker</surname> <given-names>M</given-names></name><name><surname>Howting</surname> <given-names>D</given-names></name><name><surname>Schanze</surname> <given-names>D</given-names></name><name><surname>Faqeih</surname> <given-names>EA</given-names></name><name><surname>Almontashiri</surname> <given-names>NAM</given-names></name><name><surname>Maroofian</surname> <given-names>R</given-names></name><name><surname>Houlden</surname> <given-names>H</given-names></name><name><surname>Mazaheri</surname> <given-names>N</given-names></name><name><surname>Galehdari</surname> <given-names>H</given-names></name><name><surname>Douglas</surname> <given-names>G</given-names></name><name><surname>Posey</surname> <given-names>JE</given-names></name><name><surname>Ryan</surname> <given-names>M</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name><name><surname>Laing</surname> <given-names>NG</given-names></name><name><surname>Joazeiro</surname> <given-names>CAP</given-names></name><name><surname>Cox</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease</article-title><source>Nature Communications</source><volume>11</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41467-020-18327-6</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname> <given-names>C</given-names></name><name><surname>Grummt</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases</article-title><source>Oncogene</source><volume>25</volume><fpage>6384</fpage><lpage>6391</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209883</pub-id><pub-id pub-id-type="pmid">17041624</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendell</surname> <given-names>JT</given-names></name><name><surname>Sharifi</surname> <given-names>NA</given-names></name><name><surname>Meyers</surname> <given-names>JL</given-names></name><name><surname>Martinez-Murillo</surname> <given-names>F</given-names></name><name><surname>Dietz</surname> <given-names>HC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise</article-title><source>Nature Genetics</source><volume>36</volume><fpage>1073</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1038/ng1429</pub-id><pub-id pub-id-type="pmid">15448691</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>D</given-names></name><name><surname>Frank</surname> <given-names>AR</given-names></name><name><surname>Jewell</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>mTOR signaling in stem and progenitor cells</article-title><source>Development</source><volume>145</volume><elocation-id>dev152595</elocation-id><pub-id pub-id-type="doi">10.1242/dev.152595</pub-id><pub-id pub-id-type="pmid">29311260</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meydan</surname> <given-names>S</given-names></name><name><surname>Guydosh</surname> <given-names>NR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Disome and trisome profiling reveal genome-wide targets of ribosome quality control</article-title><source>Molecular Cell</source><volume>79</volume><fpage>588</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.06.010</pub-id><pub-id pub-id-type="pmid">32615089</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>EW</given-names></name><name><surname>Wangen</surname> <given-names>J</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name><name><surname>Ingolia</surname> <given-names>NT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic regulation of a ribosome rescue pathway in erythroid cells and platelets</article-title><source>Cell Reports</source><volume>17</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.088</pub-id><pub-id pub-id-type="pmid">27681415</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>EW</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name><name><surname>Ingolia</surname> <given-names>NT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Slowed decay of mRNAs enhances platelet specific translation</article-title><source>Blood</source><volume>129</volume><fpage>e38</fpage><lpage>e48</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-08-736108</pub-id><pub-id pub-id-type="pmid">28213379</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molkentin</surname> <given-names>JD</given-names></name><name><surname>Lin</surname> <given-names>Q</given-names></name><name><surname>Duncan</surname> <given-names>SA</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis</article-title><source>Genes &amp; Development</source><volume>11</volume><fpage>1061</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1101/gad.11.8.1061</pub-id><pub-id pub-id-type="pmid">9136933</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Martín</surname> <given-names>N</given-names></name><name><surname>Sierra</surname> <given-names>R</given-names></name><name><surname>Schimmang</surname> <given-names>T</given-names></name><name><surname>Villa Del Campo</surname> <given-names>C</given-names></name><name><surname>Torres</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Myc</italic> is dispensable for cardiomyocyte development but rescues <italic>Mycn</italic>-deficient hearts through functional replacement and cell competition</article-title><source>Development</source><volume>146</volume><elocation-id>dev170753</elocation-id><pub-id pub-id-type="doi">10.1242/dev.170753</pub-id><pub-id pub-id-type="pmid">30642836</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Nagy</surname> <given-names>A</given-names></name><name><surname>Gertsenstein</surname> <given-names>M</given-names></name><name><surname>Vintersten</surname> <given-names>K</given-names></name><name><surname>Behringer</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Manipulating the mouse embryo - A laboratory manual</article-title><conf-name>Cold Spring Harb Lab Press 4th</conf-name></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notaras</surname> <given-names>M</given-names></name><name><surname>Allen</surname> <given-names>M</given-names></name><name><surname>Longo</surname> <given-names>F</given-names></name><name><surname>Volk</surname> <given-names>N</given-names></name><name><surname>Toth</surname> <given-names>M</given-names></name><name><surname>Li Jeon</surname> <given-names>N</given-names></name><name><surname>Klann</surname> <given-names>E</given-names></name><name><surname>Colak</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>UPF2 leads to degradation of dendritically targeted mRNAs to regulate synaptic plasticity and cognitive function</article-title><source>Molecular Psychiatry</source><volume>25</volume><fpage>3360</fpage><lpage>3379</lpage><pub-id pub-id-type="doi">10.1038/s41380-019-0547-5</pub-id><pub-id pub-id-type="pmid">31636381</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connell</surname> <given-names>AE</given-names></name><name><surname>Gerashchenko</surname> <given-names>MV</given-names></name><name><surname>O'Donohue</surname> <given-names>MF</given-names></name><name><surname>Rosen</surname> <given-names>SM</given-names></name><name><surname>Huntzinger</surname> <given-names>E</given-names></name><name><surname>Gleeson</surname> <given-names>D</given-names></name><name><surname>Galli</surname> <given-names>A</given-names></name><name><surname>Ryder</surname> <given-names>E</given-names></name><name><surname>Cao</surname> <given-names>S</given-names></name><name><surname>Murphy</surname> <given-names>Q</given-names></name><name><surname>Kazerounian</surname> <given-names>S</given-names></name><name><surname>Morton</surname> <given-names>SU</given-names></name><name><surname>Schmitz-Abe</surname> <given-names>K</given-names></name><name><surname>Gladyshev</surname> <given-names>VN</given-names></name><name><surname>Gleizes</surname> <given-names>PE</given-names></name><name><surname>Séraphin</surname> <given-names>B</given-names></name><name><surname>Agrawal</surname> <given-names>PB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mammalian Hbs1L deficiency causes congenital anomalies and developmental delay associated with Pelota depletion and 80S monosome accumulation</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1007917</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007917</pub-id><pub-id pub-id-type="pmid">30707697</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>N</given-names></name><name><surname>Jahan</surname> <given-names>I</given-names></name><name><surname>Lee</surname> <given-names>JE</given-names></name><name><surname>Fritzsch</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Defects in the cerebella of conditional Neurod1 null mice correlate with effective Tg(Atoh1-cre) recombination and granule cell requirements for Neurod1 for differentiation</article-title><source>Cell and Tissue Research</source><volume>337</volume><fpage>407</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1007/s00441-009-0826-6</pub-id><pub-id pub-id-type="pmid">19609565</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimentel</surname> <given-names>H</given-names></name><name><surname>Bray</surname> <given-names>NL</given-names></name><name><surname>Puente</surname> <given-names>S</given-names></name><name><surname>Melsted</surname> <given-names>P</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Differential analysis of RNA-seq incorporating quantification uncertainty</article-title><source>Nature Methods</source><volume>14</volume><fpage>687</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4324</pub-id><pub-id pub-id-type="pmid">28581496</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisareva</surname> <given-names>VP</given-names></name><name><surname>Skabkin</surname> <given-names>MA</given-names></name><name><surname>Hellen</surname> <given-names>CU</given-names></name><name><surname>Pestova</surname> <given-names>TV</given-names></name><name><surname>Pisarev</surname> <given-names>AV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dissociation by Pelota, Hbs1 and ABCE1 of mammalian vacant 80S ribosomes and stalled elongation complexes</article-title><source>The EMBO Journal</source><volume>30</volume><fpage>1804</fpage><lpage>1817</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.93</pub-id><pub-id pub-id-type="pmid">21448132</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puertollano</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>mTOR and lysosome regulation</article-title><source>F1000Prime Reports</source><volume>6</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.12703/P6-52</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>Z</given-names></name><name><surname>Cang</surname> <given-names>Y</given-names></name><name><surname>Goff</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Abl family tyrosine kinases are essential for basement membrane integrity and cortical lamination in the cerebellum</article-title><source>Journal of Neuroscience</source><volume>30</volume><fpage>14430</fpage><lpage>14439</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2861-10.2010</pub-id><pub-id pub-id-type="pmid">20980600</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabanal-Ruiz</surname> <given-names>Y</given-names></name><name><surname>Korolchuk</surname> <given-names>VI</given-names></name><collab>Viktor Korolchuk</collab></person-group><year iso-8601-date="2018">2018</year><article-title>mTORC1 and nutrient homeostasis: the central role of the lysosome</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>818</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19030818</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimondeau</surname> <given-names>E</given-names></name><name><surname>Bufton</surname> <given-names>JC</given-names></name><name><surname>Schaffitzel</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>New insights into the interplay between the translation machinery and nonsense-mediated mRNA decay factors</article-title><source>Biochemical Society Transactions</source><volume>46</volume><fpage>503</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1042/BST20170427</pub-id><pub-id pub-id-type="pmid">29626148</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainer</surname> <given-names>J</given-names></name><name><surname>Gatto</surname> <given-names>L</given-names></name><name><surname>Weichenberger</surname> <given-names>CX</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ensembldb: an R package to create and use Ensembl-based annotation resources</article-title><source>Bioinformatics</source><volume>35</volume><fpage>3151</fpage><lpage>3153</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz031</pub-id><pub-id pub-id-type="pmid">30689724</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roczniak-Ferguson</surname> <given-names>A</given-names></name><name><surname>Petit</surname> <given-names>CS</given-names></name><name><surname>Froehlich</surname> <given-names>F</given-names></name><name><surname>Qian</surname> <given-names>S</given-names></name><name><surname>Ky</surname> <given-names>J</given-names></name><name><surname>Angarola</surname> <given-names>B</given-names></name><name><surname>Walther</surname> <given-names>TC</given-names></name><name><surname>Ferguson</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis</article-title><source>Science Signaling</source><volume>5</volume><elocation-id>ra42</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2002790</pub-id><pub-id pub-id-type="pmid">22692423</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname> <given-names>DC</given-names></name><name><surname>Mufteev</surname> <given-names>M</given-names></name><name><surname>Weatheritt</surname> <given-names>RJ</given-names></name><name><surname>Djuric</surname> <given-names>U</given-names></name><name><surname>Ha</surname> <given-names>KCH</given-names></name><name><surname>Ross</surname> <given-names>PJ</given-names></name><name><surname>Wei</surname> <given-names>W</given-names></name><name><surname>Piekna</surname> <given-names>A</given-names></name><name><surname>Sartori</surname> <given-names>MA</given-names></name><name><surname>Byres</surname> <given-names>L</given-names></name><name><surname>Mok</surname> <given-names>RSF</given-names></name><name><surname>Zaslavsky</surname> <given-names>K</given-names></name><name><surname>Pasceri</surname> <given-names>P</given-names></name><name><surname>Diamandis</surname> <given-names>P</given-names></name><name><surname>Morris</surname> <given-names>Q</given-names></name><name><surname>Blencowe</surname> <given-names>BJ</given-names></name><name><surname>Ellis</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Shifts in ribosome engagement impact key gene sets in neurodevelopment and ubiquitination in Rett syndrome</article-title><source>Cell Reports</source><volume>30</volume><fpage>4179</fpage><lpage>4196</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.02.107</pub-id><pub-id pub-id-type="pmid">32209477</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapir</surname> <given-names>T</given-names></name><name><surname>Geiman</surname> <given-names>EJ</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Velasquez</surname> <given-names>T</given-names></name><name><surname>Mitsui</surname> <given-names>S</given-names></name><name><surname>Yoshihara</surname> <given-names>Y</given-names></name><name><surname>Frank</surname> <given-names>E</given-names></name><name><surname>Alvarez</surname> <given-names>FJ</given-names></name><name><surname>Goulding</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Pax6 and engrailed 1 regulate two distinct aspects of renshaw cell development</article-title><source>Journal of Neuroscience</source><volume>24</volume><fpage>1255</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3187-03.2004</pub-id><pub-id pub-id-type="pmid">14762144</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuller</surname> <given-names>AP</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Roadblocks and resolutions in eukaryotic translation</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>19</volume><fpage>526</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0011-4</pub-id><pub-id pub-id-type="pmid">29760421</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serin</surname> <given-names>G</given-names></name><name><surname>Gersappe</surname> <given-names>A</given-names></name><name><surname>Black</surname> <given-names>JD</given-names></name><name><surname>Aronoff</surname> <given-names>R</given-names></name><name><surname>Maquat</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Identification and characterization of human orthologues to <italic>Saccharomyces cerevisiae</italic> Upf2 protein and Upf3 protein (<italic>Caenorhabditis elegans</italic> SMG-4)</article-title><source>Molecular and Cellular Biology</source><volume>21</volume><fpage>209</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1128/MCB.21.1.209-223.2001</pub-id><pub-id pub-id-type="pmid">11113196</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sgaier</surname> <given-names>SK</given-names></name><name><surname>Lao</surname> <given-names>Z</given-names></name><name><surname>Villanueva</surname> <given-names>MP</given-names></name><name><surname>Berenshteyn</surname> <given-names>F</given-names></name><name><surname>Stephen</surname> <given-names>D</given-names></name><name><surname>Turnbull</surname> <given-names>RK</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genetic subdivision of the tectum and cerebellum into functionally related regions based on differential sensitivity to engrailed proteins</article-title><source>Development</source><volume>134</volume><fpage>2325</fpage><lpage>2335</lpage><pub-id pub-id-type="doi">10.1242/dev.000620</pub-id><pub-id pub-id-type="pmid">17537797</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname> <given-names>CJ</given-names></name><name><surname>Eyler</surname> <given-names>DE</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dom34:Hbs1 promotes subunit dissociation and peptidyl-tRNA drop-off to initiate no-go decay</article-title><source>Science</source><volume>330</volume><fpage>369</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1126/science.1192430</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname> <given-names>CJ</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Kinetic analysis reveals the ordered coupling of translation termination and ribosome recycling in yeast</article-title><source>PNAS</source><volume>108</volume><fpage>E1392</fpage><lpage>E1398</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113956108</pub-id><pub-id pub-id-type="pmid">22143755</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname> <given-names>CJ</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Translation drives mRNA quality control</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>19</volume><fpage>594</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2301</pub-id><pub-id pub-id-type="pmid">22664987</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Signer</surname> <given-names>RA</given-names></name><name><surname>Magee</surname> <given-names>JA</given-names></name><name><surname>Salic</surname> <given-names>A</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Haematopoietic stem cells require a highly regulated protein synthesis rate</article-title><source>Nature</source><volume>509</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1038/nature13035</pub-id><pub-id pub-id-type="pmid">24670665</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simms</surname> <given-names>CL</given-names></name><name><surname>Hudson</surname> <given-names>BH</given-names></name><name><surname>Mosior</surname> <given-names>JW</given-names></name><name><surname>Rangwala</surname> <given-names>AS</given-names></name><name><surname>Zaher</surname> <given-names>HS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An active role for the ribosome in determining the fate of oxidized mRNA</article-title><source>Cell Reports</source><volume>9</volume><fpage>1256</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.042</pub-id><pub-id pub-id-type="pmid">25456128</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simms</surname> <given-names>CL</given-names></name><name><surname>Thomas</surname> <given-names>EN</given-names></name><name><surname>Zaher</surname> <given-names>HS</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Ribosome-based quality control of mRNA and nascent peptides</article-title><source>Wiley Interdisciplinary Reviews: RNA</source><volume>8</volume><elocation-id>e1366</elocation-id><pub-id pub-id-type="doi">10.1002/wrna.1366</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simms</surname> <given-names>CL</given-names></name><name><surname>Yan</surname> <given-names>LL</given-names></name><name><surname>Zaher</surname> <given-names>HS</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Ribosome collision is critical for quality control during no-go decay</article-title><source>Molecular Cell</source><volume>68</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.08.019</pub-id><pub-id pub-id-type="pmid">28943311</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname> <given-names>WC</given-names></name><name><surname>Rosen</surname> <given-names>B</given-names></name><name><surname>West</surname> <given-names>AP</given-names></name><name><surname>Koutsourakis</surname> <given-names>M</given-names></name><name><surname>Bushell</surname> <given-names>W</given-names></name><name><surname>Iyer</surname> <given-names>V</given-names></name><name><surname>Mujica</surname> <given-names>AO</given-names></name><name><surname>Thomas</surname> <given-names>M</given-names></name><name><surname>Harrow</surname> <given-names>J</given-names></name><name><surname>Cox</surname> <given-names>T</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Biggs</surname> <given-names>P</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Nefedov</surname> <given-names>M</given-names></name><name><surname>de Jong</surname> <given-names>PJ</given-names></name><name><surname>Stewart</surname> <given-names>AF</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title><source>Nature</source><volume>474</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10163</pub-id><pub-id pub-id-type="pmid">21677750</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname> <given-names>PS</given-names></name><name><surname>Siller</surname> <given-names>E</given-names></name><name><surname>Anderson</surname> <given-names>JF</given-names></name><name><surname>Barral</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Silent substitutions predictably alter translation elongation rates and protein folding efficiencies</article-title><source>Journal of Molecular Biology</source><volume>422</volume><fpage>328</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2012.06.010</pub-id><pub-id pub-id-type="pmid">22705285</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steimle</surname> <given-names>JD</given-names></name><name><surname>Moskowitz</surname> <given-names>IP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TBX5: a key regulator of heart development</article-title><source>Current Topics in Developmental Biology</source><volume>122</volume><fpage>195</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2016.08.008</pub-id><pub-id pub-id-type="pmid">28057264</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudmant</surname> <given-names>PH</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Dominguez</surname> <given-names>D</given-names></name><name><surname>Heiman</surname> <given-names>M</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Widespread accumulation of ribosome-associated isolated 3' UTRs in neuronal cell populations of the aging brain</article-title><source>Cell Reports</source><volume>25</volume><fpage>2447</fpage><lpage>2456</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.10.094</pub-id><pub-id pub-id-type="pmid">30485811</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahmasebi</surname> <given-names>S</given-names></name><name><surname>Amiri</surname> <given-names>M</given-names></name><name><surname>Sonenberg</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Translational control in stem cells</article-title><source>Frontiers in Genetics</source><volume>9</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3389/fgene.2018.00709</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatsumi</surname> <given-names>K</given-names></name><name><surname>Isonishi</surname> <given-names>A</given-names></name><name><surname>Yamasaki</surname> <given-names>M</given-names></name><name><surname>Kawabe</surname> <given-names>Y</given-names></name><name><surname>Morita-Takemura</surname> <given-names>S</given-names></name><name><surname>Nakahara</surname> <given-names>K</given-names></name><name><surname>Terada</surname> <given-names>Y</given-names></name><name><surname>Shinjo</surname> <given-names>T</given-names></name><name><surname>Okuda</surname> <given-names>H</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Wanaka</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Olig2-lineage astrocytes: A distinct subtype of astrocytes that differs from GFAP astrocytes</article-title><source>Frontiers in Neuroanatomy</source><volume>12</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3389/fnana.2018.00008</pub-id><pub-id pub-id-type="pmid">29497365</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrey</surname> <given-names>M</given-names></name><name><surname>Adamson</surname> <given-names>SI</given-names></name><name><surname>Gibson</surname> <given-names>AL</given-names></name><name><surname>Deng</surname> <given-names>T</given-names></name><name><surname>Ishimura</surname> <given-names>R</given-names></name><name><surname>Chuang</surname> <given-names>JH</given-names></name><name><surname>Ackerman</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GTPBP1 resolves paused ribosomes to maintain neuronal homeostasis</article-title><source>eLife</source><volume>9</volume><elocation-id>e62731</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.62731</pub-id><pub-id pub-id-type="pmid">33186095</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thommen</surname> <given-names>M</given-names></name><name><surname>Holtkamp</surname> <given-names>W</given-names></name><name><surname>Rodnina</surname> <given-names>MV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Co-translational protein folding: Progress and methods</article-title><source>Current Opinion in Structural Biology</source><volume>42</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2016.11.020</pub-id><pub-id pub-id-type="pmid">27940242</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname> <given-names>PP</given-names></name><name><surname>Di Giovannantonio</surname> <given-names>LG</given-names></name><name><surname>Viegi</surname> <given-names>A</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Simeone</surname> <given-names>A</given-names></name><name><surname>Bozzi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Serotonin hyperinnervation abolishes seizure susceptibility in Otx2 conditional mutant mice</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>9271</fpage><lpage>9276</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2208-08.2008</pub-id><pub-id pub-id-type="pmid">18784307</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuboi</surname> <given-names>T</given-names></name><name><surname>Kuroha</surname> <given-names>K</given-names></name><name><surname>Kudo</surname> <given-names>K</given-names></name><name><surname>Makino</surname> <given-names>S</given-names></name><name><surname>Inoue</surname> <given-names>E</given-names></name><name><surname>Kashima</surname> <given-names>I</given-names></name><name><surname>Inada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dom34:hbs1 plays a general role in quality-control systems by dissociation of a stalled ribosome at the 3' end of aberrant mRNA</article-title><source>Molecular Cell</source><volume>46</volume><fpage>518</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.03.013</pub-id><pub-id pub-id-type="pmid">22503425</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vong</surname> <given-names>KI</given-names></name><name><surname>Leung</surname> <given-names>CK</given-names></name><name><surname>Behringer</surname> <given-names>RR</given-names></name><name><surname>Kwan</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sox9 is critical for suppression of neurogenesis but not initiation of gliogenesis in the cerebellum</article-title><source>Molecular Brain</source><volume>8</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.1186/s13041-015-0115-0</pub-id><pub-id pub-id-type="pmid">25888505</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Way</surname> <given-names>SW</given-names></name><name><surname>McKenna</surname> <given-names>J</given-names></name><name><surname>Mietzsch</surname> <given-names>U</given-names></name><name><surname>Reith</surname> <given-names>RM</given-names></name><name><surname>Wu</surname> <given-names>HC</given-names></name><name><surname>Gambello</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>1252</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp025</pub-id><pub-id pub-id-type="pmid">19150975</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weischenfeldt</surname> <given-names>J</given-names></name><name><surname>Damgaard</surname> <given-names>I</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name><name><surname>Theilgaard-Mönch</surname> <given-names>K</given-names></name><name><surname>Thoren</surname> <given-names>LA</given-names></name><name><surname>Nielsen</surname> <given-names>FC</given-names></name><name><surname>Jacobsen</surname> <given-names>SE</given-names></name><name><surname>Nerlov</surname> <given-names>C</given-names></name><name><surname>Porse</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>1381</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1101/gad.468808</pub-id><pub-id pub-id-type="pmid">18483223</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wey</surname> <given-names>A</given-names></name><name><surname>Martinez Cerdeno</surname> <given-names>V</given-names></name><name><surname>Pleasure</surname> <given-names>D</given-names></name><name><surname>Knoepfler</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>C- and N-myc regulate neural precursor cell fate, cell cycle, and metabolism to direct cerebellar development</article-title><source>The Cerebellum</source><volume>9</volume><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1007/s12311-010-0190-9</pub-id><pub-id pub-id-type="pmid">20658325</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wizeman</surname> <given-names>JW</given-names></name><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Wilion</surname> <given-names>EM</given-names></name><name><surname>Li</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Specification of diverse cell types during early neurogenesis of the mouse cerebellum</article-title><source>eLife</source><volume>8</volume><elocation-id>e42388</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42388</pub-id><pub-id pub-id-type="pmid">30735127</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojcinski</surname> <given-names>A</given-names></name><name><surname>Morabito</surname> <given-names>M</given-names></name><name><surname>Lawton</surname> <given-names>AK</given-names></name><name><surname>Stephen</surname> <given-names>DN</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic deletion of genes in the cerebellar rhombic lip lineage can stimulate compensation through adaptive reprogramming of ventricular zone-derived progenitors</article-title><source>Neural Development</source><volume>14</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s13064-019-0128-y</pub-id><pub-id pub-id-type="pmid">30764875</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname> <given-names>AS</given-names></name><name><surname>Grayhack</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Asc1, homolog of human RACK1, prevents frameshifting in yeast by ribosomes stalled at CGA Codon repeats</article-title><source>RNA</source><volume>21</volume><fpage>935</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1261/rna.049080.114</pub-id><pub-id pub-id-type="pmid">25792604</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Auerbach</surname> <given-names>AB</given-names></name><name><surname>Joyner</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum</article-title><source>Development</source><volume>120</volume><fpage>2065</fpage><lpage>2075</lpage><pub-id pub-id-type="pmid">7925010</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>mTOR and the differentiation of mesenchymal stem cells</article-title><source>Acta Biochimica Et Biophysica Sinica</source><volume>43</volume><fpage>501</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1093/abbs/gmr041</pub-id><pub-id pub-id-type="pmid">21642276</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname> <given-names>R</given-names></name><name><surname>Suzuki</surname> <given-names>Y</given-names></name><name><surname>Takeuchi</surname> <given-names>N</given-names></name><name><surname>Wakaguri</surname> <given-names>H</given-names></name><name><surname>Ueda</surname> <given-names>T</given-names></name><name><surname>Sugano</surname> <given-names>S</given-names></name><name><surname>Nakai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristics</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>3707</fpage><lpage>3715</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn248</pub-id><pub-id pub-id-type="pmid">18480124</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonashiro</surname> <given-names>R</given-names></name><name><surname>Tahara</surname> <given-names>EB</given-names></name><name><surname>Bengtson</surname> <given-names>MH</given-names></name><name><surname>Khokhrina</surname> <given-names>M</given-names></name><name><surname>Lorenz</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>KC</given-names></name><name><surname>Kigoshi-Tansho</surname> <given-names>Y</given-names></name><name><surname>Savas</surname> <given-names>JN</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name><name><surname>Kay</surname> <given-names>SA</given-names></name><name><surname>Craig</surname> <given-names>EA</given-names></name><name><surname>Mogk</surname> <given-names>A</given-names></name><name><surname>Bukau</surname> <given-names>B</given-names></name><name><surname>Joazeiro</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Rqc2/Tae2 subunit of the ribosome-associated quality control (RQC) complex marks ribosome-stalled nascent polypeptide chains for aggregation</article-title><source>eLife</source><volume>5</volume><elocation-id>e11794</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11794</pub-id><pub-id pub-id-type="pmid">26943317</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>DJ</given-names></name><name><surname>Guydosh</surname> <given-names>NR</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Hinnebusch</surname> <given-names>AG</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rli1/ABCE1 recycles terminating ribosomes and controls translation reinitiation in 3'UTRs in vivo</article-title><source>Cell</source><volume>162</volume><fpage>872</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.041</pub-id><pub-id pub-id-type="pmid">26276635</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>CH</given-names></name><name><surname>Dang</surname> <given-names>Y</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Zhao</surname> <given-names>F</given-names></name><name><surname>Sachs</surname> <given-names>MS</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Codon usage influences the local rate of translation elongation to regulate co-translational protein folding</article-title><source>Molecular Cell</source><volume>59</volume><fpage>744</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.07.018</pub-id><pub-id pub-id-type="pmid">26321254</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Sloan</surname> <given-names>SA</given-names></name><name><surname>Bennett</surname> <given-names>ML</given-names></name><name><surname>Scholze</surname> <given-names>AR</given-names></name><name><surname>O'Keeffe</surname> <given-names>S</given-names></name><name><surname>Phatnani</surname> <given-names>HP</given-names></name><name><surname>Guarnieri</surname> <given-names>P</given-names></name><name><surname>Caneda</surname> <given-names>C</given-names></name><name><surname>Ruderisch</surname> <given-names>N</given-names></name><name><surname>Deng</surname> <given-names>S</given-names></name><name><surname>Liddelow</surname> <given-names>SA</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Daneman</surname> <given-names>R</given-names></name><name><surname>Maniatis</surname> <given-names>T</given-names></name><name><surname>Barres</surname> <given-names>BA</given-names></name><name><surname>Wu</surname> <given-names>JQ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>11929</fpage><lpage>11947</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1860-14.2014</pub-id><pub-id pub-id-type="pmid">25186741</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66904.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Hatten</surname><given-names>Mary E</given-names></name><role>Reviewing Editor</role><aff><institution>The Rockefeller University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Hatten</surname><given-names>Mary E</given-names></name><role>Reviewer</role><aff><institution>The Rockefeller University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This work addresses the role of translation-dependent quality control pathways in mouse neuronal development. Not only are the ribosome rescue factors Pelo and Hbs1l shown to be required for early embryonic development and for neurogenesis in the developing cerebellum, but the detailed underlying molecular defects in translation elongation are also characterized. In addition, it is shown that inactivation of the nonsense mediated decay factor Upf2 has similar effects on cell cycle exit and cell death of granule cell progenitors as Pelo has. The study is carried out extremely well, demonstrating the importance of translation-dependent quality control, a fundamental cellular process, during neuronal development.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Defects in translation-dependent quality control pathways lead to convergent molecular and neurodevelopmental pathology&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, including Mary E Hatten as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Huda Zoghbi as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>1) Please consider the queries from Reviewer 1, especially the request to describe the different translation-dependent quality control pathways, and explain the function and interactions between Pelo and Hbs1l, to make the manuscript more easily readable for a reader who is not an expert on the field. and make any necessary changes.</p><p>2) Please consider the suggested organizational changes from Reviewer 2 and make revisions you deem necessary.</p><p><italic>Reviewer #1:</italic></p><p>The study by Terrey et al. addresses a fundamental question, the consequences of defects in translation and translation-dependent quality control pathways, and shows that the NGD/NSD factors Pelo and Hbs1l are critical for cerebellar neurogenesis but expendable for survival of these neurons after development. This is a strong paper using mouse genetics and molecular biology to demonstrate an important, novel control mechanism for CNS neurogenesis and circuit function, using the cerebellum as a model. The study is important for a number of neurological disorders.</p><p>1. In the introduction, the authors should describe the different translation-dependent quality control pathways, and explain the function and interactions between Pelo and Hbs1l, to make the manuscript more easily readable for a reader who is not an expert on the field.</p><p>2. Please explain upstream regulator analysis briefly.</p><p>3. Some of the figures (e.g., Figure 2 - supplement 1: D, L and N) would benefit from an adjustment of y-axis limits to evaluate the differences between groups.</p><p>4. While this may be beyond the scope of this study (and possibly technically challenging), it would be interesting to perform ribosome profiling specifically in purified granule cells in En1-Cre, PelocKO mice at P0 or Math1-Cre; PelocKO mice around P6-P7 to further dissect the mechanisms by which translation-dependent quality control pathways regulate cell cycle exit of neuronal progenitors during neurogenesis.</p><p><italic>Reviewer #2:</italic></p><p>The authors first demonstrate that the ribosome rescue factors Pelo and Hbs1l are critical for embryonic and brain development. They then study mouse embryonic fibroblasts (MEFs) with deficiency of Pelo or Hbs1l and show that Loss either gene induces defects in translation elongation. Similar effects were observed when they conditionally deleted the core nonsense-mediated decay component, Upf2. Impairment of these translation-dependent quality control pathways all lead to mTORC1 activation, possibly as a compensatory response.</p><p>The data in MEFs show that Pelo and Upf2 cause a greater degree of ribosomal pausing compared to Hbs1l, but interestingly, when looking at translation efficiency, there appears to be compensatory changes in ribosomal binding and pausing does not seem to be the main driver of TE. There is data throughout the manuscript looking at genes whose changes in TE are primarily driven by the transcript level changes, in comparison to genes whose changes in TE are primarily driven by changes in ribosomal binding. It would be particularly interesting to interpret the authors 'findings regarding upstream regulators in light of these data. For example, transcription factors and regulators would be more relevant in the first group, whereas other signaling and cellular pathways might be interesting in the second group.</p><p>The degree of similarity between changes in ribosomal binding in Upf2 and Pelo mutants is striking, and future work might address the similarity between Upf2 and Hbsl1, and whether Upf2 expression is affected in Pelo and Hbs1l mutants, because of the finding that Pelo and Hbs1l interact at the post-transcriptional level.</p><p>The finding that deletion of each gene leads to mTORC1 activation is interesting. In future work, it will be interesting to look at the transcript and ribosomal binding levels of mTOR pathway genes to understand whether this effect is primarily driven by dysregulation at the transcriptional/translational level or whether it is due to alterations in cellular pathways such as stress response. The mTORC1 finding deserves to be emphasized in the manuscript because it represents the best hypothesis for a mechanism underlying the observed effects, as other potential explanations, such as ribosomal pausing, NMD, etc., seem to be less consistent with the observations.</p><p>The finding that all three genes impair cerebellar development in a roughly similar manner through alteration in progenitor proliferation and differentiation is interesting. It is also striking that mTORC1 activity as measured by phosphorylated S6 is increased in the Pelo and Upf2 conditional knockouts. This represents a potential part of mechanism underlying the cerebellar defects, and this would deserve to be featured in the main figures. In future work, the same pS6 analysis could be performed for the Hbs1l condition knockouts, to determine whether the three genes are similar in this regard as well.</p><p>I found the organization of the manuscript to be somewhat confusing and worry that it obscures some of the main points of the study. I wonder if the authors would consider starting with the inducible deletion of Hbs1l, Pelo, and Upf2 in MEFs.</p><p>It was unclear to me why the authors chose to perform ribosomal profiling from the cerebellum in the Atoh1-Cre conditional line as there was no overt phenotype in this line.</p><p>There is also a great deal of other data that is present in this paper. For example, the Hbs1l gene trap, the embryonic lethality of Hbs1l deletion, and location of ribosomal footprints within the gene. However, several of the aspects, while interesting, do not appear to serve to support the main points of the paper. Therefore, the authors could consider de-emphasizing these aspects and limiting the space in both the text and figures devoted to these findings, in order to keep the focus on their main findings.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66904.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>The study by Terrey et al. addresses a fundamental question, the consequences of defects in translation and translation-dependent quality control pathways, and shows that the NGD/NSD factors Pelo and Hbs1l are critical for cerebellar neurogenesis but expendable for survival of these neurons after development. This is a strong paper using mouse genetics and molecular biology to demonstrate an important, novel control mechanism for CNS neurogenesis and circuit function, using the cerebellum as a model. The study is important for a number of neurological disorders.</p><p>1. In the introduction, the authors should describe the different translation-dependent quality control pathways, and explain the function and interactions between Pelo and Hbs1l, to make the manuscript more easily readable for a reader who is not an expert on the field.</p></disp-quote><p>We have included additional information about these translation-dependent quality control pathways in the introduction.</p><disp-quote content-type="editor-comment"><p>2. Please explain upstream regulator analysis briefly.</p></disp-quote><p>The upstream regulator analysis tries to predict/identify potential upstream transcriptional regulators that may explain the observed expression changes. We have now included an explanation of this analysis in the manuscript.</p><disp-quote content-type="editor-comment"><p>3. Some of the figures (e.g., Figure 2 - supplement 1: D, L and N) would benefit from an adjustment of y-axis limits to evaluate the differences between groups.</p></disp-quote><p>We have adjusted the y-axis limits on these graphs.</p><disp-quote content-type="editor-comment"><p>4. While this may be beyond the scope of this study (and possibly technically challenging), it would be interesting to perform ribosome profiling specifically in purified granule cells in En1-Cre, PelocKO mice at P0 or Math1-Cre; PelocKO mice around P6-P7 to further dissect the mechanisms by which translation-dependent quality control pathways regulate cell cycle exit of neuronal progenitors during neurogenesis.</p></disp-quote><p>We agree with the reviewer that interrogating the changes in elongation/translation as cell lineages become committed would be interesting. We initially considered analyzing granule cell precursors in Atoh (Math1)-<italic>Pelo</italic><sup>cKO</sup> mice as these would ultimately have defects in differentiation, but we realized the interpretation of this data would be problematic since differentiation defects were detectable for anterior granule cell precursors, but not for the posterior precursors, and separating these populations is technically challenging. The isolation of granule cell precursors from En1-<italic>Pelo</italic><sup>cKO</sup> is even more challenging given the virtual absence of these cells at birth.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…] I found the organization of the manuscript to be somewhat confusing and worry that it obscures some of the main points of the study. I wonder if the authors would consider starting with the inducible deletion of Hbs1l, Pelo, and Upf2 in MEFs.</p></disp-quote><p>We have seriously considered the reviewer’s suggestion to invert the layout of the Results section of our manuscript. However, after reflection, we still believe that the current structure is the best way to present our experiments. We think that beginning the Results section with the in vivo phenotype of <italic>Hbs1</italic> knockout mice illustrates the importance of <italic>Hbs1l</italic> for embryonic and nervous system development and thus justifies and informs the rest of the experiments in the paper. Furthermore, it is our in vivo ribosome profiling data that allows us to establish that mouse embryonic fibroblasts are a valid in vitro system for studying the function of these quality control pathways, as we observed similar translation defects in vivo and in these cells. The congruence of the <italic>Hbs1l</italic> mutant in vivo and MEF data led us to hypothesize that the similarities in the translation data from <italic>Hbs1l</italic>/<italic>Pelo</italic> and <italic>Upf2</italic> mutant MEFs would be predictive of similar in vivo CNS phenotypes when these distinct pathways were disrupted.</p><disp-quote content-type="editor-comment"><p>It was unclear to me why the authors chose to perform ribosomal profiling from the cerebellum in the Atoh1-Cre conditional line as there was no overt phenotype in this line.</p></disp-quote><p>Our observation that deletion of <italic>Hbs1l</italic> in granule cells did not evoke any cellular defects suggested that either translation defects could be less pronounced in granule cells relative to mutant embryos (which fail to develop) or that mutant granule cells could have similar levels of translation defects as mutant embryos, but are less susceptible to these defects. We performed ribosome footprint profiling on Atoh1-Cre, <italic>Hbs1l</italic><sup>cKO</sup> mice to distinguish between the two possibilities.</p><disp-quote content-type="editor-comment"><p>There is also a great deal of other data that is present in this paper. For example, the Hbs1l gene trap, the embryonic lethality of Hbs1l deletion, and location of ribosomal footprints within the gene. However, several of the aspects, while interesting, do not appear to serve to support the main points of the paper. Therefore, the authors could consider de-emphasizing these aspects and limiting the space in both the text and figures devoted to these findings, in order to keep the focus on their main findings.</p></disp-quote><p>We hope that by providing these data we may help future experimenters and studies, even if these data are not necessarily essential for the main point of our studies. For example, the <italic>Hbs1l</italic> gene trap allele (<italic>Hbs1l</italic><sup>tm1a</sup>) has been used in previous studies (Liakath-Ali et al., 2018; O’Connell et al., 2019) and will likely be used in future studies, as it is commercially available. Thus, it is important to point out that even though this allele is intended to function as a null allele, there is still residual <italic>Hbs1l</italic> expression. This clarification is critical to avoid perpetuating potentially false negative data derived from these mice (e.g. the lack of embryonic lethality). In addition, we show that this allele can easily be converted into a complete <italic>knockout</italic> allele allowing experimenters to utilize this allele with its original intention. Our analysis of the <italic>Hbs1l</italic> gene trap allele versus the <italic>Hbs1l</italic> knockout also highlights the incredible sensitivity of mammalian cells to slight differences in the levels of <italic>Hbs1l</italic> transcripts, which cannot be extrapolated from in vitro studies. This information is likely also relevant to analysis of human mutations in various components of translational quality control pathways including <italic>Hbs1l</italic> (O’Connell et al., 2019).</p></body></sub-article></article>